The microbiome in cancer

Abstract

The human microbiome is now recognized as a central regulator of cancer biology, intricately shaping tumor development, immune dynamics, and therapeutic response. This comprehensive review delineates the multifaceted roles of bacteria, viruses, and fungi in modulating the tumor microenvironment and systemic immunity across diverse cancer types. We synthesize current evidence on how microbial dysbiosis promotes carcinogenesis via chronic inflammation, metabolic reprogramming, genotoxic stress, immune evasion, and epigenetic remodeling. This review emphasizes organ-specific microbiome signatures and highlights their potential as non-invasive biomarkers for early detection, treatment stratification, and prognosis. Furthermore, we explore the impact of intratumoral microbiota on cancer therapies, uncovering how microbial metabolites and host–microbe interactions shape therapeutic efficacy and resistance. Finally, advances in microbiome-targeted strategies, such as probiotics, fecal microbiota transplantation, and engineered microbes offer new avenues for adjunctive cancer therapy. This review provides a roadmap for future investigation and underscores the transformative promise of microbiome modulation in cancer prevention and treatment.

Keywords

cancer / microbiome / precision oncology / treatment / tumor microenvironment

References

[1] Human Microbiome Project Consortium. 2012. “Structure, Function and Diversity of the Healthy Human Microbiome.” Nature 486: 207-214. https://doi.org/10.1038/nature11234

[2] Kuziel, Gavin A., Seth Rakoff-Nahoum. 2022. “The Gut Microbiome.” Current Biology 32: R257-R264. https://doi.org/10.1016/j.cub.2022.02.023

[3] Virtanen, Seppo, Schahzad Saqib, Tinja Kanerva, Rebecka Ventin-Holmberg, Pekka Nieminen, Tiina Holster, Ilkka Kalliala, Anne Salonen. 2024. “Metagenome-Validated Combined Amplicon Sequencing and Text Mining-Based Annotations for Simultaneous Profiling of Bacteria and Fungi: Vaginal Microbiota and Mycobiota in Healthy Women.” Microbiome 12: 273. https://doi.org/10.1186/s40168-024-01993-9

[4] Avershina, Ekaterina, Arfa Irej Qureshi, Hanne C. Winther-Larsen, Trine B. Rounge. 2025. “Challenges in Capturing the Mycobiome From Shotgun Metagenome Data: Lack of Software and Databases.” Microbiome 13: 66. https://doi.org/10.1186/s40168-025-02048-3

[5] Rooks, Michelle G., Wendy S. Garrett. 2016. “Gut Microbiota, Metabolites and Host Immunity.” Nature Reviews Immunology 16: 341-352. https://doi.org/10.1038/nri.2016.42

[6] Shea, Allyson E., Valerie S. Forsyth, Jolie A. Stocki, Taylor J. Mitchell, Arwen E. Frick-Cheng, Sara N. Smith, Sicily L. Hardy, Harry L. T. Mobley. 2024. “Emerging Roles for ABC Transporters as Virulence Factors in Uropathogenic Escherichia coli.” Proceedings of the National Academy of Sciences of the United States of America 121: e2310693121. https://doi.org/10.1073/pnas.2310693121

[7] Xu, Yi, Xiahui Wu, Yan Li, Xuejie Liu, Lijian Fang, Ziyu Jiang. 2024. “Probiotics and the Role of Dietary Substrates in Maintaining the Gut Health: Use of Live Microbes and Their Products for Anticancer Effects Against Colorectal Cancer.” Journal of Microbiology and Biotechnology 34: 1933-1946. https://doi.org/10.4014/jmb.2403.03056

[8] Montassier, Emmanuel, Rafael Valdés-Mas, Eric Batard, Niv Zmora, Mally Dori-Bachash, Jotham Suez, Eran Elinav. 2021. “Probiotics Impact the Antibiotic Resistance Gene Reservoir Along the Human GI Tract in a Person-Specific and Antibiotic-Dependent Manner.” Nature Microbiology 6: 1043-1054. https://doi.org/10.1038/s41564-021-00920-0

[9] Bajaj, Jasmohan S., Siew C. Ng, Bernd Schnabl. 2022. “Promises of Microbiome-Based Therapies.” Journal of Hepatology 76: 1379-1391. https://doi.org/10.1016/j.jhep.2021.12.003

[10] Serrano-Del Valle, Alfonso, Javier Naval, Alberto Anel, Isabel Marzo. 2020. “Novel Forms of Immunomodulation for Cancer Therapy.” Trends in Cancer 6: 518-532. https://doi.org/10.1016/j.trecan.2020.02.015

[11] Negrón-Figueroa, Dalissa, Lauren E. Colbert. 2024. “Mechanisms by Which the Intratumoral Microbiome May Potentiate Immunotherapy Response.” Journal of Clinical Oncology 42: 3350-3352. https://doi.org/10.1200/JCO.24.00908

[12] Dzutsev, Amiran K., Romina S. Goldszmid. 2024. “Towards Enhancing the Predictive Value of the Microbiota for Cancer Immunotherapy.” Trends in Cancer 10: 771-773. https://doi.org/10.1016/j.trecan.2024.07.007

[13] Peppercorn, MARK A., PETER Goldman. 1972. “The Role of Intestinal Bacteria in the Metabolism of Salicylazosulfapyridine.” The Journal of Pharmacology and Experimental Therapeutics 181: 555-562, https://doi.org/10.1016/S0022-3565(25)29238-2

[14] Ley, Ruth E., Peter J. Turnbaugh, Samuel Klein, Jeffrey I. Gordon. 2006. “Human Gut Microbes Associated With Obesity.” Nature 444: 1022-1023. https://doi.org/10.1038/4441022a

[15] Qin, Youwen, Aki S. Havulinna, Yang Liu, Pekka Jousilahti, Scott C. Ritchie, Alex Tokolyi, Jon G. Sanders, et al.2022. “Combined Effects of Host Genetics and Diet on Human Gut Microbiota and Incident Disease in a Single Population Cohort.” Nature Genetics 54: 134-142. https://doi.org/10.1038/s41588-021-00991-z

[16] Nakatsu, Geicho, Natalia Andreeva, Meghan H. MacDonald, Wendy S. Garrett. 2024. “Interactions Between Diet and Gut Microbiota in Cancer.” Nature Microbiology 9: 1644-1654. https://doi.org/10.1038/s41564-024-01736-4

[17] Lei, Chao, Cong Liu, Yuling Peng, Yu Zhan, Xiaoming Zhang, Ting Liu, Zhihua Liu. 2023. “A High-Salt Diet Induces Synaptic Loss and Memory Impairment via Gut Microbiota and Butyrate in Mice.” iMeta 2: e97. https://doi.org/10.1002/imt2.97

[18] Huang, Yina, Jinxin Liu, Hein Min Tun, Catherine Stanton, Tingtao Chen, Hani El-Nezami, Hua Wei, Mingfu Wang, Qinglong Wu. 2022. “Gut Microbiota Insights Into Human Adaption to High-Plateau Diet.” iMeta 1: e6. https://doi.org/10.1002/imt2.6

[19] Dapa, Tanja, Ricardo Serotte Ramiro, Miguel Filipe Pedro, Isabel Gordo, Karina Bivar Xavier. 2022. “Diet Leaves a Genetic Signature in a Keystone Member of the Gut Microbiota.” Cell Host & Microbe 30: 183-199.e10. https://doi.org/10.1016/j.chom.2022.01.002

[20] NIH HMP Working Group, Jane Peterson, Garges, Susan, Maria Giovanni, Pamela McInnes, Lu Wang, Schloss, Jeffery A., Vivien Bonazzi, McEwen Jean E., et al. 2009. “The NIH Human Microbiome Project.” Genome Research 19: 2317-2323. https://doi.org/10.1101/gr.096651.109

[21] Qin, Junjie, Ruiqiang Li, Jeroen Raes, Manimozhiyan Arumugam, Kristoffer Solvsten Burgdorf, Chaysavanh Manichanh, Trine Nielsen, et al. 2010. “A Human Gut Microbial Gene Catalogue Established by Metagenomic Sequencing.” Nature 464: 59-65. https://doi.org/10.1038/nature08821

[22] Yatsunenko, Tanya, Federico E. Rey, Mark J. Manary, Indi Trehan, Maria Gloria Dominguez-Bello, Monica Contreras, Magda Magris, et al. 2012. “Human Gut Microbiome Viewed Across Age and Geography.” Nature 486: 222-227. https://doi.org/10.1038/nature11053

[23] McDonald, Daniel, Embriette Hyde, Justine W. Debelius, James T. Morton, Antonio Gonzalez, Gail Ackermann, Alexander A. Aksenov, et al. 2018. “American Gut: An Open Platform for Citizen Science Microbiome Research.” mSystems 3: e00031-18. https://doi.org/10.1128/mSystems.00031-18

[24] Routy, Bertrand, Emmanuelle Le Chatelier, Lisa Derosa, Connie P. M. Duong, Maryam Tidjani Alou, Romain Daillère, Aurélie Fluckiger, et al. 2018. “Gut Microbiome Influences Efficacy of PD-1-Based Immunotherapy Against Epithelial Tumors.” Science 359: 91-97. https://doi.org/10.1126/science.aan3706

[25] Gagliani, Nicola, Bo Hu, Samuel Huber, Eran Elinav, Richard A. Flavell. 2014. “The Fire Within: Microbes Inflame Tumors.” Cell 157: 776-783. https://doi.org/10.1016/j.cell.2014.03.006

[26] Nejman, Deborah, Ilana Livyatan, Garold Fuks, Nancy Gavert, Yaara Zwang, Leore T. Geller, Aviva Rotter-Maskowitz, et al. 2020. “The Human Tumor Microbiome Is Composed of Tumor Type-Specific Intracellular Bacteria.” Science 368: 973-980. https://doi.org/10.1126/science.aay9189

[27] Cogdill, Alexandria P., Pierre Olivier Gaudreau, Reetakshi Arora, Vancheswaran Gopalakrishnan, Jennifer A. Wargo. 2018. “The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.” Trends in Immunology 39: 900-920. https://doi.org/10.1016/j.it.2018.09.007

[28] Wong-Rolle, Abigail, Haohan Karen Wei, Chen Zhao, Chengcheng Jin. 2021. “Unexpected Guests in the Tumor Microenvironment: Microbiome in Cancer.” Protein & Cell 12: 426-435. https://doi.org/10.1007/s13238-020-00813-8

[29] Xie, Yifan, Feng Xie, Xiaoxue Zhou, Lei Zhang, Bing Yang, Jun Huang, Fangwei Wang, et al. 2022. “Microbiota in Tumors: From Understanding to Application.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 9: e2200470. https://doi.org/10.1002/advs.202200470

[30] Schwabe, Robert F., Christian Jobin. 2013. “The Microbiome and Cancer.” Nature Reviews Cancer 13: 800-812. https://doi.org/10.1038/nrc3610

[31] Castanheira, Cristina Paula, Mayara Luciana Sallas, Rafaella Almeida Lima Nunes, Noely Paula Cristina Lorenzi, Lara Termini. 2021. “Microbiome and Cervical Cancer.” Pathobiology 88: 187-197. https://doi.org/10.1159/000511477

[32] Cao, Yaqi, Hui Xia, Xueyun Tan, Chunwei Shi, Yanling Ma, Daquan Meng, Mengmeng Zhou, et al. 2024. “Intratumoural Microbiota: A New Frontier in Cancer Development and Therapy.” Signal Transduction and Targeted Therapy 9: 15. https://doi.org/10.1038/s41392-023-01693-0

[33] Scott, Alasdair J., James L. Alexander, Claire A. Merrifield, David Cunningham, Christian Jobin, Robert Brown, John Alverdy, et al. 2019. “International Cancer Microbiome Consortium Consensus Statement on the Role of the Human Microbiome in Carcinogenesis.” Gut 68: 1624-1632. https://doi.org/10.1136/gutjnl-2019-318556

[34] Zhao, Lin-Yong, Jia-Xin Mei, Gang Yu, Lei Lei, Wei-Han Zhang, Kai Liu, Xiao-Long Chen, et al. 2023. “Role of the Gut Microbiota in Anticancer Therapy: From Molecular Mechanisms to Clinical Applications.” Signal Transduction and Targeted Therapy 8: 201. https://doi.org/10.1038/s41392-023-01406-7

[35] Yang, Li, Aitian Li, Ying Wang, Yi Zhang. 2023. “Intratumoral Microbiota: Roles in Cancer Initiation, Development and Therapeutic Efficacy.” Signal Transduction and Targeted Therapy 8: 35. https://doi.org/10.1038/s41392-022-01304-4

[36] Mou, Weiming, Zhixing Deng, Lingxuan Zhu, Aimin Jiang, Anqi Lin, Liling Xu, Gengwen Deng, et al. 2025 “Intratumoral Mycobiome Heterogeneity Influences the Tumor Microenvironment and Immunotherapy Outcomes in Renal Cell Carcinoma.” Science Advances 11:eadu1727. https://doi.org/10.1126/sciadv.adu1727

[37] Li, Lei, Shouhua He, Boyi Liao, Manchun Wang, Huimin Lin, Ben Hu, Xinyue Lan, et al. 2024. “Orally Administrated Hydrogel Harnessing Intratumoral Microbiome and Microbiota-Related Immune Responses for Potentiated Colorectal Cancer Treatment.” Research (Washington, D.C.) 7: 0364. https://doi.org/10.34133/research.0364

[38] Liu, Weici, Zheshun Pi, Ning-Ning Liu, Wenjun Mao. 2024. “Into the Era of Mycobiome-Driven Cancer Research.” Trends in Cancer 10: 389-392. https://doi.org/10.1016/j.trecan.2024.02.009

[39] Soto, David, Christine Song, Margaret E. McLaughlin-Drubin. 2017. “Epigenetic Alterations in Human Papillomavirus-Associated Cancers.” Viruses 9: 248. https://doi.org/10.3390/v9090248

[40] Amaya Arbeláez, María Isabel, Ana Carolina Alves De Paula E. Silva, Geovana Navegante, Valeria Valente, Paula Aboud Barbugli, Carlos Eduardo Vergani. 2021. “Proto-Oncogenes and Cell Cycle Gene Expression in Normal and Neoplastic Oral Epithelial Cells Stimulated With Soluble Factors From Single and Dual Biofilms of Candida albicans and Staphylococcus aureus.” Frontiers in Cellular and Infection Microbiology 11: 627043. https://doi.org/10.3389/fcimb.2021.627043

[41] Górska, Agata, Dawid Przystupski, Magdalena J. Niemczura, Julita Kulbacka. 2019. “Probiotic Bacteria: A Promising Tool in Cancer Prevention and Therapy.” Current Microbiology 76: 939-949. https://doi.org/10.1007/s00284-019-01679-8

[42] Lili, Zhao, Wei Junyan, Zhao Hongfei, Zhu Baoqing, Zhang Bolin. 2018. “Detoxification of Cancerogenic Compounds by Lactic Acid Bacteria Strains.” Critical Reviews in Food Science and Nutrition 58: 2727-2742. https://doi.org/10.1080/10408398.2017.1339665

[43] Zhong, Mengya, Yubo Xiong, Jiabao Zhao, Zhi Gao, Jingsong Ma, Zhengxin Wu, Yongxi Song, Xuehui Hong. 2021. “Candida albicans Disorder Is Associated With Gastric Carcinogenesis.” Theranostics 11: 4945-4956. https://doi.org/10.7150/thno.55209

[44] Guan, Shi-Wei, Quan Lin, Xi-Dong Wu, Hai-Bo Yu. 2023. “Weighted Gene Coexpression Network Analysis and Machine Learning Reveal Oncogenome Associated Microbiome Plays an Important Role in Tumor Immunity and Prognosis in Pan-Cancer.” Journal of Translational Medicine 21: 537. https://doi.org/10.1186/s12967-023-04411-0

[45] Liu, Le, Liping Liang, YingJie Luo, Jimin Han, Di Lu, RuiJun Cai, Gautam Sethi, Shijie Mai. 2024. “Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma.” Research (Washington, D.C.) 7: 0529. https://doi.org/10.34133/research.0529

[46] Lehouritis, Panos, Joanne Cummins, Michael Stanton, Carola T. Murphy, Florence O. McCarthy, Gregor Reid, Camilla Urbaniak, William L. Byrne, Mark Tangney. 2015. “Local Bacteria Affect the Efficacy of Chemotherapeutic Drugs.” Scientific Reports 5: 14554. https://doi.org/10.1038/srep14554

[47] Badgeley, Aja, Hina Anwar, Karan Modi, Paige Murphy, Ashakumary Lakshmikuttyamma. 2021. “Effect of Probiotics and Gut Microbiota on Anti-Cancer Drugs: Mechanistic Perspectives.” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer 1875: 188494. https://doi.org/10.1016/j.bbcan.2020.188494

[48] Zhu, Zemin, Bo Yi, Zikai Tang, Xun Chen, Ming Li, Tao Xu, Zhijian Zhao, Caixi Tang. 2023. “Lactobacillus casei Combined With Lactobacillus Reuteri Alleviate Pancreatic Cancer by Inhibiting TLR4 to Promote Macrophage M1 Polarization and Regulate Gut Microbial Homeostasis.” BMC Cancer 23: 1044. https://doi.org/10.1186/s12885-023-11557-z

[49] Khoruts, Alexander, Christopher Staley, Michael J. Sadowsky. 2021. “Faecal Microbiota Transplantation for Clostridioides difficile: Mechanisms and Pharmacology.” Nature Reviews Gastroenterology & Hepatology 18: 67-80. https://doi.org/10.1038/s41575-020-0350-4

[50] Dai, Jia-Hao, Xi-Rong Tan, Han Qiao, Na Liu. 2024. “Emerging Clinical Relevance of Microbiome in Cancer: Promising Biomarkers and Therapeutic Targets.” Protein & Cell 15: 239-260. https://doi.org/10.1093/procel/pwad052

[51] Ting, Nick Lung-Ngai, Harry Cheuk-Hay Lau, Jun Yu. 2022. “Cancer Pharmacomicrobiomics: Targeting Microbiota to Optimise Cancer Therapy Outcomes.” Gut 71: 1412-1425. https://doi.org/10.1136/gutjnl-2021-326264

[52] Matson, Vyara, Carolina Soto Chervin, Thomas F. Gajewski. 2021. “Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.” Gastroenterology 160: 600-613. https://doi.org/10.1053/j.gastro.2020.11.041

[53] Lee, Mong-Hong. 2021. “Harness the Functions of Gut Microbiome in Tumorigenesis for Cancer Treatment.” Cancer Communications 41: 937-967. https://doi.org/10.1002/cac2.12200

[54] Queen, Jessica, Fyza Shaikh, Cynthia L. Sears. 2023. “Understanding the Mechanisms and Translational Implications of the Microbiome for Cancer Therapy Innovation.” Nature Cancer 4: 1083-1094. https://doi.org/10.1038/s43018-023-00602-2

[55] Park, Elizabeth M., Manoj Chelvanambi, Neal Bhutiani, Guido Kroemer, Laurence Zitvogel, Jennifer A. Wargo. 2022. “Targeting the Gut and Tumor Microbiota in Cancer.” Nature Medicine 28: 690-703. https://doi.org/10.1038/s41591-022-01779-2

[56] Lou, Xinyu, Zhichao Chen, Zhonggui He, Mengchi Sun, Jin Sun. 2021. “Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope.” Nano-Micro Letters 13: 37. https://doi.org/10.1007/s40820-020-00560-9

[57] Glitza, Isabella C., Yongwoo David Seo, Christine N. Spencer, Jennifer R. Wortman, Elizabeth M. Burton, Farah A. Alayli, Christopher P. Loo, et al. 2024. “Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity.” Cancer Discovery 14: 1161-1175. https://doi.org/10.1158/2159-8290.CD-24-0066

[58] Fernandes, Miriam R., Poonam Aggarwal, Raquel G. F. Costa, Alicia M. Cole, Giorgio Trinchieri. 2022. “Targeting the Gut Microbiota for Cancer Therapy.” Nature Reviews Cancer 22: 703-722. https://doi.org/10.1038/s41568-022-00513-x

[59] Bhatt, Aadra P., Matthew R. Redinbo, Scott J. Bultman. 2017. “The Role of the Microbiome in Cancer Development and Therapy.” CA: A Cancer Journal for Clinicians 67: 326-344. https://doi.org/10.3322/caac.21398

[60] Zhang, Xiang, Olabisi Oluwabukola Coker, Eagle Sh Chu, Kaili Fu, Harry C. H. Lau, Yi-Xiang Wang, Anthony W. H. Chan, et al. 2021. “Dietary Cholesterol Drives Fatty Liver-Associated Liver Cancer by Modulating Gut Microbiota and Metabolites.” Gut 70: 761-774. https://doi.org/10.1136/gutjnl-2019-319664

[61] Wong, Sunny H., Jun Yu. 2019. “Gut Microbiota in Colorectal Cancer: Mechanisms of Action and Clinical Applications.” Nature Reviews Gastroenterology & Hepatology 16: 690-704. https://doi.org/10.1038/s41575-019-0209-8

[62] Ohtani, Naoko, Eiji Hara. 2021. “Gut-Liver Axis-Mediated Mechanism of Liver Cancer: A Special Focus on the Role of Gut Microbiota.” Cancer Science 112: 4433-4443. https://doi.org/10.1111/cas.15142

[63] Cheng, Wing YinWu, Chun-YingYu, Jun. 2020. “The Role of Gut Microbiota in Cancer Treatment: Friend or Foe?” Gut 69: 1867-1876. https://doi.org/10.1136/gutjnl-2020-321153

[64] Cullin, Nyssa, Camila Azevedo Antunes, Ravid Straussman, Christoph?K. Stein-Thoeringer, Eran Elinav. 2021. “Microbiome and Cancer.” Cancer Cell 39: 1317-1341. https://doi.org/10.1016/j.ccell.2021.08.006

[65] Zaidi, Ali H., Lori A. Kelly, Rachael E. Kreft, Mark Barlek, Ashten N. Omstead, Daisuke Matsui, Natalie H. Boyd, et al. 2016. “Associations of Microbiota and Toll-Like Receptor Signaling Pathway in Esophageal Adenocarcinoma.” BMC Cancer 16: 52. https://doi.org/10.1186/s12885-016-2093-8

[66] Xue, Xiaoyu, Rui Li, Zhenni Chen, Guiyu Li, Bisheng Liu, Shanshan Guo, Qianhua Yue, et al. 2023. “The Role of the Symbiotic Microecosystem in Cancer: Gut Microbiota, Metabolome, and Host Immunome.” Frontiers in Immunology 14: 1235827. https://doi.org/10.3389/fimmu.2023.1235827

[67] Jia, Xiaodong, Shanshan Lu, Zhen Zeng, Qingyan Liu, Zheng Dong, Chen, YanZhu, Zhenyu, et al. 2020. “Characterization of Gut Microbiota, Bile Acid Metabolism, and Cytokines in Intrahepatic Cholangiocarcinoma.” Hepatology 71: 893-906. https://doi.org/10.1002/hep.30852

[68] Rubenstein, Joel H., John M. Inadomi, James Scheiman, Philip Schoenfeld, Henry Appelman, Min Zhang, Val Metko, John Y. Kao. 2014. “Association Between Helicobacter Pylori and Barrett's Esophagus, Erosive Esophagitis, and Gastroesophageal Reflux Symptoms.” Clinical Gastroenterology and Hepatology 12: 239-245. https://doi.org/10.1016/j.cgh.2013.08.029

[69] Pei, Jiaxin, Chaoxu Zhang, Qian Zhang, Hao Yu, Huiya Yuan, Yufu Guo, Hui Shen, et al. 2024. “Probiotics Alleviate Chronic Ethanol Exposure-Induced Anxiety-Like Behavior and Hippocampal Neuroinflammation in Male Mice Through Gut Microbiota-Derived Extracellular Vesicles.” Journal of Nanobiotechnology 22: 730. https://doi.org/10.1186/s12951-024-03017-y

[70] Lai, Hao, Yunfeng Li, Yafang He, Fangyao Chen, Baibing Mi, Junqi Li, Jiawen Xie, et al. 2023. “Effects of Dietary Fibers or Probiotics on Functional Constipation Symptoms and Roles of Gut Microbiota: A Double-Blinded Randomized Placebo Trial.” Gut Microbes 15: 2197837. https://doi.org/10.1080/19490976.2023.2197837

[71] Khoruts, Alexander, Diane E. Hoffmann, Robert A. Britton. 2020. “Probiotics: Promise, Evidence, and Hope.” Gastroenterology 159: 409-413. https://doi.org/10.1053/j.gastro.2020.05.058

[72] Van Rossum, Thea, Annette Haiß, Rebecca L. Knoll, Janina Marißen, Daniel Podlesny, Julia Pagel, Marina Bleskina, et al. 2024. “Bifidobacterium and Lactobacillus Probiotics and Gut Dysbiosis in Preterm Infants: The PRIMAL Randomized Clinical Trial.” JAMA Pediatrics 178: 985-995. https://doi.org/10.1001/jamapediatrics.2024.2626

[73] Castro-Mejía, Josué L., Sinéad O'Ferrall, Łukasz Krych, Elaine O'Mahony, Hanifa Namusoke, Betty Lanyero, Witold Kot, et al. 2020. “Restitution of Gut Microbiota in Ugandan Children Administered With Probiotics (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12) During Treatment for Severe Acute Malnutrition.” Gut Microbes 11: 855-867. https://doi.org/10.1080/19490976.2020.1712982

[74] Ralser, Anna, Alisa Dietl, Sebastian Jarosch, Veronika Engelsberger, Andreas Wanisch, Klaus Peter Janssen, Moritz Middelhoff, et al. 2023. “Helicobacter pylori Promotes Colorectal Carcinogenesis by Deregulating Intestinal Immunity and Inducing a Mucus-Degrading Microbiota Signature.” Gut 72: 1258-1270. https://doi.org/10.1136/gutjnl-2022-328075

[75] Luo, Shiqi, Jinlong Ru, Mohammadali Khan Mirzaei, Jinling Xue, Xue Peng, Anna Ralser, Joshua Lemuel Hadi, et al. 2024. “Helicobacter pylori Infection Alters Gut Virome by Expanding Temperate Phages Linked to Increased Risk of Colorectal Cancer.” Gut 73: 1592-1595. https://doi.org/10.1136/gutjnl-2023-330362

[76] Butt, Julia, Matthew G. Varga, William J. Blot, Lauren Teras, Kala Visvanathan, Loïc Le Marchand, Christopher Haiman, et al. 2019. “Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States.” Gastroenterology 156: 175-86.e2. https://doi.org/10.1053/j.gastro.2018.09.054

[77] Hansen S., K. K. Melby, S. Aase, E. Jellum, S.E. Vollset 1999. “Helicobacter pylori Infection and Risk of Cardia Cancer and Non-Cardia Gastric Cancer. A Nested Case-Control Study.” Scandinavian Journal of Gastroenterology 34: 353-360. https://doi.org/10.1080/003655299750026353

[78] Wu, Xiao-Wei, Hong-Zan Ji, Miao-Fang Yang, Lin Wu, Fang-Yu Wang. 2015. “Helicobacter pylori Infection and Inflammatory Bowel Disease in Asians: A Meta-Analysis.” World Journal of Gastroenterology 21: 4750-4756. https://doi.org/10.3748/wjg.v21.i15.4750

[79] Gutierrez-Angulo, Melva, Maria de la Luz Ayala-Madrigal, Jose Miguel Moreno-Ortiz, Jorge Peregrina-Sandoval, Fernando Daniel Garcia-Ayala. 2023. “Microbiota Composition and Its Impact on DNA Methylation in Colorectal Cancer.” Frontiers in Genetics 14: 1037406. https://doi.org/10.3389/fgene.2023.1037406

[80] Li, Ting, Zhanyi Zhao, Meichang Peng, Lu Zhang, Cheng Wang, Feiyang Luo, Meiqin Zeng, et al. 2025. “Multi-Omics Analysis Reveals the Interplay Between Intratumoral Bacteria and Glioma.” mSystems 10: e0045724. https://doi.org/10.1128/msystems.00457-24

[81] Gur, Chamutal, Yara Ibrahim, Batya Isaacson, Rachel Yamin, Jawad Abed, Moriya Gamliel, Jonatan Enk, et al. 2015. “Binding of the Fap2 Protein of Fusobacterium nucleatum to Human Inhibitory Receptor TIGIT Protects Tumors From Immune Cell Attack.” Immunity 42: 344-355. https://doi.org/10.1016/j.immuni.2015.01.010

[82] Goodwin, Andrew C., Christina E. Destefano Shields, Shaoguang Wu, David L. Huso, XinQun Wu, Tracy R. Murray-Stewart, Amy Hacker-Prietz, et al. 2011. “Polyamine Catabolism Contributes to Enterotoxigenic Bacteroides fragilis-Induced Colon Tumorigenesis.” Proceedings of the National Academy of Sciences 108: 15354-15359. https://doi.org/10.1073/pnas.1010203108

[83] Cao, Fangfang, Lulu Jin, Yong Gao, Yuan Ding, Hongyang Wen, Zhefeng Qian, Chenyin Zhang, et al. 2023. “Artificial-Enzymes-Armed Bifidobacterium longum Probiotics for Alleviating Intestinal Inflammation and Microbiota Dysbiosis.” Nature Nanotechnology 18: 617-627. https://doi.org/10.1038/s41565-023-01346-x

[84] Spencer, Christine N., Jennifer L. McQuade, Vancheswaran Gopalakrishnan, John A. McCulloch, Marie Vetizou, Alexandria P. Cogdill, Md A. Wadud Khan, et al. 2021. “Dietary Fiber and Probiotics Influence the Gut Microbiome and Melanoma Immunotherapy Response.” Science 374: 1632-1640. https://doi.org/10.1126/science.aaz7015

[85] Zitvogel, Laurence, Lisa Derosa, Guido Kroemer. 2022. “Modulation of Cancer Immunotherapy by Dietary Fibers and Over-the-Counter Probiotics.” Cell Metabolism 34: 350-352. https://doi.org/10.1016/j.cmet.2022.02.004

[86] Sugimura, Naoki, Qing Li, Eagle Siu Hong Chu, Harry Cheuk Hay Lau, Winnie Fong, Weixin Liu, Cong Liang, et al. 2021. “Lactobacillus gallinarum Modulates the Gut Microbiota and Produces Anti-Cancer Metabolites to Protect Against Colorectal Tumourigenesis.” Gut 71: 2011-2021. https://doi.org/10.1136/gutjnl-2020-323951

[87] Nan, Ke, Ziwen Zhong, Ying Yue, Yang Shen, Hao Zhang, Zhiqiang Wang, Kameina Zhuma, et al. 2025. “Fasting-Mimicking Diet-Enriched Bifidobacterium pseudolongum Suppresses Colorectal Cancer by Inducing Memory CD8+ T Cells.” Gut 74: 775-786. https://doi.org/10.1136/gutjnl-2024-333020

[88] Mitra, Anita, Murat Gultekin, Laura Burney Ellis, Nicolò Bizzarri, Sarah Bowden, Nadja Taumberger, Taja Bracic, et al. 2024. “Genital Tract Microbiota Composition Profiles and Use of Prebiotics and Probiotics in Gynaecological Cancer Prevention: Review of the Current Evidence, the European Society of Gynaecological Oncology Prevention Committee Statement.” The Lancet. Microbe 5: e291-e300. https://doi.org/10.1016/S2666-5247(23)00257-4

[89] Yu, Guoqin, Nan Hu, Lemin Wang, Chaoyu Wang, Xiao-You Han, Mike Humphry, Jacques Ravel, et al. 2017. “Gastric Microbiota Features Associated With Cancer Risk Factors and Clinical Outcomes: A Pilot Study in Gastric Cardia Cancer Patients From Shanxi, China.” International Journal of Cancer 141: 45-51. https://doi.org/10.1002/ijc.30700

[90] Huang, Hechen, Zhigang Ren, Xingxing Gao, Xiaoyi Hu, Yuan Zhou, Jianwen Jiang, Haifeng Lu, et al. 2020. “Integrated Analysis of Microbiome and Host Transcriptome Reveals Correlations Between Gut Microbiota and Clinical Outcomes in HBV-Related Hepatocellular Carcinoma.” Genome Medicine 12: 102. https://doi.org/10.1186/s13073-020-00796-5

[91] Liu, Qisha, Fan Li, Yaoyao Zhuang, Jian Xu, Jianwei Wang, Xuhua Mao, Yewei Zhang, Xingyin Liu. 2019. “Alteration in Gut Microbiota Associated With Hepatitis B and Non-Hepatitis Virus Related Hepatocellular Carcinoma.” Gut Pathogens 11, 1: 1. https://doi.org/10.1186/s13099-018-0281-6

[92] Tanoue, Takeshi, Satoru Morita, Damian R. Plichta, Ashwin N. Skelly, Wataru Suda, Yuki Sugiura, Seiko Narushima, et al. 2019. “A Defined Commensal Consortium Elicits CD8 T Cells and Anti-Cancer Immunity.” Nature 565: 600-605. https://doi.org/10.1038/s41586-019-0878-z

[93] Bäumler, Andreas J., Vanessa Sperandio. 2016. “Interactions Between the Microbiota and Pathogenic Bacteria in the Gut.” Nature 535: 85-93. https://doi.org/10.1038/nature18849

[94] Chen, Yongyan, Wenwen Cui, Xiao Li, Huan Yang. 2021. “Interaction Between Commensal Bacteria, Immune Response and the Intestinal Barrier in Inflammatory Bowel Disease.” Frontiers in Immunology 12: 761981. https://doi.org/10.3389/fimmu.2021.761981

[95] Zheng, Yajuan, Zhaoyuan Fang, Yun Xue, Jian Zhang, Junjie Zhu, Renyuan Gao, Shun Yao, et al. 2020. “Specific Gut Microbiome Signature Predicts the Early-Stage Lung Cancer.” Gut Microbes 11: 1030-1042. https://doi.org/10.1080/19490976.2020.1737487

[96] Hu, Shixian, Arno R. Bourgonje, Ranko Gacesa, Bernadien H. Jansen, Johannes R. Björk, Amber Bangma, Iwan J. Hidding, et al. 2024. “Mucosal Host-Microbe Interactions Associate With Clinical Phenotypes in Inflammatory Bowel Disease.” Nature Communications 15: 1470. https://doi.org/10.1038/s41467-024-45855-2

[97] Grasberger, Helmut, Andrew T. Magis, Elisa Sheng, Matthew P. Conomos, Min Zhang, Lea S. Garzotto, Guoqing Hou, et al. 2021. “DUOX2 Variants Associate With Preclinical Disturbances in Microbiota-Immune Homeostasis and Increased Inflammatory Bowel Disease Risk.” The Journal of Clinical Investigation 131: e141676. https://doi.org/10.1172/JCI141676

[98] Bishehsari, Faraz, Robin M. Voigt, Ali Keshavarzian. 2020. “Circadian Rhythms and the Gut Microbiota: From the Metabolic Syndrome to Cancer.” Nature Reviews Endocrinology 16: 731-739. https://doi.org/10.1038/s41574-020-00427-4

[99] Smith, Alexander B., Matthew L., JeniorL. Jenior, Orlaith Keenan, Jessica L. Hart, Jonathan Specker, Arwa Abbas, Paula C. Rangel, et al. 2022. “Enterococci Enhance Clostridioides difficile Pathogenesis.” Nature 611: 780-786. https://doi.org/10.1038/s41586-022-05438-x

[100] Leimbach, Andreas, Jörg Hacker, Ulrich Dobrindt. 2013. “E.?coli as an All-Rounder: The Thin Line Between Commensalism and Pathogenicity.” Current Topics in Microbiology and Immunology 358: 3-32. https://doi.org/10.1007/82_2012_303

[101] Vogt, Stefanie L., Antonio Serapio-Palacios, Sarah E. Woodward, Andrew S. Santos, Stefan P. W. De Vries, Michelle C. Daigneault, Lisa V. Brandmeier, et al. 2023. “Enterohemorrhagic Escherichia coli Responds to Gut Microbiota Metabolites by Altering Metabolism and Activating Stress Responses.” Gut Microbes 15: 2190303. https://doi.org/10.1080/19490976.2023.2190303

[102] Scott, Timothy A., Kate S. Baker, Caroline Trotter, Claire Jenkins, Serge Mostowy, Jane Hawkey, Hayden Schmidt, et al. 2024. “Shigella sonnei: Epidemiology, Evolution, Pathogenesis, Resistance and Host Interactions.” Nature Reviews Microbiology 23: 303-317 https://doi.org/10.1038/s41579-024-01126-x

[103] Rao, Krishna, Preeti N. Malani. 2020. “Diagnosis and Treatment of Clostridioides (Clostridium) difficile Infection in Adults in 2020.” JAMA 323: 1403-1404. https://doi.org/10.1001/jama.2019.3849

[104] Lin, Liyuan, Yahui Du, Jia Song, Wei Wang, Chaoyong Yang. 2021. “Imaging Commensal Microbiota and Pathogenic Bacteria in the Gut.” Accounts of Chemical Research 54: 2076-2087. https://doi.org/10.1021/acs.accounts.1c00068

[105] Kong, Cheng, Lei Liang, Guang Liu, Lutao Du, Yongzhi Yang, Jianqiang Liu, Debing Shi, Xinxiang Li, Yanlei Ma. 2023. “Integrated Metagenomic and Metabolomic Analysis Reveals Distinct Gut-Microbiome-Derived Phenotypes in Early-Onset Colorectal Cancer.” Gut 72: 1129-1142. https://doi.org/10.1136/gutjnl-2022-327156

[106] Warren, René L., Douglas J. Freeman, Stephen Pleasance, Peter Watson, Richard A. Moore, Kyla Cochrane, Emma Allen-Vercoe, Robert A. Holt. 2013. “Co-Occurrence of Anaerobic Bacteria in Colorectal Carcinomas.” Microbiome 1: 16. https://doi.org/10.1186/2049-2618-1-16

[107] Wu, Na, Xi Yang, Ruifen Zhang, Jun Li, Xue Xiao, Yongfei Hu, Yanfei Chen, et al. 2013. “Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients.” Microbial Ecology 66: 462-470. https://doi.org/10.1007/s00248-013-0245-9

[108] Avilés-Jiménez, F., A. Guitron, F. Segura-López, A. Méndez-Tenorio, S. Iwai, A. Hernández-Guerrero, J. Torres. 2016. “Microbiota Studies in the Bile Duct Strongly Suggest a Role for Helicobacter pylori in Extrahepatic Cholangiocarcinoma.” Clinical Microbiology and Infection 22: 178.e11-178.e22. https://doi.org/10.1016/j.cmi.2015.10.008

[109] Nagaraja, V., G. D. Eslick. 2014. “Systematic Review With Meta-Analysis: The Relationship Between Chronic Salmonella Typhi Carrier Status and Gall-Bladder Cancer.” Alimentary Pharmacology & Therapeutics 39: 745-750. https://doi.org/10.1111/apt.12655

[110] Pushalkar, Smruti, Mautin Hundeyin, Donnele Daley, Constantinos P. Zambirinis, Emma Kurz, Ankita Mishra, Navyatha Mohan, et al. 2018. “The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression.” Cancer Discovery 8: 403-416. https://doi.org/10.1158/2159-8290.CD-17-1134

[111] Ma, Ji, Lingqi Sun, Ying Liu, Hui Ren, Yali Shen, Feng Bi, Tao Zhang, Xin Wang. 2020. “Alter Between Gut Bacteria and Blood Metabolites and the Anti-Tumor Effects of Faecalibacterium prausnitzii in Breast Cancer.” BMC Microbiology 20: 82. https://doi.org/10.1186/s12866-020-01739-1

[112] He, Chuan, Yue Liu, Shandong Ye, Shiwu Yin, Junfei Gu. 2021. “Changes of Intestinal Microflora of Breast Cancer in Premenopausal Women.” European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 40: 503-513. https://doi.org/10.1007/s10096-020-04036-x

[113] Plottel, Claudia S., Martin J. Blaser. 2011. “Microbiome and Malignancy.” Cell Host & Microbe 10: 324-335. https://doi.org/10.1016/j.chom.2011.10.003

[114] Rea, Domenica, Giovanni Coppola, Giuseppe Palma, Antonio Barbieri, Antonio Luciano, Paola Del Prete, Sabrina Rossetti, et al. 2018. “Microbiota Effects on Cancer: From Risks to Therapies.” Oncotarget 9: 17915-17927. https://doi.org/10.18632/oncotarget.24681

[115] Lu, Xingbing, Li Xiong, Xi Zheng, Qiuju Yu, Yuling Xiao, Yi Xie. 2023. “Structure of Gut Microbiota and Characteristics of Fecal Metabolites in Patients With Lung Cancer.” Frontiers in Cellular and Infection Microbiology 13: 1170326. https://doi.org/10.3389/fcimb.2023.1170326

[116] Wei, Zixin, Biying Yang, Tiantian Tang, Zijing Xiao, Fengzhan Ye, Xiaoyu Li, Shangbin Wu, Jin-gang Huang, Shanping Jiang. 2023. “Gut Microbiota and Risk of Five Common Cancers: A Univariable and Multivariable Mendelian Randomization Study.” Cancer Medicine 12: 10393-10405. https://doi.org/10.1002/cam4.5772

[117] Ajani, Jaffer A., Jeeyun Lee, Takeshi Sano, Yelena Y. Janjigian, Daiming Fan, Shumei Song. 2017. “Gastric Adenocarcinoma.” Nature Reviews Disease Primers 3: 17036. https://doi.org/10.1038/nrdp.2017.36

[118] Zhao, Ya-Shuang, Fan Wang, Dong Chang, Bing Han, Ding-Yun You. 2008. “Meta-analysis of Different Test Indicators: Helicobacter pylori Infection and the Risk of Colorectal Cancer.” International Journal of Colorectal Disease 23: 875-882. https://doi.org/10.1007/s00384-008-0479-z

[119] Ertz-Archambault, Natalie, Paul Keim, Daniel Von Hoff. 2017. “Microbiome and Pancreatic Cancer: A Comprehensive Topic Review of Literature.” World Journal of Gastroenterology 23: 1899-1908. https://doi.org/10.3748/wjg.v23.i10.1899

[120] Kim, Tae JunKim, Eun RanChang, Dong KyungKim, Young-HoBaek, Sun-YoungKim, KyungaHong, Sung Noh. 2017. “Helicobacter pylori Infection Is an Independent Risk Factor of Early and Advanced Colorectal Neoplasm.” Helicobacter 22: elocator. https://doi.org/10.1111/hel.12377

[121] Shah, Shailja C., M. Constanza Camargo, Mark Lamm, Ranier Bustamante, Christianne L. Roumie, Otis Wilson, Alese E. Halvorson, et al. 2024. “Impact of Helicobacter pylori Infection and Treatment on Colorectal Cancer in a Large, Nationwide Cohort.” Journal of Clinical Oncology 42: 1881-1889. https://doi.org/10.1200/JCO.23.00703

[122] Krüttgen, Alexander, Hans-Peter Horz, Josefine Weber-Heynemann, Mihael Vucur, Christian Trautwein, Gerhard Haase, Tom Luedde, Christoph Roderburg. 2012. “Study on the Association of Helicobacter Species With Viral Hepatitis-Induced Hepatocellular Carcinoma.” Gut Microbes 3: 228-233. https://doi.org/10.4161/gmic.19922

[123] Rocha, M. 2005. “Association of Helicobacter Species With Hepatitis C Cirrhosis With or Without Hepatocellular Carcinoma.” Gut 54: 396-401. https://doi.org/10.1136/gut.2004.042168

[124] Fox, J. G., Y. Feng, E. J. Theve, A. R. Raczynski, J. L. A. Fiala, A. L. Doernte, M. Williams, et al. 2010. “Gut Microbes Define Liver Cancer Risk in Mice Exposed to Chemical and Viral Transgenic Hepatocarcinogens.” Gut 59: 88-97. https://doi.org/10.1136/gut.2009.183749

[125] Murphy, Gwen, Angelika Michel, Philip R. Taylor, Demetrius Albanes, Stephanie J. Weinstein, Jarmo Virtamo, Dominick Parisi, et al. 2014. “Association of Seropositivity to Helicobacter Species and Biliary Tract Cancer in the ATBC Study.” Hepatology 60: 1963-1971. https://doi.org/10.1002/hep.27193

[126] Segura-López, Fany K., Francisco Avilés-Jiménez, Alfredo Güitrón-Cantú, Hilda A. Valdéz-Salazar, Samuel León-Carballo, Leoncio Guerrero-Pérez, James G. Fox, Javier Torres. 2015. “Infection With Helicobacter bilis but not Helicobacter hepaticus Was Associated With Extrahepatic Cholangiocarcinoma.” Helicobacter 20: 223-230. https://doi.org/10.1111/hel.12195

[127] Shimoyama, Tadashi, Ryoki Takahashi, Daijiro Abe, Ichiro Mizuki, Tetsu Endo, Shinsaku Fukuda. 2010. “Serological Analysis of Helicobacter hepaticus Infection in Patients With Biliary and Pancreatic Diseases.” Journal of Gastroenterology and Hepatology 25Suppl 1: S86-S89. https://doi.org/10.1111/j.1440-1746.2010.06224.x

[128] Sharma, Prateek, Shravani M. Phatak, Prisha Warikoo, Akshita Mathur, Shweta Mahant, Kunal Das, Rajashree Das. 2023. “Crosstalk Between Helicobacter pylori and Gastrointestinal Microbiota in Various Gastroduodenal Diseases—A Systematic Review.” 3 Biotech 13: 303. https://doi.org/10.1007/s13205-023-03734-5

[129] Rokkas, Theodoros, Dimitrios Pistiolas, Panos Sechopoulos, Ioannis Robotis, Georgios Margantinis. 2007. “Relationship Between Helicobacter pylori Infection and Esophageal Neoplasia: A Meta-Analysis.” Clinical Gastroenterology and Hepatology 5: 1413-7.e2.e14172. https://doi.org/10.1016/j.cgh.2007.08.010

[130] Corley, D. A., A. Kubo, T. R. Levin, G. Block, L. Habel, W. Zhao, P. Leighton, et al. 2008. “Helicobacter pylori Infection and the Risk of Barrett's Oesophagus: A Community-Based Study.” Gut 57: 727-733. https://doi.org/10.1136/gut.2007.132068

[131] Castaño-Rodríguez, Natalia, Nadeem O. Kaakoush, Way Seah Lee, Hazel M. Mitchell. 2017. “Dual Role of Helicobacter and Campylobacter Species in IBD: A Systematic Review and Meta-Analysis.” Gut 66: 235-249. https://doi.org/10.1136/gutjnl-2015-310545

[132] Whiteman, David C., Priya Parmar, Paul Fahey, Suzanne P. Moore, Mitchell Stark, Zhen Zhen Zhao, Grant W. Montgomery, et al. 2010. “Association of Helicobacter pylori Infection With Reduced Risk for Esophageal Cancer Is Independent of Environmental and Genetic Modifiers.” Gastroenterology 139: 73-83; quiz e11-12. https://doi.org/10.1053/j.gastro.2010.04.009

[133] Owyang, Stephanie Y., Jay Luther, Christopher C. Owyang, Min Zhang, John Y. Kao. 2012. “Helicobacter pylori DNA's Anti-Inflammatory Effect on Experimental Colitis.” Gut Microbes 3: 168-171. https://doi.org/10.4161/gmic.19181

[134] Luther, J., S. Y. Owyang, T. Takeuchi, T. S. Cole, M. Zhang, M. Liu, J. Erb-Downward, et al. 2011. “Helicobacter pylori DNA Decreases Pro-Inflammatory Cytokine Production by Dendritic Cells and Attenuates Dextran Sodium Sulphate-Induced Colitis.” Gut 60: 1479-1486. https://doi.org/10.1136/gut.2010.220087

[135] McColl, K. E. L., H. Watabe, M. H. Derakhshan. 2008. “Role of Gastric Atrophy in Mediating Negative Association Between Helicobacter pylori Infection and Reflux Oesophagitis, Barrett's Oesophagus and Oesophageal Adenocarcinoma.” Gut 57: 721-723. https://doi.org/10.1136/gut.2007.144774

[136] Anderson, L. A., S. J. Murphy, B. T. Johnston, R. G. P. Watson, H. R. Ferguson, K. B. Bamford, A. Ghazy, et al. 2008. “Relationship Between Helicobacter pylori Infection and Gastric Atrophy and the Stages of the Oesophageal Inflammation, Metaplasia, Adenocarcinoma Sequence: Results From the FINBAR Case-Control Study.” Gut 57: 734-739. https://doi.org/10.1136/gut.2007.132662

[137] Chen, Hui, Chuanli Ren. 2024. “Helicobacter pylori Eradication Treatment Might Help Reduce the Risk of Esophageal Adenocarcinoma.” Gastroenterology 167: 1507-1508. https://doi.org/10.1053/j.gastro.2024.08.043

[138] Wiklund, Anna-Klara, Giola Santoni, Jane Yan, Cecilia Radkiewicz, Shaohua Xie, Helgi Birgisson, Eivind Ness-Jensen, et al. 2024. “Risk of Esophageal Adenocarcinoma After Helicobacter pylori Eradication Treatment in a Population-Based Multinational Cohort Study.” Gastroenterology 167: 485-92.e3. https://doi.org/10.1053/j.gastro.2024.03.016

[139] Zhu, Lei, Xingxing Jian, Bingjing Zhou, Runqiu Liu, Melba Muñoz, Wan Sun, Lu Xie, et al. 2024. “Gut Microbiota Facilitate Chronic Spontaneous Urticaria.” Nature Communications 15: 112. https://doi.org/10.1038/s41467-023-44373-x

[140] Agaronyan, Karen, Lokesh Sharma, Bharat Vaidyanathan, Keith Glenn, Shuang Yu, Charles Annicelli, Talia D. Wiggen, et al. 2022. “Tissue Remodeling by an Opportunistic Pathogen Triggers Allergic Inflammation.” Immunity 55: 895-911.e10. https://doi.org/10.1016/j.immuni.2022.04.001

[141] Yu, Linda Chia-Hui. 2018. “Microbiota Dysbiosis and Barrier Dysfunction in Inflammatory Bowel Disease and Colorectal Cancers: Exploring a Common Ground Hypothesis.” Journal of Biomedical Science 25: 79. https://doi.org/10.1186/s12929-018-0483-8

[142] Schwabe, Robert F., Tim F. Greten. 2020. “Gut Microbiome in HCC—Mechanisms, Diagnosis and Therapy.” Journal of Hepatology 72: 230-238. https://doi.org/10.1016/j.jhep.2019.08.016

[143] Wu, Juan, Cong Zhang, Shuo Xu, Chunjie Xiang, Ruiping Wang, Dongqing Yang, Lu, Bin, et al. 2020. “Fecal Microbiome Alteration May Be a Potential Marker for Gastric Cancer.” Disease Markers 2020: 3461315. https://doi.org/10.1155/2020/3461315

[144] Boleij, Annemarie, Elizabeth M. Hechenbleikner, Andrew C. Goodwin, Ruchi Badani, Ellen M. Stein, Mark G. Lazarev, Brandon Ellis, et al. 2015. “The Bacteroides Fragilis Toxin Gene Is Prevalent in the Colon Mucosa of Colorectal Cancer Patients.” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60: 208-215. https://doi.org/10.1093/cid/ciu787

[145] Ulger Toprak, N.Yagci, A.Gulluoglu, B. M.Akin, M. L.Demirkalem, P.Celenk, T.Soyletir, G. 2006. “A Possible Role of Bacteroides Fragilis Enterotoxin in the Aetiology of Colorectal Cancer.” Clinical Microbiology and Infection 12: 782-786. https://doi.org/10.1111/j.1469-0691.2006.01494.x

[146] Wei, Zhiliang, Shougen Cao, Shanglong Liu, Zengwu Yao, Teng Sun, Yi Li, Jiante Li, Dongfeng Zhang, Yanbing Zhou. 2016. “Could Gut Microbiota Serve as Prognostic Biomarker Associated With Colorectal Cancer Patients' Survival? A Pilot Study on Relevant Mechanism.” Oncotarget 7: 46158-46172. https://doi.org/10.18632/oncotarget.10064

[147] Abdulamir, Ahmed S., Rand R. Hafidh, Fatimah Bakar. 2010. “Molecular Detection, Quantification, and Isolation of Streptococcus gallolyticus Bacteria Colonizing Colorectal Tumors: Inflammation-Driven Potential of Carcinogenesis via IL-1, COX-2, and IL-8.” Molecular Cancer 9: 249. https://doi.org/10.1186/1476-4598-9-249

[148] Boleij, Annemarie, Harold Tjalsma. 2013. “The Itinerary of Streptococcus gallolyticus Infection in Patients With Colonic Malignant Disease.” The Lancet. Infectious Diseases 13: 719-724. https://doi.org/10.1016/S1473-3099(13)70107-5

[149] Balamurugan, Ramadass, Ethendhar Rajendiran, Sarah George, G. Vijay Samuel, Balakrishnan S. Ramakrishna. 2008. “Real-Time Polymerase Chain Reaction Quantification of Specific Butyrate-Producing Bacteria, Desulfovibrio and Enterococcus faecalis in the Feces of Patients With Colorectal Cancer.” Journal of Gastroenterology and Hepatology 23: 1298-1303. https://doi.org/10.1111/j.1440-1746.2008.05490.x

[150] Huycke, Mark M., Victoria Abrams, Danny R. Moore. 2002. “Enterococcus faecalis Produces Extracellular Superoxide and Hydrogen Peroxide That Damages Colonic Epithelial Cell DNA.” Carcinogenesis 23: 529-536. https://doi.org/10.1093/carcin/23.3.529

[151] Kohi, Shiro, Anne Macgregor-Das, Mohamad Dbouk, Takeichi Yoshida, Miguel Chuidian, Toshiya Abe, Michael Borges, et al. 2022. “Alterations in the Duodenal?Fluid Microbiome of Patients With Pancreatic Cancer.” Clinical Gastroenterology and Hepatology 20: e196-e227. https://doi.org/10.1016/j.cgh.2020.11.006

[152] Riquelme, Erick, Yu Zhang, Liangliang Zhang, Maria Montiel, Michelle Zoltan, Wenli Dong, Pompeyo Quesada, et al. 2019. “Tumor Microbiome Diversity and Composition Influence Pancreatic Cancer Outcomes.” Cell 178: 795-806.e12. https://doi.org/10.1016/j.cell.2019.07.008

[153] Mitsuhashi, Kei, Katsuhiko Nosho, Yasutaka Sukawa, Yasutaka Matsunaga, Miki Ito, Hiroyoshi Kurihara, Shinichi Kanno, et al. 2015. “Association of Fusobacterium Species in Pancreatic Cancer Tissues With Molecular Features and Prognosis.” Oncotarget 6: 7209-7220. https://doi.org/10.18632/oncotarget.3109

[154] Bullman, Susan, Chandra S. Pedamallu, Ewa Sicinska, Thomas E. Clancy, Xiaoyang Zhang, Diana Cai, Donna Neuberg, et al. 2017. “Analysis of Fusobacterium Persistence and Antibiotic Response in Colorectal Cancer.” Science 358: 1443-1448. https://doi.org/10.1126/science.aal5240

[155] Yu, Jiahui, Yongyu Chen, Xiangsheng Fu, Xian Zhou, Yan Peng, Lei Shi, Ting Chen, Yaxin Wu. 2016. “Invasive Fusobacterium nucleatum May Play a Role in the Carcinogenesis of Proximal Colon Cancer Through the Serrated Neoplasia Pathway.” International Journal of Cancer 139: 1318-1326. https://doi.org/10.1002/ijc.30168

[156] Rubinstein, Mara Roxana, Xiaowei Wang, Wendy Liu, Yujun Hao, Guifang Cai, Yiping W. Han. 2013. “Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via Its FadA Adhesin.” Cell Host & Microbe 14: 195-206. https://doi.org/10.1016/j.chom.2013.07.012

[157] Zhou, Dongqin, Yongsheng Li. 2023. “Gut Microbiota and Tumor-Associated Macrophages: Potential in Tumor Diagnosis and Treatment.” Gut Microbes 15: 2276314. https://doi.org/10.1080/19490976.2023.2276314

[158] Wang, Man, Fei Yu, Peifeng Li. 2023. “Intratumor Microbiota in Cancer Pathogenesis and Immunity: From Mechanisms of Action to Therapeutic Opportunities.” Frontiers in Immunology 14: 1269054. https://doi.org/10.3389/fimmu.2023.1269054

[159] Udayasuryan, Barath, Raffae N. Ahmad, Tam T. D. Nguyen, Ariana Umaña, LaDeidra Monét Roberts, Polina Sobol, Stephen D. Jones, et al. 2022. “Fusobacterium nucleatum Induces Proliferation and Migration in Pancreatic Cancer Cells Through Host Autocrine and Paracrine Signaling.” Science Signaling 15: eabn4948. https://doi.org/10.1126/scisignal.abn4948

[160] Brennan, Caitlin A., Slater L. Clay, Sydney L. Lavoie, Sena Bae, Jessica K. Lang, Diogo Fonseca-Pereira, Kathryn G. Rosinski, et al. 2021. “Fusobacterium nucleatum Drives a Pro-Inflammatory Intestinal Microenvironment Through Metabolite Receptor-Dependent Modulation of IL-17 Expression.” Gut Microbes 13: 1987780. https://doi.org/10.1080/19490976.2021.1987780

[161] Wong, Sunny H., Thomas N. Y. Kwong, Tai-Cheong Chow, Arthur K. C. Luk, Rudin Z. W. Dai, Geicho Nakatsu, Thomas Y. T. Lam, et al. 2017. “Quantitation of Faecal Fusobacterium Improves Faecal Immunochemical Test in Detecting Advanced Colorectal Neoplasia.” Gut 66: 1441-1448. https://doi.org/10.1136/gutjnl-2016-312766

[162] Radaic, Allan, Eliah R. Shamir, Kyle Jones, Alessandro Villa, Nandita R. Garud, Aaron D. Tward, Pachiyappan Kamarajan, Yvonne L. Kapila. 2023. “Specific Oral Microbial Differences in Proteobacteria and Bacteroidetes Are Associated With Distinct Sites When Moving From Healthy Mucosa to Oral Dysplasia—A Microbiome and Gene Profiling Study and Focused Review.” Microorganisms 11: 2250. https://doi.org/10.3390/microorganisms11092250

[163] Zhang, Kai, Cheng He, Yuan Qiu, Xiuyang Li, Jian Hu, Baiping Fu. 2023. “Association of Oral Microbiota and Periodontal Disease With Lung Cancer: A Systematic Review and Meta-Analysis.” Journal of Evidence-Based Dental Practice 23: 101897. https://doi.org/10.1016/j.jebdp.2023.101897

[164] Pignatelli, Pamela, Federica Nuccio, Adriano Piattelli, Maria Cristina Curia. 2023. “The Role of Fusobacterium nucleatum in Oral and Colorectal Carcinogenesis.” Microorganisms 11: 2358. https://doi.org/10.3390/microorganisms11092358

[165] Chen, Linfu, Rui Zhao, Zheyu Kang, Zhiqin Cao, Nanhui Liu, Jingjing Shen, Cheng Wang, et al. 2023. “Delivery of Short Chain Fatty Acid Butyrate to Overcome Fusobacterium nucleatum-Induced Chemoresistance.” Journal of Controlled Release 363: 43-56. https://doi.org/10.1016/j.jconrel.2023.09.028

[166] Zhang, Sheng, Yongzhi Yang, Wenhao Weng, Bomin Guo, Guoxiang Cai, Yanlei Ma, Sanjun Cai. 2019. “Fusobacterium nucleatum Promotes Chemoresistance to 5-Fluorouracil by Upregulation of BIRC3 Expression in Colorectal Cancer.” Journal of Experimental & Clinical Cancer Research: CR 38: 14. https://doi.org/10.1186/s13046-018-0985-y

[167] Yu, TaChung, Fangfang Guo, Yanan Yu, Tiantian Sun, Ma, Dan, Jixuan Han, Yun Qian, et al. 2017. “Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy.” Cell 170: 548-63.e16. https://doi.org/10.1016/j.cell.2017.07.008

[168] Yang, Hui, Jinghui Cheng, Hao Zhuang, Hongchuang Xu, Yinuo Wang, Tingting Zhang, Yinmo Yang, et al. 2024. “Pharmacogenomic Profiling of Intra-Tumor Heterogeneity Using a Large Organoid Biobank of Liver Cancer.” Cancer Cell 42: 535-51.e8. https://doi.org/10.1016/j.ccell.2024.03.004

[169] Ma, Xiaolu, Kaixia Zhou, Tianqing Yan, Ling Hu, Suhong Xie, Hui Zheng, Ying Tong, et al. 2024. “Calpain 2 Promotes Lenvatinib Resistance and Cancer Stem Cell Traits via Both Proteolysis-Dependent and Independent Approach in Hepatocellular Carcinoma.” Molecular Biomedicine 5: 74. https://doi.org/10.1186/s43556-024-00242-7

[170] Li, Xinxiu, Hongmeng Su, Wenqing Tang, Shihui Shu, Luyu Zhao, Jinghan Sun, Hong Fan. 2024. “Targeting LEF1-Mediated Epithelial-Mesenchymal Transition Reverses Lenvatinib Resistance in Hepatocellular Carcinoma.” Investigational New Drugs 42: 185-195. https://doi.org/10.1007/s10637-024-01426-2

[171] Van der Merwe, Michelle, Gustav Van Niekerk, Alf Botha, Anna-Mart Engelbrecht. 2021. “The Onco-Immunological Implications of Fusobacterium nucleatum in Breast Cancer.” Immunology Letters 232: 60-66. https://doi.org/10.1016/j.imlet.2021.02.007

[172] Allen, D. W., P. Cole. 1973. “Oncogenic RNA Viruses.” CA: A Cancer Journal for Clinicians 23: 193-200. https://doi.org/10.3322/canjclin.23.3.193

[173] MacLennan, Signe A., Marco A. Marra. 2023. “Oncogenic Viruses and the Epigenome: How Viruses Hijack Epigenetic Mechanisms to Drive Cancer.” International Journal of Molecular Sciences 24: 9543. https://doi.org/10.3390/ijms24119543

[174] Zur Hausen, Harald 2001. “Oncogenic DNA Viruses.” Oncogene 20: 7820-7823. https://doi.org/10.1038/sj.onc.1204958

[175] Akkari, Leila, Damien Grégoire, Nicolas Floc'h, Marie Moreau, Céline Hernandez, Yannick Simonin, Arielle R. Rosenberg, Patrice Lassus, Urszula Hibner. 2012. “Hepatitis C Viral Protein NS5A Induces EMT and Participates in Oncogenic Transformation of Primary Hepatocyte Precursors.” Journal of Hepatology 57: 1021-1028. https://doi.org/10.1016/j.jhep.2012.06.027

[176] Hannigan, Geoffrey D., Melissa B. Duhaime, Mack T. Ruffin, Charlie C. Koumpouras, Patrick D. Schloss. 2018. “Diagnostic Potential and Interactive Dynamics of the Colorectal Cancer Virome.” mBio 9: e02248-18. https://doi.org/10.1128/mBio.02248-18

[177] Li, Yazhen, Qiancheng Qiu, Zhiqiang Fan, Ping He, Huanzhu Chen, Xiaoyang Jiao. 2018. “Th17 Cytokine Profiling of Colorectal Cancer Patients With or Without Enterovirus 71 Antigen Expression.” Cytokine 107: 35-42. https://doi.org/10.1016/j.cyto.2017.11.012

[178] Arzumanyan, A., T. Friedman, E. Kotei, I. O. L. Ng, Z. Lian, M. A. Feitelson. 2012. “Epigenetic Repression of E-Cadherin Expression by Hepatitis B Virus x Antigen in Liver Cancer.” Oncogene 31: 563-572. https://doi.org/10.1038/onc.2011.255

[179] Pagano, Joseph?S., Martin Blaser, Marie-Annick Buendia, Blossom Damania, Kamel Khalili, Nancy Raab-Traub, Bernard Roizman. 2004. “Infectious Agents and Cancer: Criteria for a Causal Relation.” Seminars in Cancer Biology 14: 453-471. https://doi.org/10.1016/j.semcancer.2004.06.009

[180] Shin, Wing Sum, Fuda Xie, Bonan Chen, Jun Yu, Kwok Wai Lo, Gary M. K. Tse, Ka Fai To, Wei Kang. 2023. “Exploring the Microbiome in Gastric Cancer: Assessing Potential Implications and Contextualizing Microorganisms beyond H. pylori and Epstein-Barr Virus.” Cancers 15: 4993. https://doi.org/10.3390/cancers15204993

[181] Liu, Liying, Yanan Xie, Hong Yang, Anqi Lin, Minjun Dong, Haitao Wang, Cangang Zhang, et al. 2023. “HPVTIMER: A Shiny Web Application for Tumor Immune Estimation in Human Papillomavirus-Associated Cancers.” iMeta 2: e130. https://doi.org/10.1002/imt2.130

[182] Lacunza, Ezequiel, Valeria Fink, María E. Salas, Romina Canzoneri, Julián Naipauer, Sion Williams, Omar Coso, et al. 2023. “Oral and Anal Microbiome From HIV-Exposed Individuals: Role of Host-Associated Factors in Taxa Composition and Metabolic Pathways.” NPJ Biofilms and Microbiomes 9: 48. https://doi.org/10.1038/s41522-023-00413-4

[183] Nakatsu, Geicho, Haokui Zhou, William Ka Kei Wu, Sunny Hei Wong, Olabisi Oluwabukola Coker, Zhenwei Dai, Xiangchun Li, et al. 2018. “Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes.” Gastroenterology 155: 529-41.e5. https://doi.org/10.1053/j.gastro.2018.04.018

[184] Luo, Shiqi, Jinlong Ru, Mohammadali Khan Mirzaei, Jinling Xue, Xue Peng, Anna Ralser, Raquel Mejías-Luque, Markus Gerhard, Li Deng. 2023. “Gut Virome Profiling Identifies an Association Between Temperate Phages and Colorectal Cancer Promoted by Helicobacter pylori Infection.” Gut Microbes 15: 2257291. https://doi.org/10.1080/19490976.2023.2257291

[185] Wang, Zhihan, Kai Guo, Yingying Liu, Canhua Huang, Min Wu. 2022. “Dynamic Impact of Virome on Colitis and Colorectal Cancer: Immunity, Inflammation, Prevention and Treatment.” Seminars in Cancer Biology 86: 943-954. https://doi.org/10.1016/j.semcancer.2021.10.004

[186] Gogokhia, Lasha, Kate Buhrke, Rickesha Bell, Brenden Hoffman, D. Garrett Brown, Christin Hanke-Gogokhia, Nadim J. Ajami, et al. 2019. “Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis.” Cell Host & Microbe 25: 285-99.e8. https://doi.org/10.1016/j.chom.2019.01.008

[187] Lawson, James S., Wendy K. Glenn. 2021. “Catching Viral Breast Cancer.” Infectious Agents and Cancer 16: 37. https://doi.org/10.1186/s13027-021-00366-3

[188] Herbein, Georges, Amit Kumar. 2014. “The Oncogenic Potential of Human Cytomegalovirus and Breast Cancer.” Frontiers in Oncology 4: 230. https://doi.org/10.3389/fonc.2014.00230

[189] Richardson, A. K., L. C. Walker, B. Cox, H. Rollag, B. A. Robinson, H. Morrin, J. F. Pearson, et al. 2020. “Breast Cancer and Cytomegalovirus.” Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22: 585-602. https://doi.org/10.1007/s12094-019-02164-1

[190] Curty, Gislaine, Jez L. Marston, Miguel De Mulder Rougvie, Fabio E. Leal, Douglas F. Nixon, Marcelo A. Soares. 2020. “Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target.” Viruses 12: 726. https://doi.org/10.3390/v12070726

[191] Gao, Peng, Jie Zheng. 2011. “Oncogenic Virus-Mediated Cell Fusion: New Insights Into Initiation and Progression of Oncogenic Viruses—Related Cancers.” Cancer Letters 303: 1-8. https://doi.org/10.1016/j.canlet.2010.12.021

[192] Purdy, John G., Micah A. Luftig. 2019. “Reprogramming of Cellular Metabolic Pathways by Human Oncogenic Viruses.” Current Opinion in Virology 39: 60-69. https://doi.org/10.1016/j.coviro.2019.11.002

[193] Huang, Binhao, Qin Li, Qirong Geng, Jiawen Lao, Jing Guo, Shenglin Huang, Dazhi Xu. 2022. “ASTE1 Frameshift Mutation Triggers the Immune Response in Epstein-Barr Virus-Associated Gastric Cancer.” Signal Transduction and Targeted Therapy 7: 4. https://doi.org/10.1038/s41392-021-00771-5

[194] Deng, Chu-Xia. 2024. “Revealing the Secret Behind Epstein-Barr Virus-Specific Tumor Immune Contexture.” Cancer Communications 44: 491-494. https://doi.org/10.1002/cac2.12529

[195] Armstrong, Heather, Mandana Rahbari, Heekuk Park, David Sharon, Aducio Thiesen, Naomi Hotte, Ning Sun, et al. 2023. “Mouse Mammary Tumor Virus Is Implicated in Severity of Colitis and Dysbiosis in the IL-10−/− Mouse Model of Inflammatory Bowel Disease.” Microbiome 11: 39. https://doi.org/10.1186/s40168-023-01483-4

[196] McBride, Alison A., Elizabeth A. White. 2023. “HPV Integration Can Drive the Formation of Virus-Host Extrachromosomal DNA in Tumors.” Cancer Discovery 13: 814-816. https://doi.org/10.1158/2159-8290.CD-23-0097

[197] He, Jiang, Liyu Liu, Feiyu Tang, You Zhou, Huan Liu, Can Lu, Deyun Feng, et al. 2021. “Paradoxical Effects of DNA Tumor Virus Oncogenes on Epithelium-Derived Tumor Cell Fate During Tumor Progression and Chemotherapy Response.” Signal Transduction and Targeted Therapy 6: 408. https://doi.org/10.1038/s41392-021-00787-x

[198] Sekiba, Kazuma, Motoyuki Otsuka, Kazuyoshi Funato, Yu Miyakawa, Eri Tanaka, Takahiro Seimiya, Mari Yamagami, et al. 2022. “HBx-Induced Degradation of Smc5/6 Complex Impairs Homologous Recombination-Mediated Repair of Damaged DNA.” Journal of Hepatology 76: 53-62. https://doi.org/10.1016/j.jhep.2021.08.010

[199] Xia, Wei, Lei Liu, Nan Shi, Chaoyin Zhang, Anzhou Tang, Guangyao He. 2023. “Epstein Barr Virus Infection in Tree Shrews Alters the Composition of Gut Microbiota and Metabolome Profile.” Virology Journal 20: 177. https://doi.org/10.1186/s12985-023-02147-3

[200] Easwaran, Maheswaran, Fatma Abdelrahman, Sivagnanavelmurugan Madasamy, Baskar Venkidasamy. 2024. “Phage-Delivered Melittin for Oral Squamous Cell Carcinoma: A Potential Therapeutic Agent.” International Immunopharmacology 134: 112163. https://doi.org/10.1016/j.intimp.2024.112163

[201] York, Ashley. 2025. “Predicting Phage-Host Specificity.” Nature Reviews Microbiology 23: 5. https://doi.org/10.1038/s41579-024-01132-z

[202] York, Ashley. 2020. “Prophages Are Gut Virome Pioneers.” Nature Reviews Microbiology 18: 317. https://doi.org/10.1038/s41579-020-0374-3

[203] Wahida, Adam, Fang Tang, Jeremy J. Barr. 2021. “Rethinking Phage-Bacteria-Eukaryotic Relationships and Their Influence on Human Health.” Cell Host & Microbe 29: 681-688. https://doi.org/10.1016/j.chom.2021.02.007

[204] Tisza, Michael J., Richard E. Lloyd, Kristi Hoffman, Daniel P. Smith, Marian Rewers, Sara J. Javornik Cregeen, Joseph?F. Petrosino. 2025. “Longitudinal Phage-Bacteria Dynamics in the Early Life Gut Microbiome.” Nature Microbiology 10: 420-430. https://doi.org/10.1038/s41564-024-01906-4

[205] Shkoporov, Andrey N., Colin Hill. 2019. “Bacteriophages of the Human Gut: The ‘Known Unknown’ of the Microbiome.” Cell Host & Microbe 25: 195-209. https://doi.org/10.1016/j.chom.2019.01.017

[206] Kotsiliti, Eleni. 2024. “Bacteriophages and Host Inflammation in IBD.” Nature Reviews Gastroenterology & Hepatology 21: 300. https://doi.org/10.1038/s41575-024-00925-0

[207] Putra, Ramendra Dirgantara, Diana Lyrawati. 2020. “Interactions Between Bacteriophages and Eukaryotic Cells.” Scientifica 2020: 3589316. https://doi.org/10.1155/2020/3589316

[208] Magnaye, Kevin M., Susan V. Lynch. 2021. “Fungus Fuels Mucosal Wounds in Crohn's Disease.” Immunity 54: 856-858. https://doi.org/10.1016/j.immuni.2021.04.013

[209] Huo, Xiaokui, Dawei Li, Fan Wu, Shenghui Li, Yanling Qiao, Chao Wang, Wang, Yan, et al. 2022. “Cultivated Human Intestinal Fungus Candida metapsilosis M2006B Attenuates Colitis by Secreting Acyclic Sesquiterpenoids as FXR Agonists.” Gut 71: 2205-2217. https://doi.org/10.1136/gutjnl-2021-325413

[210] Cho, Daniel H., Gloria B. Choi. 2022. “Fungus Packs a Punch in the Gut.” Immunity 55: 586-588. https://doi.org/10.1016/j.immuni.2022.03.012

[211] Bordon, Yvonne. 2022. “Fungus Hijacks TLR4 to Build a Type 2 Immune Niche.” Nature Reviews Immunology 22: 532-533. https://doi.org/10.1038/s41577-022-00773-6

[212] Ost, Kyla S., June L. Round. 2023. “Commensal Fungi in Intestinal Health and Disease.” Nature Reviews Gastroenterology & Hepatology 20: 723-734. https://doi.org/10.1038/s41575-023-00816-w

[213] Ahmadi, N., A. Ahmadi, E. Kheirali, M. Hossein Yadegari, M. Bayat, A. Shajiei, A. Ali Amini, et al. 2019. “Systemic Infection With Candida albicans in Breast Tumor Bearing Mice: Cytokines Dysregulation and Induction of Regulatory T Cells.” Journal de Mycologie Médicale 29: 49-55. https://doi.org/10.1016/j.mycmed.2018.10.006

[214] He, Shengfu, Yating Sun, Weijie Sun, Mingyang Tang, Bao Meng, Yanyan Liu, Qinxiang Kong, et al. 2023. “Oral Microbiota Disorder in GC Patients Revealed by 2b-RAD-M.” Journal of Translational Medicine 21: 831. https://doi.org/10.1186/s12967-023-04599-1

[215] Dohlman, Anders B., Jared Klug, Marissa Mesko, Iris H. Gao, Steven M. Lipkin, Xiling Shen, Iliyan D. Iliev. 2022. “A Pan-Cancer Mycobiome Analysis Reveals Fungal Involvement in Gastrointestinal and Lung Tumors.” Cell 185: 3807-22.e12. https://doi.org/10.1016/j.cell.2022.09.015

[216] Chin, Siok-Fong, Putri Intan Hafizah Megat Mohd Azlan, Luqman Mazlan, Hui-Min Neoh. 2018. “Identification of Schizosaccharomyces pombe in the Guts of Healthy Individuals and Patients With Colorectal Cancer: Preliminary Evidence From a Gut Microbiome Secretome Study.” Gut Pathogens 10: 29. https://doi.org/10.1186/s13099-018-0258-5

[217] Li, Fan, Yunhuan Gao, Wenyue Cheng, Xiaomin Su, Rongcun Yang. 2023. “Gut Fungal Mycobiome: A Significant Factor of Tumor Occurrence and Development.” Cancer Letters 569: 216302. https://doi.org/10.1016/j.canlet.2023.216302

[218] Wang, Yu, Yahui Ren, Yongming Huang, Xiangnan Yu, Yiming Yang, Di Wang, Liang Shi, et al. 2021. “Fungal Dysbiosis of the Gut Microbiota Is Associated With Colorectal Cancer in Chinese Patients.” American Journal of Translational Research 13: 11287-11301.

[219] Aykut, Berk, Smruti Pushalkar, Ruonan Chen, Qianhao Li, Raquel Abengozar, Jacqueline I. Kim, Sorin A. Shadaloey, et al. 2019. “The Fungal Mycobiome Promotes Pancreatic Oncogenesis via Activation of MBL.” Nature 574: 264-267. https://doi.org/10.1038/s41586-019-1608-2

[220] Brayer, Kathryn J., Joshua A. Hanson, Shashank Cingam, Cathleen Martinez, Scott A. Ness, Ian Rabinowitz. 2023. “The Inflammatory Response of Human Pancreatic Cancer Samples Compared to Normal Controls.” PloS One 18: e0284232. https://doi.org/10.1371/journal.pone.0284232

[221] Zhang, Lilong, Dongqi Chai, Chen Chen, Chunlei Li, Zhendong Qiu, Tianrui Kuang, Mungur Parveena, et al. 2022. “Mycobiota and C-Type Lectin Receptors in Cancers: Know Thy Neighbors.” Frontiers in Microbiology 13: 946995. https://doi.org/10.3389/fmicb.2022.946995

[222] Wang, Xu, Zejun Zhou, David Turner, Michael Lilly, Tongwen Ou, Wei Jiang. 2022. “Differential Circulating Fungal Microbiome in Prostate Cancer Patients Compared to Healthy Control Individuals.” Journal of Immunology Research 2022: 2574964. https://doi.org/10.1155/2022/2574964

[223] Cheng, Wenyue, Fan Li, Yunhuan Gao, Rongcun Yang. 2024. “Fungi and Tumors: The Role of Fungi in Tumorigenesis (Review).” International Journal of Oncology 64: 52. https://doi.org/10.3892/ijo.2024.5640

[224] Galloway-Peña, Jessica, Iliyan D. Iliev, Florencia McAllister. 2024. “Fungi in Cancer.” Nature Reviews Cancer 24: 295-298. https://doi.org/10.1038/s41568-024-00665-y

[225] Xu, Bin, Zan Luo, Xing Niu, Zhi Li, Yeping Lu, Junyu Li. 2025. “Fungi, Immunosenescence and Cancer.” Seminars in Cancer Biology 109: 67-82. https://doi.org/10.1016/j.semcancer.2025.01.002

[226] Li, Xiaopeng, Jiahui Feng, Zhanggui Wang, Gang Liu, Fan Wang. 2023. “Features of Combined Gut Bacteria and Fungi From a Chinese Cohort of Colorectal Cancer, Colorectal Adenoma, and Post-Operative Patients.” Frontiers in Microbiology 14: 1236583. https://doi.org/10.3389/fmicb.2023.1236583

[227] Coker, Olabisi Oluwabukola, Geicho Nakatsu, Rudin Zhenwei Dai, William Ka Kei Wu, Sunny Hei Wong, Siew Chien Ng, Francis Ka Leung Chan, Joseph?Jao Yiu Sung, Jun Yu. 2019. “Enteric Fungal Microbiota Dysbiosis and Ecological Alterations in Colorectal Cancer.” Gut 68: 654-662. https://doi.org/10.1136/gutjnl-2018-317178

[228] Yang, Ping, Xiaoshan Zhang, Rui Xu, Khan Adeel, Xiaofeng Lu, Min Chen, Han Shen, Zhiyang Li, Zhipeng Xu. 2022. “Fungal Microbiota Dysbiosis and Ecological Alterations in Gastric Cancer.” Frontiers in Microbiology 13: 889694. https://doi.org/10.3389/fmicb.2022.889694

[229] Huang, Hui, Qiurong Wang, Ying Yang, Wei Zhong, Feng He, Jun Li. 2024. “The Mycobiome as Integral Part of the Gut Microbiome: Crucial Role of Symbiotic Fungi in Health and Disease.” Gut Microbes 16: 2440111. https://doi.org/10.1080/19490976.2024.2440111

[230] Wang, Rui, Bo Li, Bingyuan Huang, Yikang Li, Qiaoyan Liu, Zhuwan Lyu, Ruiling Chen, et al. 2024. “Gut Microbiota-Derived Butyrate Induces Epigenetic and Metabolic Reprogramming in Myeloid-Derived Suppressor Cells to Alleviate Primary Biliary Cholangitis.” Gastroenterology 167: 733-49.e3. https://doi.org/10.1053/j.gastro.2024.05.014

[231] Sinha, Anurag K., Martin F. Laursen, Julius E. Brinck, Morten L. Rybtke, Anna Pii Hjørne, Nicola Procházková, Mikael Pedersen, Henrik M. Roager, Tine R. Licht. 2024. “Dietary Fibre Directs Microbial Tryptophan Metabolism via Metabolic Interactions in the Gut Microbiota.” Nature Microbiology 9: 1964-1978. https://doi.org/10.1038/s41564-024-01737-3

[232] Lu, Yijing, Wenlong Yang, Zhiyong Qi, Rifeng Gao, Jing Tong, Tingwen Gao, Yin Zhang, et al. 2023. “Gut Microbe-Derived Metabolite Indole-3-Carboxaldehyde Alleviates Atherosclerosis.” Signal Transduction and Targeted Therapy 8: 378. https://doi.org/10.1038/s41392-023-01613-2

[233] Kwon, Byungsuk. 2023. “A Metabolite of the Gut Microbiota: A Facilitator of Chemotherapy Efficacy in Cancer.” Signal Transduction and Targeted Therapy 8: 238. https://doi.org/10.1038/s41392-023-01506-4

[234] Huang, Kan, Zilun Li, Xi He, Jun Dai, Bingding Huang, Yongxia Shi, Dongxiao Fan, et al. 2024. “Gut Microbial Co-Metabolite 2-Methylbutyrylcarnitine Exacerbates Thrombosis via Binding to and Activating Integrin α2β1.” Cell Metabolism 36: 598-616.e9. https://doi.org/10.1016/j.cmet.2024.01.014

[235] Collins, Stephanie L., Jonathan G. Stine, Jordan E. Bisanz, C. Denise Okafor, Andrew D. Patterson. 2023. “Bile Acids and the Gut Microbiota: Metabolic Interactions and Impacts on Disease.” Nature Reviews Microbiology 21: 236-247. https://doi.org/10.1038/s41579-022-00805-x

[236] Agus, Allison, Karine Clément, Harry Sokol. 2021. “Gut Microbiota-Derived Metabolites as Central Regulators in Metabolic Disorders.” Gut 70: 1174-1182. https://doi.org/10.1136/gutjnl-2020-323071

[237] Belcheva, Antoaneta, Thergiory Irrazabal, Susan J. Robertson, Catherine Streutker, Heather Maughan, Stephen Rubino, Eduardo H. Moriyama, et al. 2014. “Gut Microbial Metabolism Drives Transformation of MSH2-Deficient Colon Epithelial Cells.” Cell 158: 288-299. https://doi.org/10.1016/j.cell.2014.04.051

[238] Zheng, Di-Wei, Run-Qing Li, Jia-Xin An, Tian-Qiu Xie, Zi-Yi Han, Rui Xu, Yu Fang, Xian-Zheng Zhang. 2020. “Prebiotics-Encapsulated Probiotic?Spores Regulate Gut Microbiota and Suppress Colon Cancer.” Advanced Materials 32: e2004529. https://doi.org/10.1002/adma.202004529

[239] Park, Hyun-Soo, Joo-Hui Han, Jeong Won Park, Do-Hyung Lee, Keun-Woo Jang, Miji Lee, Kyung-Sun Heo, Chang-Seon Myung. 2021. “Sodium Propionate Exerts Anticancer Effect in Mice Bearing Breast Cancer Cell Xenograft by Regulating JAK2/STAT3/ROS/p38 MAPK Signaling.” Acta Pharmacologica Sinica 42: 1311-1323. https://doi.org/10.1038/s41401-020-00522-2

[240] Hilakivi-Clarke, Leena, Fabia De Oliveira Andrade. 2023. “Social Isolation and Breast Cancer.” Endocrinology 164: bqad126. https://doi.org/10.1210/endocr/bqad126

[241] Luu, Maik, Zeno Riester, Adrian Baldrich, Nicole Reichardt, Samantha Yuille, Alessandro Busetti, Matthias Klein, et al. 2021. “Microbial Short-Chain Fatty Acids Modulate CD8+ T Cell Responses and Improve Adoptive Immunotherapy for Cancer.” Nature Communications 12: 4077. https://doi.org/10.1038/s41467-021-24331-1

[242] Kim, Minsuk, Emily Vogtmann, David A. Ahlquist, Mary E. Devens, John B. Kisiel, William R. Taylor, Bryan A. White, et al. 2020. “Fecal Metabolomic Signatures in Colorectal Adenoma Patients Are Associated With Gut Microbiota and Early Events of Colorectal Cancer Pathogenesis.” mBio 11: e03186-19. https://doi.org/10.1128/mBio.03186-19

[243] Hale, Vanessa L., Jun Chen, Stephen Johnson, Sean C. Harrington, Tracy C. Yab, Thomas C. Smyrk, Heidi Nelson, et al. 2017. “Shifts in the Fecal Microbiota Associated With Adenomatous Polyps.” Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 26: 85-94. https://doi.org/10.1158/1055-9965.EPI-16-0337

[244] Mikó, Edit, András Vida, Tünde Kovács, Gyula Ujlaki, György Trencsényi, Judit Márton, Zsanett Sári, et al. 2018. “Lithocholic Acid, a Bacterial Metabolite Reduces Breast Cancer Cell Proliferation and Aggressiveness.” Biochimica et Biophysica Acta (BBA)—Bioenergetics 1859: 958-974. https://doi.org/10.1016/j.bbabio.2018.04.002

[245] Kovács, Patrik, Tamás Csonka, Tünde Kovács, Zsanett Sári, Gyula Ujlaki, Adrien Sipos, Zsolt Karányi, et al. 2019. “Lithocholic Acid, a Metabolite of the Microbiome, Increases Oxidative Stress in Breast Cancer.” Cancers 11: 1255. https://doi.org/10.3390/cancers11091255

[246] Sun, Xi-Zhen, Dong-Yan Zhao, Yuan-Chen Zhou, Qian-Qian Wang, Geng Qin, Shu-Kun Yao. 2020. “Alteration of Fecal Tryptophan Metabolism Correlates With Shifted Microbiota and May Be Involved in Pathogenesis of Colorectal Cancer.” World Journal of Gastroenterology 26: 7173-7190. https://doi.org/10.3748/wjg.v26.i45.7173

[247] Díaz-Díaz, Carol J., Sean M. Ronnekleiv-Kelly, Manabu Nukaya, Peter G. Geiger, Silvia Balbo, Romel Dator, Bryant W. Megna, et al. 2016. “The Aryl Hydrocarbon Receptor Is a Repressor of Inflammation-Associated Colorectal Tumorigenesis in Mouse.” Annals of Surgery 264: 429-436. https://doi.org/10.1097/SLA.0000000000001874

[248] Zhang, Lu, Qing Ji, Qian Chen, Zhenzhen Wei, Shuochuan Liu, Long Zhang, Yuli Zhang, et al. 2023. “Akkermansia muciniphila Inhibits Tryptophan Metabolism via the AhR/β-Catenin Signaling Pathway to Counter the Progression of Colorectal Cancer.” International Journal of Biological Sciences 19: 4393-4410. https://doi.org/10.7150/ijbs.85712

[249] Patel, Dhwani, Iain A. Murray, Fangcong Dong, Andrew J. Annalora, Krishne Gowda, Denise M. Coslo, Jacek Krzeminski, et al. 2023. “Induction of AHR Signaling in Response to the Indolimine Class of Microbial Stress Metabolites.” Metabolites 13: 985. https://doi.org/10.3390/metabo13090985

[250] Seo, Su-Kil, Byungsuk Kwon. 2023. “Immune Regulation Through Tryptophan Metabolism.” Experimental & Molecular Medicine 55: 1371-1379. https://doi.org/10.1038/s12276-023-01028-7

[251] Hussain, Ahad, Li Xie, Guozhe Deng, Xuejun Kang. 2023. “Common Alterations in Plasma Free Amino Acid Profiles and Gut Microbiota-Derived Tryptophan Metabolites of Five Types of Cancer Patients.” Amino Acids 55: 1189-1200. https://doi.org/10.1007/s00726-023-03308-y

[252] He, Jin, Peiwen Zhang, Linyuan Shen, Lili Niu, Ya Tan, Lei Chen, Ye Zhao, et al. 2020. “Short-Chain Fatty Acids and Their Association With Signalling Pathways in Inflammation, Glucose and Lipid Metabolism.” International Journal of Molecular Sciences 21: 6356. https://doi.org/10.3390/ijms21176356

[253] Mann, Elizabeth R., Ying Ka Lam, Holm H. Uhlig. 2024. “Short-Chain Fatty Acids: Linking Diet, the Microbiome and Immunity.” Nature Reviews Immunology 24: 577-595. https://doi.org/10.1038/s41577-024-01014-8

[254] Vinolo, Marco A. R., Hosana G. Rodrigues, Renato T. Nachbar, Rui Curi. 2011. “Regulation of Inflammation by Short Chain Fatty Acids.” Nutrients 3: 858-876. https://doi.org/10.3390/nu3100858

[255] Van der Hee, Bart, Jerry M. Wells. 2021. “Microbial Regulation of Host Physiology by Short-chain Fatty Acids.” Trends in Microbiology 29: 700-712. https://doi.org/10.1016/j.tim.2021.02.001

[256] Tsunedomi, Ryouichi, Yoshitaro Shindo, Masao Nakajima, Kiyoshi Yoshimura, Hiroaki Nagano. 2023. “The Tumor Immune Microenvironment in Pancreatic Cancer and Its Potential in the Identification of Immunotherapy Biomarkers.” Expert Review of Molecular Diagnostics 23: 1121-1134. https://doi.org/10.1080/14737159.2023.2281482

[257] Yan, Qingzhu, Shengnan Jia, Dongfu Li, Junling Yang. 2023. “The Role and Mechanism of Action of Microbiota-Derived Short-Chain Fatty Acids in Neutrophils: From the Activation to Becoming Potential Biomarkers.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 169: 115821. https://doi.org/10.1016/j.biopha.2023.115821

[258] Sun, Mingming, Wei Wu, Zhanju Liu, Yingzi Cong. 2017. “Microbiota Metabolite Short Chain Fatty Acids, GPCR, and Inflammatory Bowel Diseases.” Journal of Gastroenterology 52: 1-8. https://doi.org/10.1007/s00535-016-1242-9

[259] Tsukuda, Naoki, Kana Yahagi, Taeko Hara, Yohei Watanabe, Hoshitaka Matsumoto, Hiroshi Mori, Koichi Higashi, et al. 2021. “Key Bacterial Taxa and Metabolic Pathways Affecting Gut Short-Chain Fatty Acid Profiles in Early Life.” The ISME Journal 15: 2574-2590. https://doi.org/10.1038/s41396-021-00937-7

[260] Quinn-Bohmann, Nick, Tomasz Wilmanski, Katherine Ramos Sarmiento, Lisa Levy, Johanna W. Lampe, Thomas Gurry, Noa Rappaport, et al. 2024. “Microbial Community-Scale Metabolic Modelling Predicts Personalized Short-Chain Fatty Acid Production Profiles in the Human Gut.” Nature Microbiology 9: 1700-1712. https://doi.org/10.1038/s41564-024-01728-4

[261] Nogal, Ana, Francesco Asnicar, Amrita Vijay, Afroditi Kouraki, Alessia Visconti, Panayiotis Louca, Kari Wong, et al. 2023. “Genetic and Gut Microbiome Determinants of SCFA Circulating and Fecal Levels, Postprandial Responses and Links to Chronic and Acute Inflammation.” Gut Microbes 15: 2240050. https://doi.org/10.1080/19490976.2023.2240050

[262] Ikeda, Takako, Akari Nishida, Mayu Yamano, Ikuo Kimura. 2022. “Short-Chain Fatty Acid Receptors and Gut Microbiota as Therapeutic Targets in Metabolic, Immune, and Neurological Diseases.” Pharmacology & Therapeutics 239: 108273. https://doi.org/10.1016/j.pharmthera.2022.108273

[263] Hu, Tongtong, Qingqing Wu, Qi Yao, Kebing Jiang, Jiabin Yu, Qizhu Tang. 2022. “Short-Chain Fatty Acid Metabolism and Multiple Effects on Cardiovascular Diseases.” Ageing Research Reviews 81: 101706. https://doi.org/10.1016/j.arr.2022.101706

[264] Gomes, Sara, Ana Catarina Rodrigues, Valerio Pazienza, Ana Preto. 2023. “Modulation of the Tumor Microenvironment by Microbiota-Derived Short-Chain Fatty Acids: Impact in Colorectal Cancer Therapy.” International Journal of Molecular Sciences 24: 5069. https://doi.org/10.3390/ijms24065069

[265] Thome, Carolin D., Patrick Tausche, Katja Hohenberger, Zuqin Yang, Susanne Krammer, Denis I. Trufa, Horia Sirbu, Joachim Schmidt, Susetta Finotto. 2024. “Short-Chain Fatty Acids Induced Lung Tumor Cell Death and Increased Peripheral Blood CD4+ T Cells in NSCLC and Control Patients Ex Vivo.” Frontiers in Immunology 15: 1328263. https://doi.org/10.3389/fimmu.2024.1328263

[266] Kim, Myunghoo, Yaqing Qie, Jeongho Park, Chang H. Kim. 2016. “Gut Microbial Metabolites Fuel Host Antibody Responses.” Cell Host & Microbe 20: 202-214. https://doi.org/10.1016/j.chom.2016.07.001

[267] Thiruvengadam, Muthu, Umadevi Subramanian, Baskar Venkidasamy, Prabhu Thirupathi, Ramkumar Samynathan, Mohammad Ali Shariati, Maksim Rebezov, Ill-Min Chung, Kannan R. R. Rengasamy. 2023. “Emerging Role of Nutritional Short-Chain Fatty Acids (SCFAs) Against Cancer via Modulation of Hematopoiesis.” Critical Reviews in Food Science and Nutrition 63: 827-844. https://doi.org/10.1080/10408398.2021.1954874

[268] Hou, Huiqin, Danfeng Chen, Kexin Zhang, Wanru Zhang, Tianyu Liu, Sinan Wang, Xin Dai, et al. 2022. “Gut Microbiota-Derived Short-Chain Fatty Acids and Colorectal Cancer: Ready for Clinical Translation?” Cancer Letters 526: 225-235. https://doi.org/10.1016/j.canlet.2021.11.027

[269] Winston, Jenessa A., Casey M. Theriot. 2020. “Diversification of Host Bile Acids by Members of the Gut Microbiota.” Gut Microbes 11: 158-171. https://doi.org/10.1080/19490976.2019.1674124

[270] Su, Xiaomin, Yunhuan Gao, Rongcun Yang. 2023. “Gut Microbiota Derived Bile Acid Metabolites Maintain the Homeostasis of Gut and Systemic Immunity.” Frontiers in Immunology 14: 1127743. https://doi.org/10.3389/fimmu.2023.1127743

[271] Sinha, Sidhartha R., Yeneneh Haileselassie, Linh P. Nguyen, Carolina Tropini, Min Wang, Laren S. Becker, Davis Sim, et al. 2020. “Dysbiosis-Induced Secondary Bile Acid Deficiency Promotes Intestinal Inflammation.” Cell Host & Microbe 27: 659-70.e5. https://doi.org/10.1016/j.chom.2020.01.021

[272] Režen, Tadeja, Damjana Rozman, Tünde Kovács, Patrik Kovács, Adrienn Sipos, Péter Bai, Edit Mikó. 2022. “The Role of Bile Acids in Carcinogenesis.” Cellular and Molecular Life Sciences 79: 243. https://doi.org/10.1007/s00018-022-04278-2

[273] Lenci, Ilaria, Martina Milana, Alessandro Signorello, Giuseppe Grassi, Leonardo Baiocchi. 2023. “Secondary Bile Acids and the Biliary Epithelia: The Good and the Bad.” World Journal of Gastroenterology 29: 357-36. https://doi.org/10.3748/wjg.v29.i2.357

[274] Situ, Yingheng, Pengpeng Zhang, Cangang Zhang, Aimin Jiang, Nan Zhang, Lingxuan Zhu, Weiming Mou, et al. 2025. “The Metabolic Dialogue Between Intratumoural Microbes and Cancer: Implications for Immunotherapy.” EBioMedicine 115: 105708. https://doi.org/10.1016/j.ebiom.2025.105708

[275] Krumz, L. M., R. B. Gudkova, L. Kh. Indejkina, E. A. Sabelnikova, A. I. Parfenov. 2020. “[Bile Acids Are a Risk Factor for Colorectal Cancer].” Terapevticheskii Arkhiv 92: 93-96. https://doi.org/10.26442/00403660.2020.02.000457

[276] Kim, Tae-Young, Seungil Kim, Yeji Kim, Yong-Soo Lee, Sohyeon Lee, Su-Hyun Lee, Mi-Na Kweon. 2022. “A High-Fat Diet Activates the BAs-FXR Axis and Triggers Cancer-Associated Fibroblast Properties in the Colon.” Cellular and Molecular Gastroenterology and Hepatology 13: 1141-1159. https://doi.org/10.1016/j.jcmgh.2021.12.015

[277] Ma, Chi, Miaojun Han, Bernd Heinrich, Qiong Fu, Qianfei Zhang, Milan Sandhu, David Agdashian, et al. 2018. “Gut Microbiome-Mediated Bile Acid Metabolism Regulates Liver Cancer via NKT Cells.” Science 360: eaan5931. https://doi.org/10.1126/science.aan5931

[278] Zha, Andong, Ming Qi, Yuankun Deng, Hao Li, Nan Wang, Chengming Wang, Simeng Liao, et al. 2024. “Gut Bifidobacterium pseudocatenulatum Protects Against Fat Deposition by Enhancing Secondary Bile Acid Biosynthesis.” iMeta 3: e261. https://doi.org/10.1002/imt2.261

[279] Tobón-Cornejo, Sandra, Monica Sanchez-Tapia, Rocio Guizar-Heredia, Laura Velázquez Villegas, Lilia G. Noriega, Janette Furuzawa-Carballeda, Rogelio Hernández-Pando, et al. 2025. “Increased Dietary Protein Stimulates Amino Acid Catabolism via the Gut Microbiota and Secondary Bile Acid Production.” Gut Microbes 17: 2465896. https://doi.org/10.1080/19490976.2025.2465896

[280] Louca, Panayiotis, Abraham S. Meijnikman, Ana Nogal, Francesco Asnicar, Ilias Attaye, Amrita Vijay, Afroditi Kouraki, et al. 2023. “The Secondary Bile Acid Isoursodeoxycholate Correlates With Post-Prandial Lipemia, Inflammation, and Appetite and Changes Post-Bariatric Surgery.” Cell Reports. Medicine 4: 100993. https://doi.org/10.1016/j.xcrm.2023.100993

[281] Lamichhane, Santosh, Partho Sen, Alex M. Dickens, Marina Amaral Alves, Taina Härkönen, Jarno Honkanen, Tommi Vatanen, et al. 2022. “Dysregulation of Secondary Bile Acid Metabolism Precedes Islet Autoimmunity and Type 1 Diabetes.” Cell Reports. Medicine 3: 100762. https://doi.org/10.1016/j.xcrm.2022.100762

[282] Wei, Yanxin, Chen Lu, Shengsheng Jiang, Yanyan Zhang, Qiuchun Li, Wen-Ju Bai, Xiqing Wang. 2020. “Directed Evolution of a Tryptophan 2,3-Dioxygenase for the Diastereoselective Monooxygenation of Tryptophans.” Angewandte Chemie International Edition 59: 3043-3047. https://doi.org/10.1002/anie.201911825

[283] Cervenka, Igor, Leandro Z. Agudelo, Jorge L. Ruas. 2017. “Kynurenines: Tryptophan's Metabolites in Exercise, Inflammation, and Mental Health.” Science 357: eaaf9794. https://doi.org/10.1126/science.aaf9794

[284] Zhu, Yueting, Aolei Hu, Meilin Chen, Yunting Zhang, Tao Gong, Zhirong Zhang, Ruilian Yu, Yao Fu. 2025. “3-Indoleacetic Acid-Modified Chondroitin Sulfate-Mediated Paclitaxel Nanocrystal Assembly for the Treatment of Pancreatic Cancer.” ACS Applied Materials & Interfaces 17: 9035-9046. https://doi.org/10.1021/acsami.4c19450

[285] Li, Zhuangzhuang, Baoyan Ding, Mustafa R. K. Ali, Lizhen Zhao, Xiaoling Zang, Zhihua Lv. 2022. “Dual Effect of Tryptamine on Prostate Cancer Cell Growth Regulation: A Pilot Study.” International Journal of Molecular Sciences 23: 11087. https://doi.org/10.3390/ijms231911087

[286] Jing, Wanghui, Sijing Dong, Yinyue Xu, Jingjing Liu, Jiawei Ren, Xue Liu, Min Zhu, et al. 2025. “Gut Microbiota-Derived Tryptophan Metabolites Regulated by Wuji Wan to Attenuate Colitis Through AhR Signaling Activation.” Acta Pharmaceutica Sinica. B 15: 205-223. https://doi.org/10.1016/j.apsb.2024.11.009

[287] Chen, Chuan, Zheng Cao, Hehua Lei, Cui Zhang, Mengjing Wu, Shaohua Huang, Xinzhi Li, et al. 2024. “Microbial Tryptophan Metabolites Ameliorate Ovariectomy-Induced Bone Loss by Repairing Intestinal AhR-Mediated Gut-Bone Signaling Pathway.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 11: e2404545. https://doi.org/10.1002/advs.202404545

[288] Arinze, Nkiruka V., Wenqing Yin, Saran Lotfollahzadeh, Marc Arthur Napoleon, Sean Richards, Joshua A. Walker, Mostafa Belghasem, et al. 2022. “Tryptophan Metabolites Suppress the Wnt Pathway and Promote Adverse Limb Events in Chronic Kidney Disease.” The Journal of Clinical Investigation 132: e142260. https://doi.org/10.1172/JCI142260

[289] Platten, Michael, Nikolaus Von Knebel Doeberitz, Iris Oezen, Wolfgang Wick, Katharina Ochs. 2014. “Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.” Frontiers in Immunology 5: 673. https://doi.org/10.3389/fimmu.2014.00673

[290] Ghosh, Sweta, Caleb Samuel Whitley, Bodduluri Haribabu, Venkatakrishna Rao Jala. 2021. “Regulation of Intestinal Barrier Function by Microbial Metabolites.” Cellular and Molecular Gastroenterology and Hepatology 11: 1463-1482. https://doi.org/10.1016/j.jcmgh.2021.02.007

[291] Turpin, Williams, Sun-Ho Lee, Juan Antonio Raygoza Garay, Karen L. Madsen, Jonathan B. Meddings, Larbi Bedrani, Namita Power, et al. 2020. “Increased Intestinal Permeability Is Associated With Later Development of Crohn's Disease.” Gastroenterology 159: 2092-100.e5. https://doi.org/10.1053/j.gastro.2020.08.005

[292] Tozzi, Michela, Alessia Fiore, Sara Travaglione, Francesca Marcon, Gabriella Rainaldi, Elena Angela Pia Germinario, Ilenia Laterza, et al. 2025. “E. Coli Cytotoxic Necrotizing Factor-1 Promotes Colorectal Carcinogenesis by Causing Oxidative Stress, DNA Damage and Intestinal Permeability Alteration.” Journal of Experimental & Clinical Cancer Research: CR 44: 29. https://doi.org/10.1186/s13046-024-03271-w

[293] Leibovitzh, Haim, Sun-Ho Lee, Mingyue Xue, Juan Antonio Raygoza Garay, Cristian Hernandez-Rocha, Karen L. Madsen, Jonathan B. Meddings, et al. 2022. “Altered Gut Microbiome Composition and Function Are Associated With Gut Barrier Dysfunction in Healthy Relatives of Patients With Crohn's Disease.” Gastroenterology 163: 1364-76.e10. https://doi.org/10.1053/j.gastro.2022.07.004

[294] Santos, Javier, Maria Rescigno. 2024. “Gut Barrier Leakiness: Time to Take It Seriously?” Gastroenterology 167: 1080-1082. https://doi.org/10.1053/j.gastro.2024.08.011

[295] Magnus, Yorick, Joelle BouSaba, Wassel Sannaa, Sanna McKinzie, Irene Busciglio, Michael Camilleri. 2022. “Bile Acid Diarrhea Is Associated With Increased Intestinal Permeability Compared With Irritable Bowel Syndrome-Diarrhea.” Gastroenterology 162: 1343-5.e1. https://doi.org/10.1053/j.gastro.2021.12.243

[296] Lee, Sun-Ho, Maham Bushra, Lanhui Qiu, Anne M. Griffiths, Williams Turpin, Kenneth Croitoru, Crohn's and Colitis Canada-Genetic, Environmental, Microbial (CCC-GEM) Project Research Consortium, Kenneth Croitoru, Sun-Ho Lee, et al. 2025. “Early Life Exposure to Parental Crohn's Disease Is Associated With Offspring's Gut Microbiome, Gut Permeability, and Increased Risk of Future Crohn's Disease.” Gastroenterology 168: 385-8.e3. https://doi.org/10.1053/j.gastro.2024.09.033

[297] Horowitz, Arie, Sandra D. Chanez-Paredes, Xenia Haest, Jerrold R. Turner. 2023. “Paracellular Permeability and Tight Junction Regulation in Gut Health and Disease.” Nature Reviews Gastroenterology & Hepatology 20: 417-432. https://doi.org/10.1038/s41575-023-00766-3

[298] Chopyk, Daniel M., Arash Grakoui. 2020. “Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.” Gastroenterology 159: 849-863. https://doi.org/10.1053/j.gastro.2020.04.077

[299] Rashidah, Nur Hannah, Siong Meng Lim, Chin Fen Neoh, Majeed, Abu Bakar AbdulTan, Maw Pin, Hui Min Khor, Ai Huey Tan, Siti Hajar Rehiman, Kalavathy Ramasamy,. 2022. “Differential Gut Microbiota and Intestinal Permeability Between Frail and Healthy Older Adults: A Systematic Review.” Ageing Research Reviews 82: 101744. https://doi.org/10.1016/j.arr.2022.101744

[300] Martel, Jan, Shih-Hsin Chang, Yun-Fei Ko, Tsong-Long Hwang, John D. Young, David M. Ojcius. 2022. “Gut Barrier Disruption and Chronic Disease.” Trends in Endocrinology & Metabolism 33: 247-265. https://doi.org/10.1016/j.tem.2022.01.002

[301] Giambra, Vincenzo, Danilo Pagliari, Pierluigi Rio, Beatrice Totti, Chiara Di Nunzio, Annalisa Bosi, Cristina Giaroni, et al. 2023. “Gut Microbiota, Inflammatory Bowel Disease, and Cancer: The Role of Guardians of Innate Immunity.” Cells 12: 2654. https://doi.org/10.3390/cells12222654

[302] Soler, A. P. 1999. “Increased Tight Junctional Permeability Is Associated With the Development of Colon Cancer.” Carcinogenesis 20: 1425-1432. https://doi.org/10.1093/carcin/20.8.1425

[303] Karczewski, Jurgen, Freddy J. Troost, Irene Konings, Jan Dekker, Kleerebezem, MichielBrummer, Robert-Jan M.Wells, Jerry M. 2010. “Regulation of Human Epithelial Tight Junction Proteins by Lactobacillus plantarum In Vivo and Protective Effects on the Epithelial Barrier.” American Journal of Physiology-Gastrointestinal and Liver Physiology 298: G851-G859. https://doi.org/10.1152/ajpgi.00327.2009

[304] Méndez-Sánchez, Nahum, Alejandro Valencia-Rodriguez, Alfonso Vera-Barajas, Ludovico Abenavoli, Emidio Scarpellini, Guadalupe Ponciano-Rodriguez. 2020. “The Mechanism of Dysbiosis in Alcoholic Liver Disease Leading to Liver Cancer.” Hepatoma Research 6: 5. https://doi.org/10.20517/2394-5079.2019.29

[305] Rychter, Anna Maria, Liliana Łykowska-Szuber, Agnieszka Zawada, Aleksandra Szymczak-Tomczak, Alicja Ewa Ratajczak, Kinga Skoracka, Michalina Kolan, Agnieszka Dobrowolska, Iwona Krela-Kaźmierczak. 2023. “Why Does Obesity as an Inflammatory Condition Predispose to Colorectal Cancer?” Journal of Clinical Medicine 12: 2451. https://doi.org/10.3390/jcm12072451

[306] Klein, Gerald L., Bryon W. Petschow, Audrey L. Shaw, Eric Weaver. 2013. “Gut Barrier Dysfunction and Microbial Translocation in Cancer Cachexia: A New Therapeutic Target.” Current Opinion in Supportive and Palliative Care 7: 361-367. https://doi.org/10.1097/SPC.0000000000000017

[307] Wang, Hong-Bo, Peng-Yuan Wang, Xin Wang, Yuan-Lian Wan, Yu-Cun Liu. 2012. “Butyrate Enhances Intestinal Epithelial Barrier Function via Up-Regulation of Tight Junction Protein Claudin-1 Transcription.” Digestive Diseases and Sciences 57: 3126-3135. https://doi.org/10.1007/s10620-012-2259-4

[308] Fachi, José Luís, Jaqueline de Souza Felipe, Laís Passariello Pral, Bruna Karadi Da Silva, Renan Oliveira Corrêa, Mirella Cristiny Pereira De Andrade, Denise Morais Da Fonseca, et al. 2019. “Butyrate Protects Mice From Clostridium Difficile-Induced Colitis Through an HIF-1-Dependent Mechanism.” Cell Reports 27: 750-61.e7. https://doi.org/10.1016/j.celrep.2019.03.054

[309] Chen, Guangxin, Xin Ran, Bai Li, Yuhang Li, Dewei He, Bingxu Huang, Shoupeng Fu, Juxiong Liu, Wei Wang. 2018. “Sodium Butyrate Inhibits Inflammation and Maintains Epithelium Barrier Integrity in a TNBS-Induced Inflammatory Bowel Disease Mice Model.” EBioMedicine 30: 317-325. https://doi.org/10.1016/j.ebiom.2018.03.030

[310] Tong, Yao, Huiru Gao, Qiuchen Qi, Xiaoyan Liu, Juan Li, Jie Gao, Peilong Li, et al. 2021. “High Fat Diet, Gut Microbiome and Gastrointestinal Cancer.” Theranostics 11: 5889-5910. https://doi.org/10.7150/thno.56157

[311] Muszyński, Damian, Anna Kudra, Bartosz Kamil Sobocki, Marcin Folwarski, Ermanno Vitale, Veronica Filetti, Wojciech Dudzic, Karolina Kaźmierczak-Siedlecka, Karol Połom. 2022. “Esophageal Cancer and Bacterial Part of Gut Microbiota—A Multidisciplinary Point of View.” Frontiers in Cellular and Infection Microbiology 12: 1057668. https://doi.org/10.3389/fcimb.2022.1057668

[312] Huang, Hui, Wei Zhong, Xiaojiao Wang, Ying Yang, Tianmu Wu, Runyang Chen, Yanling Liu, Feng He, Jun Li. 2023. “The Role of Gastric Microecological Dysbiosis in Gastric Carcinogenesis.” Frontiers in Microbiology 14: 1218395. https://doi.org/10.3389/fmicb.2023.1218395

[313] Miao, Sainan, Huan Qiu. 2024. “The Microbiome in the Pathogenesis of Lung Cancer: The Role of Microbiome in Lung Cancer Pathogenesis.” APMIS 132: 68-80. https://doi.org/10.1111/apm.13359

[314] Lo, Bobby, Mirabella Zhao, Ida Vind, Johan Burisch. 2021. “The Risk of Extraintestinal Cancer in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis of Population-Based Cohort Studies.” Clinical Gastroenterology and Hepatology 19: 1117-38.e19. https://doi.org/10.1016/j.cgh.2020.08.015

[315] Lavelle, Aonghus, Stéphane Nancey, Jean-Marie Reimund, David Laharie, Philippe Marteau, Xavier Treton, Matthieu Allez, et al. 2022. “Fecal Microbiota and Bile Acids in IBD Patients Undergoing Screening for Colorectal Cancer.” Gut Microbes 14: 2078620. https://doi.org/10.1080/19490976.2022.2078620

[316] Jin, Xuanhong, Liangkun You, Jincheng Qiao, Weidong Han, Hongming Pan. 2024. “Autophagy in Colitis-Associated Colon Cancer: Exploring Its Potential Role in Reducing Initiation and Preventing IBD-Related CAC Development.” Autophagy 20: 242-258. https://doi.org/10.1080/15548627.2023.2259214

[317] Zhao, Rui, Qian-Yi Wan, Yutao Wu, Yong Wang, Ya-Ping Cui, Xiaoding Shen, Xiao Ting Wu. 2021. “Crohn's Disease Instead of UC Might Increase the Risk of Small Bowel Cancer.” Gut 70: 809-810. https://doi.org/10.1136/gutjnl-2020-322201

[318] Wetwittayakhlang, Panu, Petra A. Golovics, Lorant Gonczi, Laszlo Lakatos, Peter L. Lakatos, Gyula David, Zsuzsanna Erdelyi, et al. VESZPREM EPIDEMIOLOGY STUDY GROUP. 2024. “Stable Incidence and Risk Factors of Colorectal Cancer in Ulcerative Colitis: A Population-Based Cohort Between 1977-2020.” Clinical Gastroenterology and Hepatology 22: 191-3.e3. https://doi.org/10.1016/j.cgh.2023.03.022

[319] Shah, Shailja C., Steven H. Itzkowitz. 2022. “Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management.” Gastroenterology 162: 715-30.e3. https://doi.org/10.1053/j.gastro.2021.10.035

[320] Axelrad, Jordan E., Ola Olén, Michael C. Sachs, Rune Erichsen, Lars Pedersen, Jonas Halfvarson, Johan Askling, et al. 2021. “Inflammatory Bowel Disease and Risk of Small Bowel Cancer: A Binational Population-Based Cohort Study From Denmark and Sweden.” Gut 70: 297-308. https://doi.org/10.1136/gutjnl-2020-320945

[321] Elmahdi, Rahma, Camilla E. Lemser, Sandra B. Thomsen, Kristine H. Allin, Manasi Agrawal, Tine Jess. 2022. “Development of Cancer Among Patients With Pediatric-Onset Inflammatory Bowel Disease: A Meta-Analysis of Population-Based Studies.” JAMA Network Open 5: e220595. https://doi.org/10.1001/jamanetworkopen.2022.0595

[322] Li, Junshu, Yanhong Ji, Na Chen, Lei Dai, Hongxin Deng. 2023. “Colitis-Associated Carcinogenesis: Crosstalk Between Tumors, Immune Cells and Gut Microbiota.” Cell & Bioscience 13: 194. https://doi.org/10.1186/s13578-023-01139-8

[323] Deris Zayeri, Zeinab, Abazar Parsi, Saeid Shahrabi, Masoud Kargar, Nader Davari, Najmaldin Saki. 2023. “Epigenetic and Metabolic Reprogramming in Inflammatory Bowel Diseases: Diagnostic and Prognostic Biomarkers in Colorectal Cancer.” Cancer Cell International 23: 264. https://doi.org/10.1186/s12935-023-03117-z

[324] Liang, Bing, Yanhong Wang, Jiazhen Xu, Yingchun Shao, Dongming Xing. 2023. “Unlocking the Potential of Targeting Histone-Modifying Enzymes for Treating IBD and CRC.” Clinical Epigenetics 15: 146. https://doi.org/10.1186/s13148-023-01562-1

[325] Silveira, Denise Sayuri Calheiros, Luciana Chain Veronez, Luís Carlos Lopes-Júnior, Elen Anatriello, Mariângela Ottoboni Brunaldi, Gabriela Pereira-da-Silva. 2020. “Lactobacillus bulgaricus Inhibits Colitis-Associated Cancer via a Negative Regulation of Intestinal Inflammation in Azoxymethane/Dextran Sodium Sulfate Model.” World Journal of Gastroenterology 26: 6782-6794. https://doi.org/10.3748/wjg.v26.i43.6782

[326] Javid, Hossein, Mahsa Akbari Oryani, Sanaz Akbari, Taghi Amiriani, Samaneh Ravanbakhsh, Nastaran Rezagholinejad, Amir-R. Afshari, Mehdi Karimi-Shahri. 2023. “L. plantarum and L. lactis as a Promising Agent in Treatment of Inflammatory Bowel Disease and Colorectal Cancer.” Future Microbiology 18: 1197-1209. https://doi.org/10.2217/fmb-2023-0076

[327] Wittek, Agnes, Babett Steglich, Christian Casar, Oliver Seiz, Philipp Huber, Hanno Ehlken, Dominik Reher, et al. 2024. “A Gradient of Intestinal Inflammation in Primary Sclerosing Cholangitis.” Inflammatory Bowel Diseases 30: 900-910. https://doi.org/10.1093/ibd/izad137

[328] Zhang, Henan, Junrui Wu, Na Li, Rina Wu, Wei Chen. 2023. “Microbial Influence on Triggering and Treatment of Host Cancer: An Intestinal Barrier Perspective.” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer 1878: 188989. https://doi.org/10.1016/j.bbcan.2023.188989

[329] Wang, Lei, Mengfan Li, Yu Gu, Junli Shi, Jing Yan, Xin Wang, Bingqing Li, et al. 2024. “Dietary Flavonoids-Microbiota Crosstalk in Intestinal Inflammation and Carcinogenesis.” The Journal of Nutritional Biochemistry 125: 109494. https://doi.org/10.1016/j.jnutbio.2023.109494

[330] Intratumor Microbes Promote Murine Breast Cancer Cell Invasion. 2022. Cancer Discovery 12: 1407. https://doi.org/10.1158/2159-8290.CD-RW2022-067

[331] Liu, Ning-Ning, Cheng-Xiang Yi, Lu-Qi Wei, Jin-An Zhou, Tong Jiang, Cong-Cong Hu, Lu Wang, et al. 2024. “The Intratumor Mycobiome Promotes Lung Cancer Progression via Myeloid-Derived Suppressor Cells.” Cancer Cell 42: 318-322. https://doi.org/10.1016/j.ccell.2024.01.005

[332] Liu, Ning-Ning, Cheng-Xiang Yi, Lu-Qi Wei, Jin-An Zhou, Tong Jiang, Cong-Cong Hu, Lu Wang, et al. 2023. “The Intratumor Mycobiome Promotes Lung Cancer Progression via Myeloid-Derived Suppressor Cells.” Cancer Cell 41: 1927-44.e9. https://doi.org/10.1016/j.ccell.2023.08.012

[333] Gao, Zhifei, Aimin Jiang, Zizhuo Li, Lingxuan Zhu, Weiming Mou, Weitao Shen, Peng Luo, et al. 2025. “Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development.” Med Research 1(1): 32-61. https://doi.org/10.1002/mdr2.70006

[334] Yu, Chunyue, Zeqi Su, Yicong Li, Yadong Li, Kaige Liu, Fuhao Chu, Ting Liu, Runhua Chen, Xia Ding. 2020. “Dysbiosis of Gut Microbiota Is Associated With Gastric Carcinogenesis in Rats.” Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 126: 110036. https://doi.org/10.1016/j.biopha.2020.110036

[335] Sun, Lejia, Xindi Ke, Ai Guan, Bao Jin, Jiangming Qu, Yinhan Wang, Xiang Xu, et al. 2023. “Intratumoural Microbiome Can Predict the Prognosis of Hepatocellular Carcinoma After Surgery.” Clinical and Translational Medicine 13: e1331. https://doi.org/10.1002/ctm2.1331

[336] Liu, Fangjie, Qiaoting Luo, Yu Xi, Pengxin Zhang, Yingjia Wu, Suping Guo, Yaoling Dong, et al. 2025. “Early Nutritional Intervention in Patients With Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy: A Phase II Prospective Study.” Nutrients 17: 1389. https://doi.org/10.3390/nu17081389

[337] Huang, Jian-Hang, Jie Wang, Xiao-Qiang Chai, Zhong-Chen Li, Ying-Hua Jiang, Jun Li, Xing Liu, et al. 2022. “The Intratumoral Bacterial Metataxonomic Signature of Hepatocellular Carcinoma.” Microbiology Spectrum 10: e0098322. https://doi.org/10.1128/spectrum.00983-22

[338] Fu, Aikun, Bingqing Yao, Tingting Dong, Yongyi Chen, Jia Yao, Yu Liu, Hang Li, et al. 2022. “Tumor-Resident Intracellular Microbiota Promotes Metastatic Colonization in Breast Cancer.” Cell 185: 1356-72.e26. https://doi.org/10.1016/j.cell.2022.02.027

[339] An, Jeongshin, Hyungju Kwon, Young Ju Kim. 2023. “The Firmicutes/Bacteroidetes Ratio as a Risk Factor of Breast Cancer.” Journal of Clinical Medicine 12: 2216. https://doi.org/10.3390/jcm12062216

[340] Mouradov, Dmitri, Paul Greenfield, Shan Li, Eun-Jung In, Claire Storey, Anuratha Sakthianandeswaren, Peter Georgeson, et al. 2023. “Oncomicrobial Community Profiling Identifies Clinicomolecular and Prognostic Subtypes of Colorectal Cancer.” Gastroenterology 165: 104-120. https://doi.org/10.1053/j.gastro.2023.03.205

[341] Zeng, Xuejun, Hang Jia, Xiao Zhang, Xin Wang, Zhouli Wang, Zhenpeng Gao, Yahong Yuan, Tianli Yue. 2021. “Supplementation of Kefir Ameliorates Azoxymethane/Dextran Sulfate Sodium Induced Colorectal Cancer by Modulating the Gut Microbiota.” Food & Function 12: 11641-11655. https://doi.org/10.1039/d1fo01729b

[342] Liu, Yanhong, Jacqueline L. O'Brien, Nadim J. Ajami, Michael E. Scheurer, E. Susan Amirian, Georgina Armstrong, Spiridon Tsavachidis, et al. 2018. “Lung Tissue Microbial Profile in Lung Cancer Is Distinct From Emphysema.” American Journal of Cancer Research 8: 1775-1787.

[343] Yu, Guoqin, Mitchell H. Gail, Dario Consonni, Michele Carugno, Michael Humphrys, Angela C. Pesatori, Neil E. Caporaso, et al. 2016. “Characterizing Human Lung Tissue Microbiota and Its Relationship to Epidemiological and Clinical Features.” Genome Biology 17: 163. https://doi.org/10.1186/s13059-016-1021-1

[344] Jang, Hye Jin, Ji Yeon Choi, Kangjoon Kim, Seung Hyun Yong, Yeon Wook Kim, Song Yee Kim, Eun Young Kim, et al. 2021. “Relationship of the Lung Microbiome With PD-L1 Expression and Immunotherapy Response in Lung Cancer.” Respiratory Research 22: 322. https://doi.org/10.1186/s12931-021-01919-1

[345] Hilmi, Marc, Maud Kamal, Sophie Vacher, Célia Dupain, Sabrina Ibadioune, Maral Halladjian, Marie Paule Sablin, et al. 2023. “Intratumoral Microbiome Is Driven by Metastatic Site and Associated With Immune Histopathological Parameters: An Ancillary Study of the SHIVA Clinical Trial.” European Journal of Cancer 183: 152-161. https://doi.org/10.1016/j.ejca.2023.01.024

[346] Peng, Shengkun, Anqi Lin, Aimin Jiang, Cangang Zhang, Jian Zhang, Quan Cheng, Peng Luo, Yifeng Bai. 2024. “CTLs Heterogeneity and Plasticity: Implications for Cancer Immunotherapy.” Molecular Cancer 23: 58. https://doi.org/10.1186/s12943-024-01972-6

[347] Zhu, Zhuxian, Jixu Cai, Weiwei Hou, Ke Xu, Xuxiao Wu, Yuanlin Song, Chunxue Bai, Yin-Yuan Mo, Ziqiang Zhang. 2023. “Microbiome and Spatially Resolved Metabolomics Analysis Reveal the Anticancer Role of Gut Akkermansia muciniphila by Crosstalk With Intratumoral Microbiota and Reprogramming Tumoral Metabolism in Mice.” Gut Microbes 15: 2166700. https://doi.org/10.1080/19490976.2023.2166700

[348] Abed, Jawad, Johanna E. M. Emgård, Gideon Zamir, Mouhammad Faroja, Gideon Almogy, Amalie Grenov, Asaf Sol, et al. 2016. “Fap2 Mediates Fusobacterium nucleatum Colorectal Adenocarcinoma Enrichment by Binding to Tumor-Expressed Gal-GalNAc.” Cell Host & Microbe 20: 215-225. https://doi.org/10.1016/j.chom.2016.07.006

[349] Wong-Rolle, Abigail, Qiang Dong, Yunhua Zhu, Prajan Divakar, Jyh Liang Hor, Noemi Kedei, Madeline Wong, et al. 2022. “Spatial Meta-Transcriptomics Reveal Associations of Intratumor Bacteria Burden With Lung Cancer Cells Showing a Distinct Oncogenic Signature.” Journal for Immunotherapy of Cancer 10: e004698. https://doi.org/10.1136/jitc-2022-004698

[350] Shirai, Hiroaki, Cocoro Ito, Kosuke Tsukada. 2022. “pH-Taxis Drives Aerobic Bacteria in Duodenum to Migrate Into the Pancreas With Tumors.” Scientific Reports 12: 1783. https://doi.org/10.1038/s41598-022-05554-8

[351] Zhang, Zhilin, Yiqun Liao, Dong Tang. 2022. “Intratumoral Microbiota: New Frontiers in Tumor Immunity.” Carcinogenesis 43: 719-727. https://doi.org/10.1093/carcin/bgac063

[352] Peng, Fei, Mengyuan Hu, Zhiyue Su, Lin Hu, Lingchuan Guo, Kai Yang. 2024. “Intratumoral Microbiota as a Target for Advanced Cancer Therapeutics.” Advanced Materials 36: e2405331. https://doi.org/10.1002/adma.202405331

[353] Lu, Ying-Qi, Han Qiao, Xi-Rong Tan, Na Liu. 2024. “Broadening Oncological Boundaries: The Intratumoral Microbiota.” Trends in Microbiology 32: 807-822. https://doi.org/10.1016/j.tim.2024.01.007

[354] Ferrari, Valentina, Maria Rescigno. 2023. “The Intratumoral Microbiota: Friend or Foe?” Trends in Cancer 9: 472-479. https://doi.org/10.1016/j.trecan.2023.03.005

[355] Zhang, Baochun, Il-Kyu Choi. 2022. “Facts and Hopes in the Relationship of EBV With Cancer Immunity and Immunotherapy.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 28: 4363-4369. https://doi.org/10.1158/1078-0432.CCR-21-3408

[356] Yang, Jing, Zhifeng Liu, Bin Zeng, Hu, GuangshengGan, Runliang. 2020. “Epstein-Barr Virus-Associated Gastric Cancer: A Distinct Subtype.” Cancer Letters 495: 191-199. https://doi.org/10.1016/j.canlet.2020.09.019

[357] Berti, Fernanda Costa Brandão, Ana Paula Lombardi Pereira, Guilherme Cesar Martelossi Cebinelli, Kleber Paiva Trugilo, Karen Brajão de Oliveira. 2017. “The Role of Interleukin 10 in Human Papilloma Virus Infection and Progression to Cervical Carcinoma.” Cytokine & Growth Factor Reviews 34: 1-13. https://doi.org/10.1016/j.cytogfr.2017.03.002

[358] Zur Hausen, Harald. 2002. “Papillomaviruses and Cancer: From Basic Studies to Clinical Application.” Nature Reviews Cancer 2: 342-350. https://doi.org/10.1038/nrc798

[359] Zheng, Zhi-Ming. 2010. “Viral Oncogenes, Noncoding RNAs, and RNA Splicing in Human Tumor Viruses.” International Journal of Biological Sciences 6: 730-755. https://doi.org/10.7150/ijbs.6.730

[360] Tu, Thomas, Magdalena Budzinska, Nicholas Shackel, Stephan Urban. 2017. “HBV DNA Integration: Molecular Mechanisms and Clinical Implications.” Viruses 9: 75. https://doi.org/10.3390/v9040075

[361] Tan, Benjy J. Y., Kenji Sugata, Omnia Reda, Misaki Matsuo, Kyosuke Uchiyama, Paola Miyazato, Vincent Hahaut, et al. 2021. “HTLV-1 Infection Promotes Excessive T Cell Activation and Transformation Into Adult T Cell Leukemia/Lymphoma.” The Journal of Clinical Investigation 131: e150472. https://doi.org/10.1172/JCI150472

[362] He, Yunlong, Nagesh Pasupala, Huijun Zhi, Batsuhk Dorjbal, Imran Hussain, Hsiu-Ming Shih, Sharmistha Bhattacharyya, et al. 2021. “NF-κB-Induced R-Loop Accumulation and DNA Damage Select for Nucleotide Excision Repair Deficiencies in Adult T Cell Leukemia.” Proceedings of the National Academy of Sciences of the United States of America 118: e2005568118. https://doi.org/10.1073/pnas.2005568118

[363] Ameya, Gemechu, Dagim Jirata Birri. 2023. “The Molecular Mechanisms of Virus-Induced Human Cancers.” Microbial Pathogenesis 183: 106292. https://doi.org/10.1016/j.micpath.2023.106292

[364] Chen, Jiezhong. 2015. “Signaling Pathways in HPV-Associated Cancers and Therapeutic Implications.” Reviews in Medical Virology 25Suppl 1: 24-53. https://doi.org/10.1002/rmv.1823

[365] Stanland, Lyla J., Micah A. Luftig. 2020. “The Role of EBV-Induced Hypermethylation in Gastric Cancer Tumorigenesis.” Viruses 12: 1222. https://doi.org/10.3390/v12111222

[366] Lamontagne, R. Jason, Sumedha Bagga, Michael J. Bouchard. 2016. “Hepatitis B Virus Molecular Biology and Pathogenesis.” Hepatoma Research 2: 163-186. https://doi.org/10.20517/2394-5079.2016.05

[367] Yeh, Chau-Ting 2000. “Hepatitis B Virus X Protein: Searching for a Role in Hepatocarcinogenesis.” Journal of Gastroenterology and Hepatology 15: 339-341. https://doi.org/10.1046/j.1440-1746.2000.02166.x

[368] Levrero, Massimo, Jessica Zucman-Rossi. 2016. “Mechanisms of HBV-Induced Hepatocellular Carcinoma.” Journal of Hepatology 64: S84-S101. https://doi.org/10.1016/j.jhep.2016.02.021

[369] Wu, Qiong, Lu Zhang, Xiazhen Xu, Yi Zhang, Jiajian Shi, Xu Lin, Wannan Chen. 2022. “Hepatitis B Virus X Protein Is Stabilized by the Deubiquitinating Enzyme VCPIP1 in a Ubiquitin-Independent Manner by Recruiting the 26S Proteasome Subunit PSMC3.” Journal of Virology 96: e0061122. https://doi.org/10.1128/jvi.00611-22

[370] Kim, Chang-Min, Kazuhiko Koike, Izumu Saito, Tatsuo Miyamura, Gilbert Jay. 1991. “HBx Gene of Hepatitis B Virus Induces Liver Cancer in Transgenic Mice.” Nature 351: 317-320. https://doi.org/10.1038/351317a0

[371] Pol, Stanislas, Anaïs Vallet-Pichard, Olivier Hermine. 2018. “Extrahepatic Cancers and Chronic HCV Infection.” Nature Reviews Gastroenterology & Hepatology 15: 283-290. https://doi.org/10.1038/nrgastro.2017.172

[372] Liang, T. JakeHeller, Theo. 2004. “Pathogenesis of Hepatitis C-Associated Hepatocellular Carcinoma.” Gastroenterology 127: S62-S71. https://doi.org/10.1053/j.gastro.2004.09.017

[373] Cinatl, Jindrich, Martin Scholz, Hans Wilhelm Doerr. 2005. “Role of Tumor Cell Immune Escape Mechanisms in Cytomegalovirus-Mediated Oncomodulation.” Medicinal Research Reviews 25: 167-185. https://doi.org/10.1002/med.20018

[374] Doorbar, John, Nagayasu Egawa, Heather Griffin, Christian Kranjec, Isao Murakami. 2015. “Human Papillomavirus Molecular Biology and Disease Association.” Reviews in Medical Virology 25Suppl 1: 2-23. https://doi.org/10.1002/rmv.1822

[375] Tian, Tian, Cai Aijie, Huang Bingxue, Dai Jianghong. 2016. “Research Progress of Human Papilloma Virus Immune Evasion Mechanisms.” Chinese Journal of Disease Control and Prevention 20: 1172-1175. https://doi.org/10.16462/j.cnki.zhjbkz.2016.11.024

[376] Židovec Lepej, Snježana, Maja Matulić, Paula Gršković, Mirjana Pavlica, Leona Radmanić, Petra Korać. 2020. “miRNAs: EBV Mechanism for Escaping Host's Immune Response and Supporting Tumorigenesis.” Pathogens (Basel, Switzerland) 9: 353. https://doi.org/10.3390/pathogens9050353

[377] Yang, Pengyuan, Geoffrey J. Markowitz, Xiao-Fan Wang. 2014. “The Hepatitis B Virus-Associated Tumor Microenvironment in Hepatocellular Carcinoma.” National Science Review 1: 396-412. https://doi.org/10.1093/nsr/nwu038

[378] Narunsky-Haziza, Lian, Gregory D. Sepich-Poore, Ilana Livyatan, Omer Asraf, Cameron Martino, Deborah Nejman, Nancy Gavert, et al. 2022. “Pan-Cancer Analyses Reveal Cancer-Type-Specific Fungal Ecologies and Bacteriome Interactions.” Cell 185: 3789-806.e17. https://doi.org/10.1016/j.cell.2022.09.005

[379] Rahal, Zahraa, Humam Kadara. 2023. “Beyond Bacteria: How the Intratumor Mycobiome Modulates Lung Adenocarcinoma Progression.” Cancer Cell 41: 1846-1848. https://doi.org/10.1016/j.ccell.2023.09.002

[380] Li, Xin, Deepak Saxena. 2022. “The Mycobiome-Immune Axis: The Next Frontier in Pancreatic Cancer.” Cancer Cell 40: 120-122. https://doi.org/10.1016/j.ccell.2022.01.009

[381] Alam, Aftab, Eric Levanduski, Parker Denz, Helena Solleiro Villavicencio, Maulasri Bhatta, Lamees Alhorebi, Yali Zhang, et al. 2022. “Fungal Mycobiome Drives IL-33 Secretion and Type 2 Immunity in Pancreatic Cancer.” Cancer Cell 40: 153-67.e11. https://doi.org/10.1016/j.ccell.2022.01.003

[382] Chevalier, Mathieu F., Sara Trabanelli, Julien Racle, Bérengère Salomé, Valérie Cesson, Dalila Gharbi, Perrine Bohner, et al. 2017. “ILC2-Modulated T Cell-to-MDSC Balance Is Associated With Bladder Cancer Recurrence.” The Journal of Clinical Investigation 127: 2916-2929. https://doi.org/10.1172/JCI89717

[383] Liu, Lanxiang, Haiyang Wang, Xueyi Chen, Yangdong Zhang, Hanping Zhang, Peng Xie. 2023. “Gut Microbiota and Its Metabolites in Depression: From Pathogenesis to Treatment.” EBioMedicine 90: 104527. https://doi.org/10.1016/j.ebiom.2023.104527

[384] Li, Xinpei, Shijie Shang, Meng Wu, Qian Song, Dawei Chen. 2024. “Gut Microbial Metabolites in Lung Cancer Development and Immunotherapy: Novel Insights Into Gut-Lung Axis.” Cancer Letters 598: 217096. https://doi.org/10.1016/j.canlet.2024.217096

[385] Koh, Ara, Filipe De Vadder, Petia Kovatcheva-Datchary, Fredrik Bäckhed. 2016. “From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites.” Cell 165: 1332-1345. https://doi.org/10.1016/j.cell.2016.05.041

[386] Jia, Dingjiacheng, Zheng Kuang, Liangjing Wang. 2024. “The Role of Microbial Indole Metabolites in Tumor.” Gut Microbes 16: 2409209. https://doi.org/10.1080/19490976.2024.2409209

[387] Descamps, Hélène C., Beatrice Herrmann, Daphne Wiredu, Christoph?A. Thaiss. 2019. “The Path Toward Using Microbial Metabolites as Therapies.” EBioMedicine 44: 747-754. https://doi.org/10.1016/j.ebiom.2019.05.063

[388] Qiu, Zilin, Zhengrui Li, Cangang Zhang, Qun Zhao, Zaoqu Liu, Quan Cheng, Jian Zhang, Anqi Lin, Peng Luo. 2025. “NK Cell Senescence in Cancer: From Molecular Mechanisms to Therapeutic Opportunities.” Aging and Disease. https://doi.org/10.14336/AD.2025.0053

[389] Wang, Zeyu, Ziyu Dai, Hao Zhang, Nan Zhang, Xisong Liang, Luo Peng, Jian Zhang, et al. 2023. “Comprehensive Analysis of Pyroptosis-Related Gene Signatures for Glioblastoma Immune Microenvironment and Target Therapy.” Cell Proliferation 56: e13376. https://doi.org/10.1111/cpr.13376

[390] Huang, Lihaoyun, Cangang Zhang, Aimin Jiang, Anqi Lin, Lingxuan Zhu, Weiming Mou, Dongqiang Zeng, et al. 2025. “T-Cell Senescence in the Tumor Microenvironment.” Cancer Immunology Research 13: 618-632. https://doi.org/10.1158/2326-6066.CIR-24-0894

[391] Lin, Anqi, Ting Wei, Hui Meng, Peng Luo, Jian Zhang. 2019. “Role of the Dynamic Tumor Microenvironment in Controversies Regarding Immune Checkpoint Inhibitors for the Treatment of Non-Small Cell Lung Cancer (NSCLC) With EGFR Mutations.” Molecular Cancer 18: 139. https://doi.org/10.1186/s12943-019-1062-7

[392] Ma, Jiayao, Lingjuan Huang, Die Hu, Shan Zeng, Ying Han, Hong Shen. 2021. “The Role of the Tumor Microbe Microenvironment in the Tumor Immune Microenvironment: Bystander, Activator, or Inhibitor?” Journal of Experimental & Clinical Cancer Research: CR 40: 327. https://doi.org/10.1186/s13046-021-02128-w

[393] Li, Yu, Cangang Zhang, Aimin Jiang, Anqi Lin, Zaoqu Liu, Xiangshu Cheng, Wanting Wang, et al. 2024. “Potential Anti-Tumor Effects of Regulatory T Cells in the Tumor Microenvironment: A Review.” Journal of Translational Medicine 22: 293. https://doi.org/10.1186/s12967-024-05104-y

[394] Bender, Mackenzie J., Alex C. McPherson, Catherine M. Phelps, Surya P. Pandey, Colin R. Laughlin, Jake H. Shapira, Luzmariel Medina Sanchez, et al. 2023. “Dietary Tryptophan Metabolite Released by Intratumoral Lactobacillus reuteri Facilitates Immune Checkpoint Inhibitor Treatment.” Cell 186: 1846-62.e26. https://doi.org/10.1016/j.cell.2023.03.011

[395] Wang, Yan, Mingshuai Bai, Qifan Peng, Leping Li, Feng Tian, Ying Guo, Changqing Jing. 2024. “Angiogenesis, a Key Point in the Association of Gut Microbiota and Its Metabolites With Disease.” European Journal of Medical Research 29: 614. https://doi.org/10.1186/s40001-024-02224-5

[396] Liu, Jiankun, Yuzhong Duan, Xiaoming Cheng, Xi Chen, Wei Xie, Haixia Long, Zhihua Lin, Bo Zhu. 2011. “IL-17 Is Associated With Poor Prognosis and Promotes Angiogenesis via Stimulating VEGF Production of Cancer Cells in Colorectal Carcinoma.” Biochemical and Biophysical Research Communications 407: 348-354. https://doi.org/10.1016/j.bbrc.2011.03.021

[397] Abe, Shohei, Atsuhiro Masuda, Tomonori Matsumoto, Jun Inoue, Hirochika Toyama, Arata Sakai, Takashi Kobayashi, et al. 2024. “Impact of Intratumoral Microbiome on Tumor Immunity and Prognosis in Human Pancreatic Ductal Adenocarcinoma.” Journal of Gastroenterology 59: 250-262. https://doi.org/10.1007/s00535-023-02069-5

[398] Zhang, Shuyue, Shuishen Zhang, Xiaofan Ma, Jing Zhan, Chuqing Pan, Huizhong Zhang, Xiuying Xie, Jing Wen, Xuan Xie. 2023. “Intratumoral Microbiome Impacts Immune Infiltrates in Tumor Microenvironment and Predicts Prognosis in Esophageal Squamous Cell Carcinoma Patients.” Frontiers in Cellular and Infection Microbiology 13: 1165790. https://doi.org/10.3389/fcimb.2023.1165790

[399] Gao, Kan, Chun-Long Mu, Aitak Farzi, Wei-Yun Zhu. 2020. “Tryptophan Metabolism: A Link Between the Gut Microbiota and Brain.” Advances in Nutrition 11: 709-723. https://doi.org/10.1093/advances/nmz127

[400] Peters, Marloes A. M., Annemiek M. E. Walenkamp, Ido P. Kema, Coby Meijer, Elisabeth G. E. De Vries, Sjoukje F. Oosting. 2014. “Dopamine and Serotonin Regulate Tumor Behavior by Affecting Angiogenesis.” Drug Resistance Updates 17: 96-104. https://doi.org/10.1016/j.drup.2014.09.001

[401] Yang, Qiqing, Bin Wang, Qinghui Zheng, Heyu Li, Xuli Meng, Fangfang Zhou, Long Zhang. 2023. “A Review of Gut Microbiota-Derived Metabolites in Tumor Progression and Cancer Therapy.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 10: e2207366. https://doi.org/10.1002/advs.202207366

[402] Liu, Yali, Harry Cheuk-Hay Lau, Jun Yu. 2023. “Microbial Metabolites in Colorectal Tumorigenesis and Cancer Therapy.” Gut Microbes 15: 2203968. https://doi.org/10.1080/19490976.2023.2203968

[403] Hofmanová, J., A. Vaculová, A. Lojek, A. Kozubík. 2005. “Interaction of Polyunsaturated Fatty Acids and Sodium Butyrate During Apoptosis in HT-29 Human Colon Adenocarcinoma Cells.” European Journal of Nutrition 44: 40-51. https://doi.org/10.1007/s00394-004-0490-2

[404] Choi, Juliana K., Samer A. Naffouje, Masahide Goto, Jing Wang, Konstantin Christov, David J. Rademacher, Albert Green, et al. 2023. “Cross-Talk Between Cancer and Pseudomonas aeruginosa Mediates Tumor Suppression.” Communications Biology 6: 16. https://doi.org/10.1038/s42003-022-04395-5

[405] Li, Ruomeng, Jing Li, Xikun Zhou. 2024. “Lung Microbiome: New Insights Into the Pathogenesis of Respiratory Diseases.” Signal Transduction and Targeted Therapy 9: 19. https://doi.org/10.1038/s41392-023-01722-y

[406] Dickson, Robert P., John R. Erb-Downward, Fernando J. Martinez, Gary B. Huffnagle. 2016. “The Microbiome and the Respiratory Tract.” Annual Review of Physiology 78: 481-504. https://doi.org/10.1146/annurev-physiol-021115-105238

[407] Łaniewski, Paweł, Zehra Esra Ilhan, Melissa M. Herbst-Kralovetz. 2020. “The Microbiome and Gynaecological Cancer Development, Prevention and Therapy.” Nature Reviews Urology 17: 232-250. https://doi.org/10.1038/s41585-020-0286-z

[408] Markowski, Mark C., Stephen A. Boorjian, Jeremy P. Burton, Noah M. Hahn, Molly A. Ingersoll, Saman Maleki Vareki, Sumanta K. Pal, Karen S. Sfanos. 2019. “The Microbiome and Genitourinary Cancer: A Collaborative Review.” European Urology 75: 637-646. https://doi.org/10.1016/j.eururo.2018.12.043

[409] Scharschmidt, Tiffany C., Julia A. Segre. 2025. “Skin Microbiome and Dermatologic Disorders.” The Journal of Clinical Investigation 135: e184315. https://doi.org/10.1172/JCI184315

[410] Boxberger, Manon, Valérie Cenizo, Nadim Cassir, Bernard La Scola. 2021. “Challenges in Exploring and Manipulating the Human Skin Microbiome.” Microbiome 9: 125. https://doi.org/10.1186/s40168-021-01062-5

[411] Sedghi, Lea, Vincent DiMassa, Anthony Harrington, Susan V. Lynch, Yvonne L. Kapila. 2021. “The Oral Microbiome: Role of Key Organisms and Complex Networks in Oral Health and Disease.” Periodontology 2000 87: 107-131. https://doi.org/10.1111/prd.12393

[412] Lim, Yenkai, Makrina Totsika, Mark Morrison, Chamindie Punyadeera. 2017. “Oral Microbiome: A New Biomarker Reservoir for Oral and Oropharyngeal Cancers.” Theranostics 7: 4313-4321. https://doi.org/10.7150/thno.21804

[413] Yang, Zhixin, Shiyu Zhang, Ning Ji, Jing Li, Qianming Chen. 2024. “The Evil Companion of OSCC: Candida albicans.” Oral Diseases 30: 1873-1886. https://doi.org/10.1111/odi.14700

[414] Diwan, Prerna, Mohit Nirwan, Mayank Bahuguna, Shashi Prabha Kumari, James Wahlang, Rakesh Kumar Gupta. 2023. “Evaluating Alterations of the Oral Microbiome and Its Link to Oral Cancer among Betel Quid Chewers: Prospecting Reversal Through Probiotic Intervention.” Pathogens (Basel, Switzerland) 12: 996. https://doi.org/10.3390/pathogens12080996

[415] Karpiński, Tomasz M. 2019. “Role of Oral Microbiota in Cancer Development.” Microorganisms 7: 20. https://doi.org/10.3390/microorganisms7010020

[416] Saikia, Partha Jyoti, Lekhika Pathak, Shirsajit Mitra, Bikul Das 2023. “The Emerging Role of Oral Microbiota in Oral Cancer Initiation, Progression and Stemness.” Frontiers in Immunology 14: 1198269. https://doi.org/10.3389/fimmu.2023.1198269

[417] Ramirez-Garcia, Andoni, Aitor Rementeria, Jose Manuel Aguirre-Urizar, Maria Dolores Moragues, Aitziber Antoran, Aize Pellon, Ana Abad-Diaz-de-Cerio, Fernando Luis Hernando. 2016. “Candida albicans and Cancer: Can This Yeast Induce Cancer Development or Progression?” Critical Reviews in Microbiology 42: 181-193. https://doi.org/10.3109/1040841X.2014.913004

[418] Arzmi, Mohd Hafiz, Stuart Dashper, Michael McCullough. 2019. “Polymicrobial Interactions of Candida albicans and Its Role in Oral Carcinogenesis.” Journal of Oral Pathology & Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 48: 546-551. https://doi.org/10.1111/jop.12905

[419] Madhusudhan, Nandhitha, Manuela R. Pausan, Bettina Halwachs, Marija Durdević, Markus Windisch, Jan Kehrmann, VijayKumar Patra, et al. 2020. “Molecular Profiling of Keratinocyte Skin Tumors Links Staphylococcus aureus Overabundance and Increased Human β-Defensin-2 Expression to Growth Promotion of Squamous Cell Carcinoma.” Cancers 12: 541. https://doi.org/10.3390/cancers12030541

[420] Nakatsuji, Teruaki, Tiffany H. Chen, Anna M. Butcher, Lynnie L. Trzoss, Sang-Jip Nam, Karina T. Shirakawa, Wei Zhou, et al. 2018. “A Commensal Strain of Staphylococcus epidermidis Protects Against Skin Neoplasia.” Science Advances 4: eaao4502. https://doi.org/10.1126/sciadv.aao4502

[421] Bhardwaj, Sanjeev K., Harpreet Singh, Akash Deep, Madhu Khatri, Jayeeta Bhaumik, Ki-Hyun Kim, Neha Bhardwaj. 2021. “UVC-Based Photoinactivation as an Efficient Tool to Control the Transmission of Coronaviruses.” Science of The Total Environment 792: 148548. https://doi.org/10.1016/j.scitotenv.2021.148548

[422] Patel, Tejas, L. Katie Morrison, Peter Rady, Stephen Tyring. 2010. “Epidermodysplasia Verruciformis and Susceptibility to HPV.” Disease Markers 29: 199-206. https://doi.org/10.1155/2010/345436

[423] Hussein, Ahmed A., Tariq A. Bhat, Zhe Jing, Eduardo Cortes Gomez, Mahmood Abdul Wasay, Prashant K. Singh, Song Liu, Gary Smith, Khurshid A. Guru. 2023. “Does the Urinary Microbiome Profile Change After Treatment of Bladder Cancer?” World Journal of Urology 41: 3593-3598. https://doi.org/10.1007/s00345-023-04627-1

[424] Prakash, Pranav, Shiv Verma, Sanjay Gupta. 2024. “Influence of Microbiome in Intraprostatic Inflammation and Prostate Cancer.” The Prostate 84: 1179-1188. https://doi.org/10.1002/pros.24756

[425] Li, Xiaoge, Jin Wu, Yutong Wu, Zhaoning Duan, Ming Luo, Ling Li, Sijing Li, Ying Jia. 2023. “Imbalance of Vaginal Microbiota and Immunity: Two Main Accomplices of Cervical Cancer in Chinese Women.” International Journal of Women's Health 15: 987-1002. https://doi.org/10.2147/IJWH.S406596

[426] Kombe, Arnaud John KombeZoa-Assoumou, SamiraBounda, Guy-ArmelNsole-Biteghe, Fleury-AugustinJin, TengchuanZouré, Abdou Azaque. 2023. “Advances in Etiopathological Role and Control of HPV in Cervical Cancer Oncogenesis.” Frontiers in Bioscience-Landmark 28: 245. https://doi.org/10.31083/j.fbl2810245

[427] Zhang, Yong, Xiangxiang Chen, Yuan Wang, Ling Li, Qing Ju, Yan Zhang, Hangtian Xi, et al. 2023. “Alterations of Lower Respiratory Tract Microbiome and Short-Chain Fatty Acids in Different Segments in Lung Cancer: A Multiomics Analysis.” Frontiers in Cellular and Infection Microbiology 13: 1261284. https://doi.org/10.3389/fcimb.2023.1261284

[428] Bello, Salvador, José J. Vengoechea, Manuel Ponce-Alonso, Ana L. Figueredo, Elisa Mincholé, Antonio Rezusta, Paula Gambó, et al. 2021. “Core Microbiota in Central Lung Cancer With Streptococcal Enrichment as a Possible Diagnostic Marker.” Archivos De Bronconeumologia 57: 681-689. https://doi.org/10.1016/j.arbres.2020.05.034

[429] Tsay, Jun-Chieh J., Benjamin G. Wu, Imran Sulaiman, Katherine Gershner, Rosemary Schluger, Yonghua Li, Ting-An Yie, et al. 2021. “Lower Airway Dysbiosis Affects Lung Cancer Progression.” Cancer Discovery 11: 293-307. https://doi.org/10.1158/2159-8290.CD-20-0263

[430] Apopa, Patrick L., Lisa Alley, Rosalind B. Penney, Konstantinos Arnaoutakis, Mathew A. Steliga, Susan Jeffus, Emine Bircan, et al. 2018. “PARP1 Is Up-Regulated in Non-Small Cell Lung Cancer Tissues in the Presence of the Cyanobacterial Toxin Microcystin.” Frontiers in Microbiology 9: 1757. https://doi.org/10.3389/fmicb.2018.01757

[431] Lan, Zhou, Wei-Jia Liu, Hao Cui, Ke-Long Zou, Hao Chen, Yu-Yue Zhao, Guang-Tao Yu. 2023. “The Role of Oral Microbiota in Cancer.” Frontiers in Microbiology 14: 1253025. https://doi.org/10.3389/fmicb.2023.1253025

[432] Drokow, Emmanuel Kwateng, Clement Yaw Effah, Clement Agboyibor, Jemima Twumwaah Budu, Francisca Arboh, Priscilla Akyaa Kyei-Baffour, Yao Xiao, Fan Zhang, Irene Xy Wu. 2023. “Microbial Infections as Potential Risk Factors for Lung Cancer: Investigating the Role of Human Papillomavirus and Chlamydia pneumoniae.” AIMS Public Health 10: 627-646. https://doi.org/10.3934/publichealth.2023044

[433] Aitmanaitė, Lina, Karolis Širmonaitis, Giancarlo Russo. 2023. “Microbiomes, Their Function, and Cancer: How Metatranscriptomics Can Close the Knowledge Gap.” International Journal of Molecular Sciences 24: 13786. https://doi.org/10.3390/ijms241813786

[434] Actis, Silvia, Massimiliano Cazzaniga, Valentina Elisabetta Bounous, Marta D'Alonzo, Roberta Rosso, Francesca Accomasso, Carola Minella, Nicoletta Biglia. 2023. “Emerging Evidence on the Role of Breast Microbiota on the Development of Breast Cancer in High-Risk Patients.” Carcinogenesis 44: 718-725. https://doi.org/10.1093/carcin/bgad071

[435] Xuan, Caiyun, Jaime M. Shamonki, Alice Chung, Maggie L. Dinome, Maureen Chung, Peter A. Sieling, Delphine J. Lee. 2014. “Microbial Dysbiosis Is Associated With Human Breast Cancer.” PloS One 9: e83744. https://doi.org/10.1371/journal.pone.0083744

[436] Colbert, Lauren E., Molly B. El Alam, Rui Wang, Tatiana Karpinets, David Lo, Erica J. Lynn, Timothy A. Harris, et al. 2023. “Tumor-Resident Lactobacillus iners Confer Chemoradiation Resistance Through Lactate-Induced Metabolic Rewiring.” Cancer Cell 41: 1945-62.e11. https://doi.org/10.1016/j.ccell.2023.09.012

[437] Jian, Xingxing, Yinghong Zhu, Jian Ouyang, Yihui Wang, Qian Lei, Jiliang Xia, Yongjun Guan, et al. 2020. “Alterations of Gut Microbiome Accelerate Multiple Myeloma Progression by Increasing the Relative Abundances of Nitrogen-Recycling Bacteria.” Microbiome 8: 74. https://doi.org/10.1186/s40168-020-00854-5

[438] Zheng, Xiao-Hui, Xi-Zhao Li, Cao-Li Tang, Yu-Meng Zhang, Ting Zhou, Xiao-Jing Yang, Ying Liao, et al. 2024. “Detection of Epstein‒Barr Virus DNA Methylation as Tumor Markers of Nasopharyngeal Carcinoma Patients in Saliva, Oropharyngeal Swab, Oral Swab, and Mouthwash.” MedComm 5: e673. https://doi.org/10.1002/mco2.673

[439] Muñoz-Grez, Camila Paz, Mabel Angélica Vidal, Tamara Beatriz Rojas, Luciano Esteban Ferrada, Felipe Andrés Zuñiga, Agustin Andrés Vera, Sergio Andrés Sanhueza, et al. 2025. “Host-Microbe Computational Proteomic Landscape in Oral Cancer Revealed Key Functional and Metabolic Pathways Between Fusobacterium nucleatum and Cancer Progression.” International Journal of Oral Science 17, 1: 1. https://doi.org/10.1038/s41368-024-00326-8

[440] Wang, Xiu-Li, Hua-Wen Xu, Ning-Ning Liu. 2023. “Oral Microbiota: A New Insight into Cancer Progression, Diagnosis and Treatment.” Phenomics 3: 535-547. https://doi.org/10.1007/s43657-023-00124-y

[441] Anjali, Kanadan, Muhammed Manzoor, Mangesh Vasant Suryavanshi, Parthiban Rudrapathy, Punchappady Devasya Rekha, Ranajit Das, Asif Hameed, Ananthapadmanabha Bhagwath Arun. 2023. “Dysbiosis of the Oral Microbiota Composition Is Associated With Oral Squamous Cell Carcinoma and the Impact of Radiotherapy: A Pilot Study.” FEMS Microbiology Letters 370: fnad111. https://doi.org/10.1093/femsle/fnad111

[442] Mauceri, Rodolfo, Martina Coppini, Davide Vacca, Giorgio Bertolazzi, Valeria Cancila, Claudio Tripodo, Giuseppina Campisi. 2023. “No Clear Clustering Dysbiosis From Salivary Microbiota Analysis by Long Sequencing Reads in Patients Affected by Oral Squamous Cell Carcinoma: A Single Center Study.” Cancers 15: 4211. https://doi.org/10.3390/cancers15174211

[443] Han, Zewen, Yichen Hu, Xin Lin, Hongyu Cheng, Biao Dong, Xuan Liu, Buling Wu, Zhenjiang Zech Xu. 2025. “Systematic Analyses Uncover Robust Salivary Microbial Signatures and Host-Microbiome Perturbations in Oral Squamous Cell Carcinoma.” mSystems 10: e0124724. https://doi.org/10.1128/msystems.01247-24

[444] Wang, Zizheng, Yilong Chen, Haoning Li, Yuan Yue, Haopeng Yu. 2025. “Exploring Oral Microbiome in Oral Squamous Cell Carcinoma Across Environment-Associated Sample Types.” Microbiology Spectrum 13: e0085224. https://doi.org/10.1128/spectrum.00852-24

[445] Li, Shuluan, Tianyu Wang, Ya Ren, Zhou Liu, Jidong Gao, Zhi Guo. 2024. “Prognostic Impact of Oral Microbiome on Survival of Malignancies: A Systematic Review and Meta-Analysis.” Systematic Reviews 13: 41. https://doi.org/10.1186/s13643-023-02419-7

[446] Monson, Kelsey R., Brandilyn A. Peters, Mykhaylo Usyk, Caroline Y. Um, Paul E. Oberstein, Marjorie L. McCullough, Mark P. Purdue, et al. 2022. “Elevated Dietary Carbohydrate and Glycemic Intake Associate With an Altered Oral Microbial Ecosystem in Two Large U.S. Cohorts.” Cancer Research Communications 2: 1558-1568. https://doi.org/10.1158/2767-9764.crc-22-0323

[447] Menon, Anil, Vimi S. Mutalik, Yongqiang Chen, Spd Ponamgi, Sujatha Peela, Robert J. Schroth, Saeid Ghavami, Prashen Chelikani. 2025. “Beyond Genetics: Exploring Lifestyle, Microbiome, and Social Determinants in Oral Cancer Development.” Cancers 17: 1094. https://doi.org/10.3390/cancers17071094

[448] Wang, Xue, Qili Mi, Ji Yang, Ying Guan, Wanli Zeng, Haiying Xiang, Xin Liu, et al. 2022. “Effect of Electronic Cigarette and Tobacco Smoking on the Human Saliva Microbial Community.” Brazilian Journal of Microbiology 53: 991-1000. https://doi.org/10.1007/s42770-022-00721-5

[449] Petersen, Poul Erik. 2009. “Oral Cancer Prevention and Control—The Approach of the World Health Organization.” Oral Oncology 45: 454-460. https://doi.org/10.1016/j.oraloncology.2008.05.023

[450] Al-Hebshi, Nezar N., Akram T. Nasher, David J. Speicher, Mushfiq H. Shaikh, Newell W. Johnson. 2016. “Possible Interaction Between Tobacco Use and EBV in Oral Squamous Cell Carcinoma.” Oral Oncology 59: e4-e5. https://doi.org/10.1016/j.oraloncology.2016.06.005

[451] Zhang, Yaobang, Pimporn Thongmuang, Sarisak Soontornchai. 2025. “Analysis on Risk Factors of Oral Cancer in Chengdu Community.” Proceeding National & International Conference 18: 204. http://www.journalgrad.ssru.ac.th/index.php/8thconference/article/view/5078

[452] Liu, Qiao-Yun, Ying Liao, Yan-Xia Wu, Hua Diao, Yan Du, Yi-Wei Chen, Jin-Ru Xie, et al. 2023. “The Oral Microbiome as Mediator Between Oral Hygiene and Its Impact on Nasopharyngeal Carcinoma.” Microorganisms 11: 719. https://doi.org/10.3390/microorganisms11030719

[453] Conway, Erica, Haisheng Wu, Linwei Tian. 2023. “Overview of Risk Factors for Esophageal Squamous Cell Carcinoma in China.” Cancers 15: 5604. https://doi.org/10.3390/cancers15235604

[454] La Rosa, Giusy Rita Maria, Giuseppe Gattuso, Eugenio Pedullà, Ernesto Rapisarda, Daria Nicolosi, Mario Salmeri. 2020. “Association of Oral Dysbiosis With Oral Cancer Development.” Oncology Letters 19: 3045-3058. https://doi.org/10.3892/ol.2020.11441

[455] Salem, Abdelhakim, Rabeia Almahmoudi, Jaana Hagström, Holger Stark, Dan Nordström, Tuula Salo, Kari K. Eklund. 2019. “Human β-Defensin 2 Expression in Oral Epithelium: Potential Therapeutic Targets in Oral Lichen Planus.” International Journal of Molecular Sciences 20: 1780. https://doi.org/10.3390/ijms20071780

[456] Triarico, Silvia, Pierpaolo Agresti, Emanuele Rinninella, Maria Cristina Mele, Alberto Romano, Giorgio Attinà, Palma Maurizi, Stefano Mastrangelo, Antonio Ruggiero. 2022. “Oral Microbiota During Childhood and Its Role in Chemotherapy-Induced Oral Mucositis in Children With Cancer.” Pathogens (Basel, Switzerland) 11: 448. https://doi.org/10.3390/pathogens11040448

[457] Akbari, Elahe, Alireza Milani, Masoud Seyedinkhorasani, Azam Bolhassani. 2023. “HPV Co-Infections With Other Pathogens in Cancer Development: A Comprehensive Review.” Journal of Medical Virology 95: e29236. https://doi.org/10.1002/jmv.29236

[458] Wallace, Nicholas A., Sujita Khanal, Kristin L. Robinson, Sebastian O. Wendel, Joshua J. Messer, Denise A. Galloway. 2017. “High-Risk Alphapapillomavirus Oncogenes Impair the Homologous Recombination Pathway.” Journal of Virology 91: e01084-17. https://doi.org/10.1128/JVI.01084-17

[459] Zhou, Chaozheng, Anqi Lin, Manming Cao, Weimin Ding, Weiming Mou, Ningyi Guo, Zhenyu Chen, Jian Zhang, Peng Luo. 2021. “Activation of the DDR Pathway Leads to the Down-Regulation of the TGFβ Pathway and a Better Response to ICIs in Patients With Metastatic Urothelial Carcinoma.” Frontiers in Immunology 12: 634741. https://doi.org/10.3389/fimmu.2021.634741

[460] Shi, Congqi, Kaiyu Qin, Anqi Lin, Aimin Jiang, Quan Cheng, Zaoqu Liu, Jian Zhang, Peng Luo. 2022. “The Role of DNA Damage Repair (DDR) System in Response to Immune Checkpoint Inhibitor (ICI) Therapy.” Journal of Experimental & Clinical Cancer Research: CR 41: 268. https://doi.org/10.1186/s13046-022-02469-0

[461] Raudenská, Martina, Maria Bugajová, David Kalfeřt, Jan Plzák, Šubrt, AdamTesařová, PetraMasařík, Michal. 2024. “The Interplay Between Microbiome and Host Factors in Pathogenesis and Therapy of Head and Neck Cancer.” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer 1879: 189216. https://doi.org/10.1016/j.bbcan.2024.189216

[462] Stasiewicz, Mark, Tomasz M. Karpiński. 2022. “The Oral Microbiota and Its Role in Carcinogenesis.” Seminars in Cancer Biology 86: 633-642. https://doi.org/10.1016/j.semcancer.2021.11.002

[463] Dai, Zhujiang, Jingqiu Zhang, Qi Wu, Juan Chen, Jun Liu, Lu Wang, Chaowu Chen, et al. 2019. “The ROLE of Microbiota in the development of colorectal cancer.” International Journal of Cancer 145: 2032-2041. https://doi.org/10.1002/ijc.32017

[464] Karati, Dipanjan, Dileep Kumar. 2024. “Molecular Insight Into the Apoptotic Mechanism of Cancer Cells: An Explicative Review.” Current Molecular Pharmacology 17: e18761429273223. https://doi.org/10.2174/0118761429273223231124072223

[465] Kumai, Takumi, Hirotaka Shinomiya, Hirofumi Shibata, Hideaki Takahashi, Toshihiro Kishikawa, Ryuhei Okada, Shigeharu Fujieda, Masafumi Sakashita. 2024. “Translational Research in Head and Neck Cancer: Molecular and Immunological Updates.” Auris, Nasus, Larynx 51: 391-400. https://doi.org/10.1016/j.anl.2023.08.006

[466] Zhou, Jiaying, Zixuan Hu, Lei Wang, Qinchao Hu, Zixu Chen, Tao Lin, Rui Zhou, et al. 2024. “Tumor-Colonized Streptococcus mutans Metabolically Reprograms Tumor Microenvironment and Promotes Oral Squamous Cell Carcinoma.” Microbiome 12: 193. https://doi.org/10.1186/s40168-024-01907-9

[467] Hayes, Conall, Claire L. Donohoe, Maria Davern, Noel E. Donlon. 2021. “The Oncogenic and Clinical Implications of Lactate Induced Immunosuppression in the Tumour Microenvironment.” Cancer Letters 500: 75-86. https://doi.org/10.1016/j.canlet.2020.12.021

[468] Zang, Wenli, Junchao Liu, Fengxue Geng, Dongjuan Liu, Shuwei Zhang, Yuchao Li, Yaping Pan. 2022. “Butyrate Promotes Oral Squamous Cell Carcinoma Cells Migration, Invasion and Epithelial-Mesenchymal Transition.” PeerJ 10: e12991. https://doi.org/10.7717/peerj.12991

[469] Barbour, Abdelahhad, Omnia Elebyary, Noah Fine, Morvarid Oveisi, Michael Glogauer. 2022. “Metabolites of the Oral Microbiome: Important Mediators of Multikingdom Interactions.” FEMS Microbiology Reviews 46: fuab039. https://doi.org/10.1093/femsre/fuab039

[470] Chattopadhyay, Indranil, Mukesh Verma, Madhusmita Panda. 2019. “Role of Oral Microbiome Signatures in Diagnosis and Prognosis of Oral Cancer.” Technology in Cancer Research & Treatment 18: 1533033819867354. https://doi.org/10.1177/1533033819867354

[471] Chen, Yiyin ErinTsao, Hensin. 2013. “The Skin Microbiome: Current Perspectives and Future Challenges.” Journal of the American Academy of Dermatology 69: 143-55.e3. https://doi.org/10.1016/j.jaad.2013.01.016

[472] Skin Cancer and Ultraviolet-Radiation Exposure in Different Jobs. 2023. The British Journal of Dermatology 188: e22. https://doi.org/10.1093/bjd/ljad020

[473] Wittlich, Marc, Stephan Westerhausen, Benjamin Strehl, Helmut Versteeg, Wiho Stöppelmann. 2023. “The GENESIS-UV Study on Ultraviolet Radiation Exposure Levels in 250 Occupations to Foster Epidemiological and Legislative Efforts to Combat Nonmelanoma Skin Cancer.” The British Journal of Dermatology 188: 350-360. https://doi.org/10.1093/bjd/ljac093

[474] Pega, Frank, Natalie C. Momen, Kai N. Streicher, Maria Leon-Roux, Subas Neupane, Mary K. Schubauer-Berigan, Joachim Schüz, et al. 2023. “Global, Regional and National Burdens of Non-Melanoma Skin Cancer Attributable to Occupational Exposure to Solar Ultraviolet Radiation for 183 Countries, 2000-2019: A Systematic Analysis From the WHO/ILO Joint Estimates of the Work-Related Burden of Disease and Injury.” Environment International 181: 108226. https://doi.org/10.1016/j.envint.2023.108226

[475] Kullander, Johanna, Ola Forslund, Joakim Dillner. 2009. “Staphylococcus aureus and Squamous Cell Carcinoma of the Skin.” Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 18: 472-478. https://doi.org/10.1158/1055-9965.EPI-08-0905

[476] Mrázek, Jakub, Chahrazed Mekadim, Petra Kučerová, Roman Švejstil, Hana Salmonová, Jitka Vlasáková, Renata Tarasová, Jana Čížková, Monika Červinková. 2019. “Melanoma-Related Changes in Skin Microbiome.” Folia Microbiologica 64: 435-442. https://doi.org/10.1007/s12223-018-00670-3

[477] Mizuhashi, Satoru, Ikko Kajihara, Soichiro Sawamura, Hisashi Kanemaru, Katsunari Makino, Jun Aoi, Takamitsu Makino, et al. 2021. “Skin Microbiome in Acral Melanoma: Corynebacterium Is Associated With Advanced Melanoma.” The Journal of Dermatology 48: e15-e16. https://doi.org/10.1111/1346-8138.15633

[478] Zhu, Yuhang, Wanguo Liu, Mei Wang, Xu Wang, Sibo Wang. 2024. “Causal Roles of Skin Microbiota in Skin Cancers Suggested by Genetic Study.” Frontiers in Microbiology 15: 1426807. https://doi.org/10.3389/fmicb.2024.1426807

[479] Takei, Itsuki, Soichiro Sawamura, Tselmeg Mijiddorj Myangat, Ikko Kajihara, Hisashi Kanemaru, Kayo Kashiwada-Nakamura, Katsunari Makino, et al. 2021. “Clinical Significance of Skin Colonization of Pseudomonas aeruginosa in Cutaneous Squamous Cell Carcinoma.” The Journal of Dermatology 48: e581-e582. https://doi.org/10.1111/1346-8138.16148

[480] Voigt, Anita Y., Akintunde Emiola, Jethro S. Johnson, Elizabeth S. Fleming, Hoan Nguyen, Wei Zhou, Kenneth Y. Tsai, Christine Fink, Julia Oh. 2022. “Skin Microbiome Variation With Cancer Progression in Human Cutaneous Squamous Cell Carcinoma.” Journal of Investigative Dermatology 142: 2773-82.e16. https://doi.org/10.1016/j.jid.2022.03.017

[481] Xia, Chenglai, Jiyan Su, Can Liu, Zhikai Mai, Shuanghong Yin, Chuansheng Yang, Liwu Fu. 2023. “Human Microbiomes in Cancer Development and Therapy.” MedComm 4: e221. https://doi.org/10.1002/mco2.221

[482] Rangwala, S., K. Y. Tsai. 2011. “Roles of the Immune System in Skin Cancer.” The British Journal of Dermatology 165: 953-965. https://doi.org/10.1111/j.1365-2133.2011.10507.x

[483] Yu, Zhen-Wei, Min Zheng, Hua-Yang Fan, Xin-Hua Liang, Ya-Ling Tang. 2024. “Ultraviolet (UV) Radiation: A Double-Edged Sword in Cancer Development and Therapy.” Molecular Biomedicine 5: 49. https://doi.org/10.1186/s43556-024-00209-8

[484] Yamada, Miko, Tarl W. Prow. 2020. “Physical Drug Delivery Enhancement for Aged Skin, UV Damaged Skin and Skin Cancer: Translation and Commercialization.” Advanced Drug Delivery Reviews 153: 2-17. https://doi.org/10.1016/j.addr.2020.04.008

[485] Lopes, Fabiana C. P. S., Marc G. Sleiman, Kate Sebastian, Roxanne Bogucka, Elizabeth A. Jacobs, Adewole S. Adamson. 2021. “UV Exposure and the Risk of Cutaneous Melanoma in Skin of Color: A Systematic Review.” JAMA Dermatology 157: 213-219. https://doi.org/10.1001/jamadermatol.2020.4616

[486] Coohill, Thomas P., Jose-Luis Sagripanti. 2008. “Overview of the Inactivation by 254?nm Ultraviolet Radiation of Bacteria With Particular Relevance to Biodefense.” Photochemistry and Photobiology 84: 1084-1090. https://doi.org/10.1111/j.1751-1097.2008.00387.x

[487] Burns, Erin M., Hana Ahmed, Prescilia N. Isedeh, Indermeet Kohli, William Van Der Pol, Abdullah Shaheen, Anum F. Muzaffar, et al. 2019. “Ultraviolet Radiation, Both UVA and UVB, Influences the Composition of the Skin Microbiome.” Experimental Dermatology 28: 136-141. https://doi.org/10.1111/exd.13854

[488] Willmott, Thomas, Paul M. Campbell, Christopher E. M. Griffiths, Clare O'Connor, Michael Bell, Rachel E. B. Watson, Andrew J. McBain, Abigail K. Langton. 2023. “Behaviour and Sun Exposure in Holidaymakers Alters Skin Microbiota Composition and Diversity.” Frontiers in Aging 4: 1217635. https://doi.org/10.3389/fragi.2023.1217635

[489] Azzimonti, Barbara, Chiara Ballacchino, Paola Zanetta, Marie Angele Cucci, Chiara Monge, Margherita Grattarola, Chiara Dianzani, Giuseppina Barrera, Stefania Pizzimenti. 2023. “Microbiota, Oxidative Stress, and Skin Cancer: An Unexpected Triangle.” Antioxidants (Basel, Switzerland) 12: 546. https://doi.org/10.3390/antiox12030546

[490] Tang Hongbo, Ma Qingyu, Sang Yingbing, Mao Lidan, Liang Junqin, Kang Xiaojing. 2022. “Mechanisms Underlying Synergistic Induction and Promotion of Cutaneous Squamous Cell Carcinoma in Nude Mice by Ultraviolet Light and Human Papillomavirus 16 E6.” Chinese Journal of Dermatology 55: 982-989. https://doi.org/10.35541/cjd.20220084

[491] Harden, Mallory E., Karl Munger. 2017. “Human Papillomavirus Molecular Biology.” Mutation Research/Reviews in Mutation Research 772: 3-12. https://doi.org/10.1016/j.mrrev.2016.07.002

[492] Rogers, Heather D., Jennifer L. Macgregor, Kristin M. Nord, Stephen Tyring, Peter Rady, Danielle E. Engler, Marc E. Grossman. 2009. “Acquired Epidermodysplasia Verruciformis.” Journal of the American Academy of Dermatology 60: 315-320. https://doi.org/10.1016/j.jaad.2008.08.035

[493] Dupin, Nicolas. 2020. “Update on Oncogenesis and Therapy for Kaposi Sarcoma.” Current Opinion in Oncology 32: 122-128. https://doi.org/10.1097/CCO.0000000000000601

[494] Feng, Huichen, Masahiro Shuda, Yuan Chang, Patrick S. Moore. 2008. “Clonal Integration of a Polyomavirus in Human Merkel Cell Carcinoma.” Science 319: 1096-1100. https://doi.org/10.1126/science.1152586

[495] Zhao, Qihang, Qiang Wang, Tengjiao Wang, Junfang Xu, Tingting Li, Qiuyan Liu, Qinghua Yao, Pin Wang. 2021. “Pattern Recognition Receptors (PRRs) in Macrophages Possess Prognosis and Immunotherapy Potential for Melanoma.” Frontiers in Immunology 12: 765615. https://doi.org/10.3389/fimmu.2021.765615

[496] Vijay, Kumar. 2018. “Toll-Like Receptors in Immunity and Inflammatory Diseases: Past, Present, and Future.” International Immunopharmacology 59: 391-412. https://doi.org/10.1016/j.intimp.2018.03.002

[497] Hoste, Esther, Esther N. Arwert, Rohit Lal, Andrew P. South, Julio C. Salas-Alanis, Dedee F. Murrell, Giacomo Donati, Fiona M. Watt. 2015. “Innate Sensing of Microbial Products Promotes Wound-Induced Skin Cancer.” Nature Communications 6: 5932. https://doi.org/10.1038/ncomms6932

[498] Severn, Morgan M., Alexander R. Horswill. 2023. “Staphylococcus epidermidis and Its Dual Lifestyle in Skin Health and Infection.” Nature Reviews Microbiology 21: 97-111. https://doi.org/10.1038/s41579-022-00780-3

[499] Yu, Jinlei, Yang Luo, Zhenlai Zhu, Yufeng Zhou, Licheng Sun, Jixin Gao, Jinlv Sun, et al. 2019. “A Tryptophan Metabolite of the skin Microbiota Attenuates Inflammation in Patients With Atopic Dermatitis Through the Aryl Hydrocarbon Receptor.” Journal of Allergy and Clinical Immunology 143: 2108-2119.e12. https://doi.org/10.1016/j.jaci.2018.11.036

[500] Axelrod, Margaret L., Douglas B. Johnson, Justin M. Balko. 2018. “Emerging Biomarkers for Cancer Immunotherapy Iin Melanoma.” Seminars in Cancer Biology 52: 207-215. https://doi.org/10.1016/j.semcancer.2017.09.004

[501] Hoeijmakers, Lotte L., Irene L. M. Reijers, Christian U. Blank. 2023. “Biomarker-Driven Personalization of Neoadjuvant Immunotherapy in Melanoma.” Cancer Discovery 13: 2319-2338. https://doi.org/10.1158/2159-8290.CD-23-0352

[502] Long, Georgina V., Alexander M. Menzies, Richard A. Scolyer. 2023. “Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now.” Journal of Clinical Oncology 41: 3236-3248. https://doi.org/10.1200/JCO.22.02575

[503] Ianiro, Gianluca. 2025. “Longitudinal Gut Microbiome Shifts Correlate With Clinical Outcomes of Immune Checkpoint Inhibitors-Treated Melanoma: Time for Microbial Biomarkers in Oncology?” Gastroenterology 168: 177-178. https://doi.org/10.1053/j.gastro.2024.07.034

[504] Ballerini, Mattia, Serena Galiè, Punit Tyagi, Carlotta Catozzi, Hariam Raji, Amir Nabinejad, Angeli D. G. Macandog, et al. 2025, 9, 967-984. “A Gut-on-a-Chip Incorporating Human Faecal Samples and Peristalsis Predicts Responses to Immune Checkpoint Inhibitors for Melanoma.” Nature Biomedical Engineering. https://doi.org/10.1038/s41551-024-01318-z

[505] Pinato, David J., Daria Gramenitskaya, Daniel M. Altmann, Rosemary J. Boyton, Benjamin H. Mullish, Julian R. Marchesi, Mark Bower. 2019. “Antibiotic Therapy and Outcome From Immune-Checkpoint Inhibitors.” Journal for Immunotherapy of Cancer 7: 287. https://doi.org/10.1186/s40425-019-0775-x

[506] Chen, Y. Erin, Djenet Bousbaine, Alessandra Veinbachs, Katayoon Atabakhsh, Alex Dimas, Victor K. Yu, Aishan Zhao, et al. 2023. “Engineered Skin Bacteria Induce Antitumor T Cell Responses Against Melanoma.” Science 380: 203-210. https://doi.org/10.1126/science.abp9563

[507] He, Mengying, Tao Yang, Yuhan Wang, Mengyuan Wang, Xingye Chen, Dawei Ding, Yiran Zheng, Huabing Chen. 2021. “Immune Checkpoint Inhibitor-Based Strategies for Synergistic Cancer Therapy.” Advanced Healthcare Materials 10: e2002104. https://doi.org/10.1002/adhm.202002104

[508] Plaçais, Léo, Stéphane Dalle, Olivier Dereure, Sabiha Trabelsi, Sophie Dalac, Delphine Legoupil, Henri Montaudié, et al. 2022. “Risk of irAEs in Patients With Autoimmune Diseases Treated by Immune Checkpoint Inhibitors for Stage III or IV Melanoma: Results From a Matched Case-Control Study.” Annals of the Rheumatic Diseases 81: 1445-1452. https://doi.org/10.1136/ard-2022-222186

[509] Pan, Catherina X., Mofei Liu, Charles B. Lau, William C. Lau, Daniel Y. Kim, Shahin A. Saberi, Rachael Rowley, et al. 2024. “Histopathological Predictors of Immune-Related Adverse Events Among Patients With Melanoma Treated With Immune Checkpoint Inhibitors.” Journal of the American Academy of Dermatology 90: 826-829. https://doi.org/10.1016/j.jaad.2023.11.037

[510] Otto, Grant. 2023. “Diverse Routes to Melanoma Metastasis and ICI Resistance.” Nature Cancer 4: 1643. https://doi.org/10.1038/s43018-023-00679-9

[511] Killock, David. 2020. “ICI for resected Stage IV Melanoma.” Nature Reviews Clinical Oncology 17: 450. https://doi.org/10.1038/s41571-020-0397-8

[512] Carlino, Matteo S., James Larkin, Georgina V. Long. 2021. “Immune Checkpoint Inhibitors in Melanoma.” The Lancet 398: 1002-1014. https://doi.org/10.1016/S0140-6736(21)01206-X

[513] Yacouba, Abdourahamane, Maryam Tidjani Alou, Jean-Christophe Lagier, Grégory Dubourg, Didier Raoult. 2022. “Urinary Microbiota and Bladder Cancer: A Systematic Review and a Focus on Uropathogens.” Seminars in Cancer Biology 86: 875-884. https://doi.org/10.1016/j.semcancer.2021.12.010

[514] Wahid, Mohd, Sajad A. Dar, Arshad Jawed, Raju Kumar Mandal, Naseem Akhter, Saif Khan, Farah Khan, et al. 2022. “Microbes in Gynecologic Cancers: Causes or Consequences and Therapeutic Potential.” Seminars in Cancer Biology 86: 1179-1189. https://doi.org/10.1016/j.semcancer.2021.07.013

[515] Lee, Seoho, Karen Sfanos, Nirmish Singla. 2025. “The Role of the Urinary Microbiome in Genitourinary Cancers.” Nature Reviews Urology 22: 544-561. https://doi.org/10.1038/s41585-025-01011-z

[516] Mansour, Bassel, Ádám Monyók, Márió Gajdács, Balázs Stercz, Nóra Makra, Kinga Pénzes, István Vadnay, Dóra Szabó, Eszter Ostorházi. 2022. “Bladder Tissue Microbiome Composition in Patients of Bladder Cancer or Benign Prostatic Hyperplasia and Related Human Beta Defensin Levels.” Biomedicines 10: 1758. https://doi.org/10.3390/biomedicines10071758

[517] Yin, Zhaofa, Bohan Liu, Shijian Feng, Yushi He, Cai Tang, Pengan Chen, Xinyi Wang, Kunjie Wang. 2023. “A Large Genetic Causal Analysis of the Gut Microbiota and Urological Cancers: A Bidirectional Mendelian Randomization Study.” Nutrients 15: 4086. https://doi.org/10.3390/nu15184086

[518] Porto, Joao G., Maria Camila Suarez Arbelaez, Brandon Pena, Archan Khandekar, Ankur Malpani, Bruno Nahar, Sanoj Punnen, et al. 2023. “The Influence of the Microbiome on Urological Malignancies: A Systematic Review.” Cancers 15: 4984. https://doi.org/10.3390/cancers15204984

[519] Shrestha, Eva, James R. White, Shu-Han Yu, Ibrahim Kulac, Onur Ertunc, Angelo M. De Marzo, Srinivasan Yegnasubramanian, et al. 2018. “Profiling the Urinary Microbiome in Men With Positive Versus Negative Biopsies for Prostate Cancer.” Journal of Urology 199: 161-171. https://doi.org/10.1016/j.juro.2017.08.001

[520] Qi, Xiaoyu, Jing Zhou, Xinyue Wang, Yan Shen, Yuxun Cao, Liangzi Jiang, Miaomiao Shen, et al. 2025. “HPV E6/E7-Induced Acetylation of a Peptide Encoded by a Long Non-Coding RNA Inhibits Ferroptosis to Promote the Malignancy of Cervical Cancer.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 12: e2414018. https://doi.org/10.1002/advs.202414018

[521] Molina, Mariano A., Renske D. M. Steenbergen, Anna Pumpe, Angelique N. Kenyon, Willem J. G. Melchers. 2024. “HPV Integration and Cervical Cancer: A Failed Evolutionary Viral Trait.” Trends in Molecular Medicine 30: 890-902. https://doi.org/10.1016/j.molmed.2024.05.009

[522] Dias Gonçalves Lima, Fernando, Mariano A. Molina. 2024. “Uncovering the HPV Types Causing Cervical Cancer.” Nature Microbiology 9: 2795-2796. https://doi.org/10.1038/s41564-024-01835-2

[523] Mitra, Anita, David A. MacIntyre, Julian R. Marchesi, Yun S. Lee, Phillip R. Bennett, Maria Kyrgiou. 2016. “The Vaginal Microbiota, Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia: What Do We Know and Where Are We Going Next?” Microbiome 4: 58. https://doi.org/10.1186/s40168-016-0203-0

[524] Wei, Zhen-Tong, Hong-Liang Chen, Chun-Feng Wang, Gui-Lian Yang, Shu-Mei Han, Song-Ling Zhang. 2020. “Depiction of Vaginal Microbiota in Women With High-Risk Human Papillomavirus Infection.” Frontiers in Public Health 8: 587298. https://doi.org/10.3389/fpubh.2020.587298

[525] Gillet, Evy, Joris Fa Meys, Hans Verstraelen, Carolyne Bosire, Philippe De Sutter, Marleen Temmerman, Davy Vanden Broeck. 2011. “Bacterial vaginosis Is Associated With Uterine Cervical Human Papillomavirus Infection: A Meta-Analysis.” BMC Infectious Diseases 11: 10. https://doi.org/10.1186/1471-2334-11-10

[526] Chen, Yulian, Xingdi Qiu, Wenjing Wang, Dong Li, Anyue Wu, Zubei Hong, Wen Di, Lihua Qiu. 2020. “Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia Progression Are Associated With Increased Vaginal Microbiome Diversity in a Chinese Cohort.” BMC Infectious Diseases 20: 629. https://doi.org/10.1186/s12879-020-05324-9

[527] Gong, Xiangjin, Hao Chi, Zhijia Xia, Guanhu Yang, Gang Tian. 2023. “Advances in HPV-Associated Tumor Management: Therapeutic Strategies and Emerging Insights.” Journal of Medical Virology 95: e28950. https://doi.org/10.1002/jmv.28950

[528] Usyk, Mykhaylo, Christine P. Zolnik, Philip E. Castle, Carolina Porras, Rolando Herrero, Ana Gradissimo, Paula Gonzalez, et al. 2020. “Cervicovaginal Microbiome and Natural History of HPV in a Longitudinal Study.” PLoS Pathogens 16: e1008376. https://doi.org/10.1371/journal.ppat.1008376

[529] Wu, Ke, Yaorong Li, Kangli Ma, Weiguang Zhao, Zhixian Yao, Zhong Zheng, Feng Sun, et al. 2024. “The Microbiota and Renal Cell Carcinoma.” Cellular Oncology (Dordrecht, Netherlands) 47: 397-413. https://doi.org/10.1007/s13402-023-00876-9

[530] Jiang, Shuanghong, Shan Xie, Dan Lv, Pu Wang, Hanchang He, Ting Zhang, Youlian Zhou, et al. 2017. “Alteration of the Gut Microbiota in Chinese Population With Chronic Kidney Disease.” Scientific Reports 7: 2870. https://doi.org/10.1038/s41598-017-02989-2

[531] Hurst, Rachel, Emma Meader, Abraham Gihawi, Ghanasyam Rallapalli, Jeremy Clark, Gemma L. Kay, Martyn Webb, et al. 2022. “Microbiomes of Urine and the Prostate Are Linked to Human Prostate Cancer Risk Groups.” European Urology Oncology 5: 412-419. https://doi.org/10.1016/j.euo.2022.03.006

[532] Marshall, Erin A., Fernando S. L. Filho, Don D. Sin, Stephen Lam, Janice M. Leung, Wan L. Lam. 2022. “Distinct Bronchial Microbiome Precedes Clinical Diagnosis of Lung Cancer.” Molecular Cancer 21: 68. https://doi.org/10.1186/s12943-022-01544-6

[533] Li, Bowen, Daoyun Wang, Chengye Zhang, Yadong Wang, Zhicheng Huang, Libing Yang, Huaxia Yang, et al. 2024. “Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application.” iMeta 3: e232. https://doi.org/10.1002/imt2.232

[534] Goto, Taichiro. 2022. “Microbiota and Lung Cancer.” Seminars in Cancer Biology 86: 1-10. https://doi.org/10.1016/j.semcancer.2022.07.006

[535] O'Shaughnessy, Megan, Orla Sheils, Anne-Marie Baird. 2023. “The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs.” International Journal of Molecular Sciences 24: 12296. https://doi.org/10.3390/ijms241512296

[536] Tsay, Jun-Chieh J., Benjamin G. Wu, Michelle H. Badri, Jose C. Clemente, Nan Shen, Peter Meyn, Yonghua Li, et al. 2018. “Airway Microbiota Is Associated With Upregulation of the PI3K Pathway in Lung Cancer.” American Journal of Respiratory and Critical Care Medicine 198: 1188-1198. https://doi.org/10.1164/rccm.201710-2118OC

[537] Gomes, Sílvia, Bruno Cavadas, Joana Catarina Ferreira, Patrícia Isabel Marques, Catarina Monteiro, Maria Sucena, Catarina Sousa, et al. 2019. “Profiling of Lung Microbiota Discloses Differences in Adenocarcinoma and Squamous Cell Carcinoma.” Scientific Reports 9: 12838. https://doi.org/10.1038/s41598-019-49195-w

[538] Ashique, Sumel, Gabriele De Rubis, Ekta Sirohi, Neeraj Mishra, Mohd Rihan, Ashish Garg, Ruby-Jean Reyes, et al. 2022. “Short Chain Fatty Acids: Fundamental Mediators of the Gut-Lung Axis and Their Involvement in Pulmonary Diseases.” Chemico-Biological Interactions 368: 110231. https://doi.org/10.1016/j.cbi.2022.110231

[539] Liu, Weici, Jingtong Xu, Zheshun Pi, Yundi Chen, Guanyu Jiang, Yuan Wan, Wenjun Mao. 2023. “Untangling the Web of Intratumor Microbiota in Lung Cancer.” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer 1878: 189025. https://doi.org/10.1016/j.bbcan.2023.189025

[540] Yang, Junjie, Xiaofeng Mu, Ye Wang, Dequan Zhu, Jiaming Zhang, Cheng Liang, Chen, Bin, et al. 2018. “Dysbiosis of the Salivary Microbiome Is Associated With Non-smoking Female Lung Cancer and Correlated With Immunocytochemistry Markers.” Frontiers in Oncology 8: 520. https://doi.org/10.3389/fonc.2018.00520

[541] Czarnecka-Chrebelska, Karolina H., Jacek Kordiak, Ewa Brzeziańska-Lasota, Dorota Pastuszak-Lewandoska. 2023. “Respiratory Tract Oncobiome in Lung Carcinogenesis: Where Are We Now?” Cancers 15: 4935. https://doi.org/10.3390/cancers15204935

[542] Otoshi, Takehiro, Tatsuya Nagano, Jonguk Park, Koji Hosomi, Tomoya Yamashita, Motoko Tachihara, Tokiko Tabata, et al. 2022. “The Gut Microbiome as a Biomarker of Cancer Progression Among Female Never-Smokers With Lung Adenocarcinoma.” Anticancer Research 42: 1589-1598. https://doi.org/10.21873/anticanres.15633

[543] Gui, Qifeng, Hanyu Li, Ange Wang, Xinxiu Zhao, Zhongju Tan, Lufang Chen, Keying Xu, Chi Xiao. 2020. “The Association Between Gut Butyrate-Producing Bacteria and Non-Small-Cell Lung Cancer.” Journal of Clinical Laboratory Analysis 34: e23318. https://doi.org/10.1002/jcla.23318

[544] Upreti, Deepa, Susumu Ishiguro, Morgan Phillips, Ayaka Nakashima, Kengo Suzuki, Jeffrey Comer, Masaaki Tamura. 2023. “Euglena gracilis Extract Protects From Tobacco Smoke Carcinogen-Induced Lung Cancer by Altering Gut Microbiota Metabolome.” Integrative Cancer Therapies 22: 15347354231195323. https://doi.org/10.1177/15347354231195323

[545] Shin, Yoonhwa, Sunhee Han, Juhui Kwon, Songhyun Ju, Tae Choi, Insug Kang, Sung Kim. 2023. “Roles of Short-Chain Fatty Acids in Inflammatory Bowel Disease.” Nutrients 15: 4466. https://doi.org/10.3390/nu15204466

[546] Xiong, Xin, Le-Wei Zheng, Yu Ding, Yu-Fei Chen, Yu-Wen Cai, Lei-Ping Wang, Liang Huang, et al. 2025. “Breast Cancer: Pathogenesis and Treatments.” Signal Transduction and Targeted Therapy 10: 49. https://doi.org/10.1038/s41392-024-02108-4

[547] Chadha, Jatin, Deeptashree Nandi, Yama Atri, Alo Nag. 2021. “Significance of Human Microbiome in Breast Cancer: Tale of an Invisible and an Invincible.” Seminars in Cancer Biology 70: 112-127. https://doi.org/10.1016/j.semcancer.2020.07.010

[548] Thu, May Soe, Korn Chotirosniramit, Tanawin Nopsopon, Nattiya Hirankarn, Krit Pongpirul. 2023. “Human Gut, Breast, and Oral Microbiome in Breast Cancer: A Systematic Review and Meta-Analysis.” Frontiers in Oncology 13: 1144021. https://doi.org/10.3389/fonc.2023.1144021

[549] Tzeng, Alice, Naseer Sangwan, Margaret Jia, Chin-Chih Liu, Karen S. Keslar, Erinn Downs-Kelly, Robert L. Fairchild, et al. 2021. “Human Breast Microbiome Correlates With Prognostic Features and Immunological Signatures in Breast Cancer.” Genome Medicine 13: 60. https://doi.org/10.1186/s13073-021-00874-2

[550] Parida, Sheetal, Julia L. Drewes. 2022. “Unwanted Passengers: Microbes Hitchiking in Breast Cancer Metastases.” Cell Host & Microbe 30: 875-877. https://doi.org/10.1016/j.chom.2022.05.010

[551] Hou, Ting, Xiaoling Huang, Jiahui Lai, Dongfang Zhou. 2025. “Intra-Tumoral Bacteria in Breast Cancer and Intervention Strategies.” Advanced Drug Delivery Reviews 217: 115516. https://doi.org/10.1016/j.addr.2025.115516

[552] Arnone, Alana A., Yu-Ting Tsai, J. Mark Cline, Adam S. Wilson, Brian Westwood, Meghan E. Seger, Akiko Chiba, et al. 2025. “Endocrine-Targeting Therapies Shift the Breast Microbiome to Reduce Estrogen Receptor-α Breast Cancer Risk.” Cell Reports. Medicine 6: 101880. https://doi.org/10.1016/j.xcrm.2024.101880

[553] Wang, Wenhui, Zihao Ou, Xixin Huang, Jingyu Wang, Qianbei Li, Minghui Wen, Lei Zheng. 2024. “Microbiota and Glioma: A New Perspective From Association to Clinical Translation.” Gut Microbes 16: 2394166. https://doi.org/10.1080/19490976.2024.2394166

[554] Ge, Yanshan, Xinhui Wang, Yali Guo, Junting Yan, Aliya Abuduwaili, Kasimujiang Aximujiang, Jie Yan, Minghua Wu. 2021. “Gut Microbiota Influence Tumor Development and Alter Interactions With the Human Immune System.” Journal of Experimental & Clinical Cancer Research: CR 40: 42. https://doi.org/10.1186/s13046-021-01845-6

[555] Chatterjee, Jit, Xuanhe Qi, Rui Mu, Xuanwei Li, Talia Eligator, Megan Ouyang, Stephanie L. Bozeman, et al. 2025. “Intestinal Bacteroides Drives Glioma Progression by Regulating CD8+ T Cell Tumor Infiltration.” Neuro-Oncology 27(6): 1579-1593. https://doi.org/10.1093/neuonc/noaf024

[556] Lin, Ben, Zhen Ye, Zhan Cao, Zhao Ye, Yifei Yu, Weiliang Jiang, Sichen Guo, et al. 2024. “Integrated Microbiome and Metabolome Analysis Reveals Hypothalamic-Comorbidities Related Signatures in Craniopharyngioma.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 11: e2400684. https://doi.org/10.1002/advs.202400684

[557] Chandra, Vidhi, Le, Li, Olivereen Le Roux, Yu Zhang, Rian M. Howell, Dhwani N. Rupani, Seyda Baydogan, et al. 2024. “Gut Epithelial Interleukin-17 Receptor A Signaling Can Modulate Distant Tumors Growth Through Microbial Regulation.” Cancer Cell 42: 85-100.e6. https://doi.org/10.1016/j.ccell.2023.12.006

[558] Mehrian-Shai, Ruty, Juergen K. V. Reichardt, Curtis C. Harris, Amos Toren. 2019. “The Gut-Brain Axis, Paving the Way to Brain Cancer.” Trends in Cancer 5: 200-207. https://doi.org/10.1016/j.trecan.2019.02.008

[559] Zhu, Gengjun, Lifang Jin, Weizhang Shen, Meng Zhao, Ning Liu. 2023. “Intratumor Microbiota: Occult Participants in the Microenvironment of Multiple Myeloma.” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer 1878: 188959. https://doi.org/10.1016/j.bbcan.2023.188959

[560] Shah, Urvi A., Richa Parikh, Francesca Castro, Matteo Bellone, Alexander M. Lesokhin. 2023. “Dietary and Microbiome Evidence in Multiple Myeloma and Other Plasma Cell Disorders.” Leukemia 37: 964-980. https://doi.org/10.1038/s41375-023-01874-4

[561] Fernandez Sanchez, Josaura, Arushana A. Maknojia, Katherine Y. King. 2024. “Blood and Guts: How the Intestinal Microbiome Shapes Hematopoiesis and Treatment of Hematologic Disease.” Blood 143: 1689-1701. https://doi.org/10.1182/blood.2023021174

[562] Manzo, Veronica E., Ami S. Bhatt. 2015. “The Human Microbiome in Hematopoiesis and Hematologic Disorders.” Blood 126: 311-318. https://doi.org/10.1182/blood-2015-04-574392

[563] Manohar, Sonal M. 2024. “At the Crossroads of TNF α Signaling and Cancer.” Current Molecular Pharmacology 17: e060923220758. https://doi.org/10.2174/1874467217666230908111754

[564] Li, Guoqing, Yuxuan Wan, Alan Jiao, Ke Jiang, Gaoyuan Cui, Jinxin Tang, Simin Yu, et al. “Breaking Boundaries: Chronic Diseases and the Frontiers of Immune Microenvironments.” Med Research 1: 62-102. https://doi.org/10.1002/mdr2.70007

[565] Zhang, Sheng, Cheng Kong, Yongzhi Yang, Sanjun Cai, Xinxiang Li, Guoxiang Cai, Yanlei Ma. 2020. “Human Oral Microbiome Dysbiosis as a Novel Non-Invasive Biomarker in Detection of Colorectal Cancer.” Theranostics 10: 11595-11606. https://doi.org/10.7150/thno.49515

[566] Xian, Rena R., Richard F. Ambinder. 2023. “Cell-Free Circulating Tumor DNA and Epstein-Barr Virus DNA for Early Diagnosis of Epstein-Barr Virus-Associated Cancers.” Journal of Clinical Oncology 41: 4290-4292. https://doi.org/10.1200/JCO.23.00687

[567] Wang, Ni, Jing-Yuan Fang. 2023. “Fusobacterium nucleatum, a Key Pathogenic Factor and Microbial Biomarker for Colorectal Cancer.” Trends in Microbiology 31: 159-172. https://doi.org/10.1016/j.tim.2022.08.010

[568] Li, Chiao-Ling, Ming-Chih Ho, You-Yu Lin, Sheng-Tai Tzeng, Yun-Ju Chen, Hsin-Yung Pai, Ya-Chun Wang, et al. 2020. “Cell-Free Virus-Host Chimera DNA From Hepatitis B Virus Integration Sites as a Circulating Biomarker of Hepatocellular Cancer.” Hepatology 72: 2063-2076. https://doi.org/10.1002/hep.31230

[569] Hakozaki, Taiki, Kentaro Tanaka, Yoshimasa Shiraishi, Yuta Sekino, Noriko Mitome, Yusuke Okuma, Tomoiki Aiba, et al. 2025, 20, 912-927. “Gut Microbiota in Advanced NSCLC Receiving Chemoimmunotherapy: An Ancillary Biomarker Study From the Phase III Trial JCOG2007 (NIPPON).” Journal of Thoracic Oncology. https://doi.org/10.1016/j.jtho.2025.02.026

[570] Kwong, Thomas N. Y., Xiansong Wang, Geicho Nakatsu, Tai Cheong Chow, Timothy Tipoe, Rudin Z. W. Dai, Kelvin K. K. Tsoi, et al. 2018. “Association Between Bacteremia From Specific Microbes and Subsequent Diagnosis of Colorectal Cancer.” Gastroenterology 155: 383-90.e8. https://doi.org/10.1053/j.gastro.2018.04.028

[571] Coker, Olabisi Oluwabukola, Changan Liu, William Ka Kei Wu, Sunny Hei Wong, Wei Jia, Joseph?J. Y. Sung, Jun Yu. 2022. “Altered Gut Metabolites and Microbiota Interactions Are Implicated in Colorectal Carcinogenesis and Can Be Non-Invasive Diagnostic Biomarkers.” Microbiome 10: 35. https://doi.org/10.1186/s40168-021-01208-5

[572] Zhang, Jia, Yangting He, Lu Xia, Jing Yi, Zhen Wang, Yingying Zhao, Xuemei Song, et al. 2022. “Expansion of Colorectal Cancer Biomarkers Based on Gut Bacteria and Viruses.” Cancers 14: 4662. https://doi.org/10.3390/cancers14194662

[573] Zhao, Liuyang, Yu, Shi, Harry Cheuk-Hay Lau, Weixin Liu, Guangwen Luo, Guoping Wang, Changan Liu, et al. 2022. “Uncovering 1058 Novel Human Enteric DNA Viruses Through Deep Long-Read Third-Generation Sequencing and Their Clinical Impact.” Gastroenterology 163: 699-711. https://doi.org/10.1053/j.gastro.2022.05.048

[574] Yunus, Aisyah, Norfilza Mohd Mokhtar, Raja Affendi Ali, Siti Maryam Ahmad Kendong, Hajar Fauzan Ahmad. 2024. “Methods for Identification of the Opportunistic Gut Mycobiome From Colorectal Adenocarcinoma Biopsy Tissues.” MethodsX 12: 102623. https://doi.org/10.1016/j.mex.2024.102623

[575] Chen, Jijun, Siru Nie, Xunan Qiu, Shuwen Zheng, Chuxuan Ni, Yuan Yuan, Yuehua Gong. 2023. “Leveraging Existing 16S rRNA Microbial Data to Identify Diagnostic Biomarker in Chinese Patients With Gastric Cancer: A Systematic Meta-Analysis.” mSystems 8: e0074723. https://doi.org/10.1128/msystems.00747-23

[576] Xu, Shuo, Chunjie Xiang, Juan Wu, Yuhao Teng, Zhenfeng Wu, Ruiping Wang, Bin Lu, et al. 2021. “Tongue Coating Bacteria as a Potential Stable Biomarker for Gastric Cancer Independent of Lifestyle.” Digestive Diseases and Sciences 66: 2964-2980. https://doi.org/10.1007/s10620-020-06637-0

[577] Schinzari, V., V. Barnaba, S. Piconese. 2015. “Chronic Hepatitis B Virus and Hepatitis C Virus Infections and Cancer: Synergy Between Viral and Host Factors.” Clinical Microbiology and Infection 21: 969-974. https://doi.org/10.1016/j.cmi.2015.06.026

[578] Han, Kathy, Jinfeng Zou, Zhen Zhao, Zeynep Baskurt, Yangqiao Zheng, Elizabeth Barnes, Jennifer Croke, et al. 2024. “Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.” Journal of Clinical Oncology 42: 431-440. https://doi.org/10.1200/JCO.23.00954

[579] Mendez, Roberto, Kousik Kesh, Nivedita Arora, Leá Di Martino, Florencia McAllister, Nipun Merchant, Sulagna Banerjee, Santanu Banerjee. 2020. “Microbial Dysbiosis and Polyamine Metabolism as Predictive Markers for Early Detection of Pancreatic Cancer.” Carcinogenesis 41: 561-570. https://doi.org/10.1093/carcin/bgz116

[580] Yazdi, Hamid Reza, Abolfazl Movafagh, Fateme Fallah, Shohreh Alizadeh Shargh, Neda Mansouri, Atefeh Heidary Pour, Mehrdad Hashemi. 2016. “Evaluation of Methylobacterium Radiotolerance and Sphyngomonas yanoikoaie in Sentinel Lymph?Nodes of Breast Cancer Cases.” Asian Pacific Journal of Cancer Prevention 17: 279-285. https://doi.org/10.7314/apjcp.2016.17.s3.279

[581] Liang, Te, Hao Chen, Lei Liu, Yongqiang Zheng, Zhaoen Ma, Ling Min, Jiahui Zhang, et al. 2024. “Antibody Profiling of Pan-Cancer Viral Proteome Reveals Biomarkers for Nasopharyngeal Carcinoma Diagnosis and Prognosis.” Molecular & Cellular Proteomics: MCP 23: 100729. https://doi.org/10.1016/j.mcpro.2024.100729

[582] Wang, Na, Si Wu, Lanxiang Huang, Yue Hu, Xin He, Jourong He, Ben Hu, et al. 2025. “Intratumoral Microbiome: Implications for Immune Modulation and Innovative Therapeutic Strategies in Cancer.” Journal of Biomedical Science 32: 23. https://doi.org/10.1186/s12929-025-01117-x

[583] Jiang, Zhengting, Wenjie Zhang, Zhilin Zhang, Gengyu Sha, Daorong Wang, Dong Tang. 2023. “Intratumoral Microbiota: A New Force in Diagnosing and Treating Pancreatic Cancer.” Cancer Letters 554: 216031. https://doi.org/10.1016/j.canlet.2022.216031

[584] Liu, Lanxiang, Haiyang Wang, Hanping Zhang, Xueyi Chen, Yangdong Zhang, Ji Wu, Libo Zhao, et al. 2022. “Toward a Deeper Understanding of Gut Microbiome in Depression: The Promise of Clinical Applicability.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 9: e2203707. https://doi.org/10.1002/advs.202203707

[585] Kang, Xing, Harry Cheuk-Hay Lau, Jun Yu. 2024. “Modulating Gut Microbiome in Cancer Immunotherapy: Harnessing Microbes to Enhance Treatment Efficacy.” Cell Reports. Medicine 5: 101478. https://doi.org/10.1016/j.xcrm.2024.101478

[586] Han, Eui-Jeong, Ji-Seon Ahn, Yu-Jin Choi, Da-Hye Kim, Jong-Soon Choi, Hea-Jong Chung. 2025. “Exploring the Gut Microbiome: A Potential Biomarker for Cancer Diagnosis, Prognosis, and Therapy.” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer 1880: 189251. https://doi.org/10.1016/j.bbcan.2024.189251

[587] Liu, Yali, Harry Cheuk-Hay Lau, Wing Yin Cheng, Jun Yu. 2023. “Gut Microbiome in Colorectal Cancer: Clinical Diagnosis and Treatment.” Genomics, Proteomics & Bioinformatics 21: 84-96. https://doi.org/10.1016/j.gpb.2022.07.002

[588] Zhang, Limin, Ziying Feng, Yinghua Li, Cuiting Lv, Chunchun Li, Yue Hu, Mingsheng Fu, Liang Song. 2023. “Salivary and Fecal Microbiota: Potential New Biomarkers for Early Screening of Colorectal Polyps.” Frontiers in Microbiology 14: 1182346. https://doi.org/10.3389/fmicb.2023.1182346

[589] Che, Shusheng, Zhiyong Yan, Yugong Feng, Hai Zhao. 2024. “Unveiling the Intratumoral Microbiota Within Cancer Landscapes.” iScience 27: 109893. https://doi.org/10.1016/j.isci.2024.109893

[590] Li, Xuebo, Xuelian Yuan, Xiumin Zhu, Changjun Li, Lei Ji, Kebo Lv, Geng Tian, Kang Ning, Jialiang Yang. 2023. “A Meta-Analysis Of Tissue Microbial Biomarkers for Recurrence and Metastasis in Multiple Cancer Types.” Journal of Medical Microbiology 72. https://doi.org/10.1099/jmm.0.001744

[591] Ren, Zhigang, Ang Li, Jianwen Jiang, Lin Zhou, Zujiang Yu, Haifeng Lu, Haiyang Xie, et al. 2019. “Gut Microbiome Analysis as a Tool Towards Targeted Non-Invasive Biomarkers for Early Hepatocellular Carcinoma.” Gut 68: 1014-1023. https://doi.org/10.1136/gutjnl-2017-315084

[592] Cho, Eun Ju, Sangseob Leem, Sun Ah Kim, Jinho Yang, Yun Bin Lee, Soon Sun Kim, Jae Youn Cheong, et al. 2019. “Circulating Microbiota-Based Metagenomic Signature for Detection of Hepatocellular Carcinoma.” Scientific Reports 9: 7536. https://doi.org/10.1038/s41598-019-44012-w

[593] Loomba, Rohit, Victor Seguritan, Weizhong Li, Tao Long, Niels Klitgord, Archana Bhatt, Parambir Singh Dulai, et al. 2017. “Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.” Cell Metabolism 25: 1054-62.e5. https://doi.org/10.1016/j.cmet.2017.04.001

[594] Liu, Ying, Hao Ai. 2024. “Comprehensive Insights Into Human Papillomavirus and Cervical Cancer: Pathophysiology, Screening, and Vaccination Strategies.” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer 1879: 189192. https://doi.org/10.1016/j.bbcan.2024.189192

[595] Malpica, Luis, Mario L. Marques-Piubelli, Brady E. Beltran, Julio C. Chavez, Roberto N. Miranda, Jorge J. Castillo. 2024. “EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified: 2024 Update on the Diagnosis, Risk-Stratification, and Management.” American Journal of Hematology 99: 2002-2015. https://doi.org/10.1002/ajh.27430

[596] Zoulim, Fabien, Pei-Jer Chen, Maura Dandri, Patrick T. Kennedy, Christoph Seeger. 2024. “Hepatitis B Virus DNA Integration: Implications for Diagnostics, Therapy, and Outcome.” Journal of Hepatology 81: 1087-1099. https://doi.org/10.1016/j.jhep.2024.06.037

[597] Arbyn, Marc, Marie Simon, Eliana Peeters, Lan Xu, Chris J. L. M. Meijer, Johannes Berkhof, Kate Cuschieri, et al. 2021. “2020 List of Human Papillomavirus Assays Suitable for Primary Cervical Cancer Screening.” Clinical Microbiology and Infection 27: 1083-1095. https://doi.org/10.1016/j.cmi.2021.04.031

[598] Wolf, Jonas, Lucas Felipe Kist, Samanta Brangel Pereira, Marilze Alves Quessada, Helena Petek, Arthur Pille, Juçara Gasparetto Maccari, Mohamed Parrini Mutlaq, Luiz Antonio Nasi. 2024. “Human Papillomavirus Infection: Epidemiology, Biology, Host Interactions, Cancer Development, Prevention, and Therapeutics.” Reviews in Medical Virology 34: e2537. https://doi.org/10.1002/rmv.2537

[599] Emlet, Cade, Mack Ruffin, Regina Lamendella. 2020. “Enteric Virome and Carcinogenesis in the Gut.” Digestive Diseases and Sciences 65: 852-864. https://doi.org/10.1007/s10620-020-06126-4

[600] Zhang, Zhemei, Yongqing Yang, Lei Zhang, Yang Wu, Pengxia Jia, Qingmei Ma, Danni Wang. 2023. “Relationship Between Cervicovaginal Microecological Changes and HPV16/18 Infection and Cervical Cancer in Women of Childbearing Age.” Annals of Clinical and Laboratory Science 53: 825-834.

[601] Elbehi, Attia M., R. I. Anu, Bene Ekine-Afolabi, Elizabeth Cash. 2020. “Emerging Role of Immune Checkpoint Inhibitors and Predictive Biomarkers in Head and Neck Cancers.” Oral Oncology 109: 104977. https://doi.org/10.1016/j.oraloncology.2020.104977

[602] Xu, Jian-Hua. 2013. “Hepatitis B or C Viral Infection and Risk of Pancreatic Cancer: A Meta-Analysis of Observational Studies.” World Journal of Gastroenterology 19: 4234-4241. https://doi.org/10.3748/wjg.v19.i26.4234

[603] Saftien, Aurelia, Jens Puschhof, Eran Elinav. 2023. “Fungi and Cancer.” Gut 72: 1410-1425. https://doi.org/10.1136/gutjnl-2022-327952

[604] Xu, Jing, Chunjie Xiang, Cong Zhang, Boqi Xu, Juan Wu, Ruiping Wang, Yaping Yang, et al. 2019. “Microbial Biomarkers of Common Tongue Coatings in Patients With Gastric Cancer.” Microbial Pathogenesis 127: 97-105. https://doi.org/10.1016/j.micpath.2018.11.051

[605] Kaźmierczak-Siedlecka, Karolina, Aleš Dvořák, Marcin Folwarski, Agnieszka Daca, Katarzyna Przewłócka, Wojciech Makarewicz. 2020. “Fungal Gut Microbiota Dysbiosis and Its Role in Colorectal, Oral, and Pancreatic Carcinogenesis.” Cancers 12: 1326. https://doi.org/10.3390/cancers12051326

[606] Chung, Li-Min, Ji-An Liang, Cheng-Li Lin, Li-Min Sun, Chia-Hung Kao. 2017. “Cancer Risk in Patients With Candidiasis: A Nationwide Population-Based Cohort Study.” Oncotarget 8: 63562-63573. https://doi.org/10.18632/oncotarget.18855

[607] Kashyap, Sheetal, Soumya Pal, Gourav Chandan, Vipin Saini, Sasanka Chakrabarti, Neeraj K. Saini, Amit Mittal, et al. 2022. “Understanding the Cross-Talk Between Human Microbiota and Gastrointestinal Cancer for Developing Potential Diagnostic and Prognostic Biomarkers.” Seminars in Cancer Biology 86: 643-651. https://doi.org/10.1016/j.semcancer.2021.04.020

[608] Malhotra, Pratibha, Ranjith Palanisamy, Jose A. Caparros-Martin, Marco Falasca. 2023. “Bile Acids and Microbiota Interplay in Pancreatic Cancer.” Cancers 15: 3573. https://doi.org/10.3390/cancers15143573

[609] Chalova, Petra, Anton Tazky, Ludovit Skultety, Lenka Minichova, Michal Chovanec, Sona Ciernikova, Peter Mikus, Juraj Piestansky. 2023. “Determination of Short-Chain Fatty Acids as Putative Biomarkers of Cancer Diseases by Modern Analytical Strategies and Tools: A Review.” Frontiers in Oncology 13: 1110235. https://doi.org/10.3389/fonc.2023.1110235

[610] Fang, Chuan-Yin, Jung-Sheng Chen, Bing-Mu Hsu, Bashir Hussain, Jagat Rathod, Kuo-Hsin Lee. 2021. “Colorectal Cancer Stage-Specific Fecal Bacterial Community Fingerprinting of the Taiwanese Population and Underpinning of Potential Taxonomic Biomarkers.” Microorganisms 9: 1548. https://doi.org/10.3390/microorganisms9081548

[611] Chen, Feng, Xudong Dai, Chang-Chun Zhou, Ke-Xin Li, Yu-Juan Zhang, Xiao-Ying Lou, Yuan-Min Zhu, et al. 2022. “Integrated Analysis of the Faecal Metagenome and Serum Metabolome Reveals the Role of Gut Microbiome-Associated Metabolites in the Detection of Colorectal Cancer and Adenoma.” Gut 71: 1315-1325. https://doi.org/10.1136/gutjnl-2020-323476

[612] Liu, Bo, Yige Li, Lijun Suo, Wei Zhang, Hongyun Cao, Ruicai Wang, Jiahui Luan, et al. 2022. “Characterizing Microbiota and Metabolomics Analysis to Identify Candidate Biomarkers in Lung Cancer.” Frontiers in Oncology 12: 1058436. https://doi.org/10.3389/fonc.2022.1058436

[613] Louis, Petra, Georgina L. Hold, Harry J. Flint. 2014. “The Gut Microbiota, Bacterial Metabolites and Colorectal Cancer.” Nature Reviews Microbiology 12: 661-672. https://doi.org/10.1038/nrmicro3344

[614] Hatta, Muhammad Nur Adam, Ezanee Azlina Mohamad Hanif, Siok-Fong Chin, Teck Yew Low, Hui-Min Neoh. 2023. “Parvimonas micra Infection Enhances Proliferation, Wound Healing, and Inflammation of a Colorectal Cancer Cell Line.” Bioscience Reports 43: BSR20230609. https://doi.org/10.1042/BSR20230609

[615] Ding, Ruojun, ShengYang Bertrand Lian, Yew Chong Tam, Choon Chiat Oh. 2024. “The Cutaneous Microbiome in Skin Cancer—A Systematic Review.” Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology: JDDG 22: 177-184. https://doi.org/10.1111/ddg.15294

[616] Wu, Peng, Guihao Zhang, Jie Zhao, Jiawei Chen, Yang Chen, Weina Huang, Jialei Zhong, Jiarong Zeng. 2018. “Profiling the Urinary Microbiota in Male Patients With Bladder Cancer in China.” Frontiers in Cellular and Infection Microbiology 8: 167. https://doi.org/10.3389/fcimb.2018.00167

[617] Derosa, Lisa, Bertrand Routy, Andrew Maltez Thomas, Valerio Iebba, Gerard Zalcman, Sylvie Friard, Julien Mazieres, et al. 2022. “Intestinal Akkermansia muciniphila Predicts Clinical Response to PD-1 Blockade in Patients With Advanced Non-Small-Cell Lung Cancer.” Nature Medicine 28: 315-324. https://doi.org/10.1038/s41591-021-01655-5

[618] Liu, Yuting, Huiwen Wang, Haiyang Jiang, Zhumei Sun, Anyang Sun. 2023. “Alloprevotella Can be Considered as a Potential Oral Biomarker in Intestinal Metaphase of Gastric Patients.” Studies in Health Technology and Informatics 308: 155-167. https://doi.org/10.3233/SHTI230836

[619] Lee, Wei-Hsiang, Hui-Mei Chen, Shun-Fa Yang, Chao Liang, Chih-Yu Peng, Feng-Mao Lin, Lo-Lin Tsai, et al. 2017. “Bacterial Alterations in Salivary Microbiota and Their Association in Oral Cancer.” Scientific Reports 7: 16540. https://doi.org/10.1038/s41598-017-16418-x

[620] Mai, Guoqin, Limei Chen, Ran Li, Quan Liu, Haoran Zhang, Yingfei Ma. 2019. “Common Core Bacterial Biomarkers of Bladder Cancer Based on Multiple Datasets.” BioMed Research International 2019: 4824909. https://doi.org/10.1155/2019/4824909

[621] Law, Helen Ka Wai, Howard Chi Ho Yim. 2024. “Early Diagnosis of Cancer Using Circulating Microbial DNA.” Cell Reports. Medicine 5: 101502. https://doi.org/10.1016/j.xcrm.2024.101502

[622] Kataria, Radhika, Saeed Shoaie, Anita Grigoriadis, Jonathan C. M. Wan. 2023. “Leveraging Circulating Microbial DNA for Early Cancer Detection.” Trends in Cancer 9: 879-882. https://doi.org/10.1016/j.trecan.2023.08.001

[623] Dzutsev, Amiran, Giorgio Trinchieri. 2020. “Microbial DNA Signature in Plasma Enables Cancer Diagnosis.” Nature Reviews Clinical Oncology 17: 453-454. https://doi.org/10.1038/s41571-020-0391-1

[624] Xiao, Qian, Wei Lu, Xiangxing Kong, Yang W. Shao, Yeting Hu, Ao Wang, Hua Bao, et al. 2021. “Alterations of Circulating Bacterial DNA in Colorectal Cancer and Adenoma: A Proof-of-Concept Study.” Cancer Letters 499: 201-208. https://doi.org/10.1016/j.canlet.2020.11.030

[625] Ahn, Sun M., Jason Y. K. Chan, Zhe Zhang, Hao Wang, Zubair Khan, Justin A. Bishop, William Westra, Wayne M. Koch, Joseph?A. Califano. 2014. “Saliva and Plasma Quantitative Polymerase Chain Reaction-Based Detection and Surveillance of Human Papillomavirus-Related Head and Neck Cancer.” JAMA Otolaryngology—Head & Neck Surgery 140: 846-854. https://doi.org/10.1001/jamaoto.2014.1338

[626] Yang, Jinho, Hyo Eun Moon, Hyung Woo Park, Andrea McDowell, Tae-Seop Shin, Young-Koo Jee, Sungmin Kym, Sun Ha Paek, Yoon-Keun Kim. 2020. “Brain Tumor Diagnostic Model and Dietary Effect Based on Extracellular Vesicle Microbiome Data in Serum.” Experimental & Molecular Medicine 52: 1602-1613. https://doi.org/10.1038/s12276-020-00501-x

[627] Melo, Sonia A., Linda B. Luecke, Christoph Kahlert, Agustin F. Fernandez, Seth T. Gammon, Judith Kaye, Valerie S. LeBleu, et al. 2015. “Glypican-1 Identifies Cancer Exosomes and Detects Early Pancreatic Cancer.” Nature 523: 177-182. https://doi.org/10.1038/nature14581

[628] Barteneva, Natasha S., Yeldar Baiken, Elizaveta Fasler-Kan, Kenneth Alibek, Sheng Wang, Natalia Maltsev, Eugene D. Ponomarev, et al. 2017. “Extracellular Vesicles in Gastrointestinal Cancer in Conjunction With Microbiota: On the Border of Kingdoms.” Biochimica et Biophysica Acta (BBA)—Reviews on Cancer 1868: 372-393. https://doi.org/10.1016/j.bbcan.2017.06.005

[629] Gilbert, Jack A., Martin J. Blaser, J. Gregory Caporaso, Janet K. Jansson, Susan V. Lynch, Rob Knight. 2018. “Current Understanding of the Human Microbiome.” Nature Medicine 24: 392-400. https://doi.org/10.1038/nm.4517

[630] Baron, Ellen Jo, J. Michael Miller, Melvin P. Weinstein, Sandra S. Richter, Peter H. Gilligan, Richard B. Thomson, Paul Bourbeau, et al. 2013. “A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2013 Recommendations by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM)(a).” Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 57: e22-e121. https://doi.org/10.1093/cid/cit278

[631] Sánchez-Romero, M.Isabel, Juan ManuelGarcía-Lechuz Moya, Juan JoséGonzález López, NievesOrta Mira. 2019. “Collection, Transport and General Processing of Clinical Specimens in Microbiology Laboratory.” Enfermedades Infecciosas Y Microbiologia Clinica (English Ed.) 37: 127-134. https://doi.org/10.1016/j.eimc.2017.12.002

[632] Bharti, Richa, Dominik G. Grimm. 2021. “Current Challenges and Best-Practice Protocols for Microbiome Analysis.” Briefings in Bioinformatics 22: 178-193. https://doi.org/10.1093/bib/bbz155

[633] Fabre, Valeria, Angelina Davis, Daniel J. Diekema, Bruno Granwehr, Mary K. Hayden, Christopher F. Lowe, Christopher D. Pfeiffer, et al. 2023. “Principles of Diagnostic Stewardship: A Practical Guide From the Society for Healthcare Epidemiology of America Diagnostic Stewardship Task Force.” Infection Control & Hospital Epidemiology 44: 178-185. https://doi.org/10.1017/ice.2023.5

[634] Derosa, Lisa, Bertrand Routy, Antoine Desilets, Romain Daillère, Safae Terrisse, Guido Kroemer, Laurence Zitvogel. 2021. “Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?” Cancer Discovery 11: 2396-2412. https://doi.org/10.1158/2159-8290.CD-21-0236

[635] Guerrero-Preston, Rafael, Filipa Godoy-Vitorino, Anne Jedlicka, Arnold Rodríguez-Hilario, Herminio González, Jessica Bondy, Fahcina Lawson, et al. 2016. “16S rRNA Amplicon Sequencing Identifies Microbiota Associated With Oral Cancer, Human Papilloma Virus Infection and Surgical Treatment.” Oncotarget 7: 51320-51334. https://doi.org/10.18632/oncotarget.9710

[636] Ren, Shengnan, Lingxin Feng, Haoran Liu, Yuke Mao, Zhuang Yu. 2024. “Gut Microbiome Affects the Response to Immunotherapy in Non-Small Cell Lung Cancer.” Thoracic Cancer 15: 1149-1163. https://doi.org/10.1111/1759-7714.15303

[637] Lee, Pei-Chang, Wu, Chi-JungHung, Ya-WenLee, Chieh JuChi, Chen-TaLee, I-Cheng.-Kuo Yu-Lun, et al. 2022. “Gut Microbiota and Metabolites Associate With Outcomes of Immune Checkpoint Inhibitor-Treated Unresectable Hepatocellular Carcinoma.” Journal for Immunotherapy of Cancer 10: e004779. https://doi.org/10.1136/jitc-2022-004779

[638] Zhou, Xin, Lili Chen, Wanrun Lin, Wenxin Zheng, Huijuan Zhang, Feng Zhou. 2024. “Diagnostic and Prognostic Potential of the Intra-Tumoral Microbiota Profile in HPV-Independent Endocervical Adenocarcinoma.” Frontiers in Cellular and Infection Microbiology 14: 1440017. https://doi.org/10.3389/fcimb.2024.1440017

[639] Dora, David, Glen J. Weiss, Zsolt Megyesfalvi, Gabriella Gállfy, Edit Dulka, Anna Kerpel-Fronius, Judit Berta, et al. 2023. “Computed Tomography-Based Quantitative Texture Analysis and Gut Microbial Community Signatures Predict Survival in Non-Small Cell Lung Cancer.” Cancers 15: 5091. https://doi.org/10.3390/cancers15205091

[640] Zhu, Chengpei, Chenchen Zhang, Shanshan Wang, Ziyu Xun, Dongya Zhang, Zhou Lan, Longhao Zhang, et al. 2024. “Characterizations of Multi-Kingdom Gut Microbiota in Immune Checkpoint Inhibitor-Treated Hepatocellular Carcinoma.” Journal for Immunotherapy of Cancer 12: e008686. https://doi.org/10.1136/jitc-2023-008686

[641] Zhu, Xinhai, Ke Li, Guichao Liu, Ruan Wu, Yan Zhang, Siying Wang, Meng Xu, Ligong Lu, Peng Li. 2023. “Microbial Metabolite Butyrate Promotes Anti-PD-1 Antitumor Efficacy by Modulating T Cell Receptor Signaling of Cytotoxic CD8 T Cell.” Gut Microbes 15: 2249143. https://doi.org/10.1080/19490976.2023.2249143

[642] Geller, Leore T., Michal Barzily-Rokni, Tal Danino, Oliver H. Jonas, Noam Shental, Deborah Nejman, Nancy Gavert, et al. 2017. “Potential Role of Intratumor Bacteria in Mediating Tumor Resistance to the Chemotherapeutic Drug Gemcitabine.” Science 357: 1156-1160. https://doi.org/10.1126/science.aah5043

[643] Coutzac, Clélia, Jean-Mehdi Jouniaux, Angelo Paci, Julien Schmidt, Domenico Mallardo, Atmane Seck, Vahe Asvatourian, et al. 2020. “Systemic Short Chain Fatty Acids Limit Antitumor Effect of CTLA-4 Blockade in Hosts With Cancer.” Nature Communications 11: 2168. https://doi.org/10.1038/s41467-020-16079-x

[644] Wallace, Bret D., Hongwei Wang, Kimberly T. Lane, John E. Scott, Jillian Orans, Ja Seol Koo, Madhukumar Venkatesh, et al. 2010. “Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme.” Science 330: 831-835. https://doi.org/10.1126/science.1191175

[645] Richardson, Brianna N., Jolinta Lin, Zachary S. Buchwald, Jinbing Bai. 2022. “Skin Microbiome and Treatment-Related Skin Toxicities in Patients With Cancer: A Mini-Review.” Frontiers in Oncology 12: 924849. https://doi.org/10.3389/fonc.2022.924849

[646] Porcari, Serena, Nicolas Benech, Mireia Valles-Colomer, Nicola Segata, Antonio Gasbarrini, Giovanni Cammarota, Harry Sokol, Gianluca Ianiro. 2023. “Key Determinants of Success in Fecal Microbiota Transplantation: From Microbiome to Clinic.” Cell Host & Microbe 31: 712-733. https://doi.org/10.1016/j.chom.2023.03.020

[647] Frey-Furtado, Leonor, Inês Magalhães, Benedita Sampaio-Maia, Maria João Azevedo. 2023. “Oral Microbiome Characterization in Oral Mucositis Patients—A Systematic Review.” Journal of Oral Pathology & Medicine: Official Publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 52: 911-918. https://doi.org/10.1111/jop.13492

[648] Gui, Q.-F., H.-F. Lu, C.-X. Zhang, Z.-R. Xu, Y.-H. Yang. 2015. “Well-Balanced Commensal Microbiota Contributes to Anti-Cancer Response in a Lung Cancer Mouse Model.” Genetics and Molecular Research 14: 5642-5651. https://doi.org/10.4238/2015.May.25.16

[649] Stolzenberg-Solomon, Rachael Z., Kevin W. Dodd, Martin J. Blaser, Jarmo Virtamo, Philip R. Taylor, Demetrius Albanes. 2003. “Tooth Loss, Pancreatic Cancer, and Helicobacter pylori.” The American Journal of Clinical Nutrition 78: 176-181. https://doi.org/10.1093/ajcn/78.1.176

[650] Farrell, James J., Lei Zhang, Hui Zhou, David Chia, David Elashoff, David Akin, Bruce J. Paster, Kaumudi Joshipura, David T. W. Wong. 2012. “Variations of Oral Microbiota Are Associated With Pancreatic Diseases Including Pancreatic Cancer.” Gut 61: 582-588. https://doi.org/10.1136/gutjnl-2011-300784

[651] Peters, Brandilyn A., Richard B. Hayes, Chandra Goparaju, Christopher Reid, Harvey I. Pass, Jiyoung Ahn. 2019. “The Microbiome in Lung Cancer Tissue and Recurrence-Free Survival.” Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 28: 731-740. https://doi.org/10.1158/1055-9965.EPI-18-0966

[652] Hu, Min, Samuel Coleman, Muhammad Zaki Hidayatullah Fadlullah, Daniel Spakowicz, Christine H. Chung, Aik Choon Tan. 2023. “Deciphering the Tumor-Immune-Microbe Interactions in HPV-Negative Head and Neck Cancer.” Genes 14: 1599. https://doi.org/10.3390/genes14081599

[653] Garajová, Ingrid, Rita Balsano, Heling Wang, Francesco Leonardi, Elisa Giovannetti, Dongmei Deng, Godefridus J. Peters. 2021. “The Role of the Microbiome in Drug Resistance in Gastrointestinal Cancers.” Expert Review of Anticancer Therapy 21: 165-176. https://doi.org/10.1080/14737140.2021.1844007

[654] Wang, Feng, Qian Yin, Liang Chen, Mark M. Davis. 2018. “Bifidobacterium Can Mitigate Intestinal Immunopathology in the Context Of CTLA-4 Blockade.” Proceedings of the National Academy of Sciences 115: 157-161. https://doi.org/10.1073/pnas.1712901115

[655] Klufa, Jörg, Thomas Bauer, Buck Hanson, Craig Herbold, Philipp Starkl, Beate Lichtenberger, Dagmar Srutkova, et al. 2019. “Hair Eruption Initiates and Commensal Skin Microbiota Aggravate Adverse Events of Anti-EGFR Therapy.” Science Translational Medicine 11: eaax2693. https://doi.org/10.1126/scitranslmed.aax2693

[656] Pal, Sumanta K., Sierra M. Li, Xiwei Wu, Hanjun Qin, Marcin Kortylewski, JoAnn Hsu, Courtney Carmichael, Paul Frankel. 2015. “Stool Bacteriomic Profiling in Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor-Tyrosine Kinase Inhibitors.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 21: 5286-5293. https://doi.org/10.1158/1078-0432.CCR-15-0724

[657] Bawaneh, Alaa, Adam S. Wilson, Nicole Levi, Marissa M. Howard-McNatt, Akiko Chiba, David R. Soto-Pantoja, Katherine L. Cook. 2022. “Intestinal Microbiota Influence Doxorubicin Responsiveness in Triple-Negative Breast Cancer.” Cancers 14: 4849. https://doi.org/10.3390/cancers14194849

[658] Geng, Hong-Wei, Feng-Yi Yin, Zhi-Fa Zhang, Xu Gong, Yun Yang. 2021. “Butyrate Suppresses Glucose Metabolism of Colorectal Cancer Cells via GPR109a-AKT Signaling Pathway and Enhances Chemotherapy.” Frontiers in Molecular Biosciences 8: 634874. https://doi.org/10.3389/fmolb.2021.634874

[659] Geller, Leore T., Ravid Straussman. 2018. “Intratumoral Bacteria May Elicit Chemoresistance by Metabolizing Anticancer Agents.” Molecular & Cellular Oncology 5: e1405139. https://doi.org/10.1080/23723556.2017.1405139

[660] Wang, Xinyi, Xicai Sun, Jinjin Chu, Wenchang Sun, Shushan Yan, Yaowen Wang. 2023. “Gut Microbiota and Microbiota-Derived Metabolites in Colorectal Cancer: Enemy or Friend.” World Journal of Microbiology & Biotechnology 39: 291. https://doi.org/10.1007/s11274-023-03742-w

[661] Zheng, Di-Wei, Xue Dong, Pei Pan, Ke-Wei Chen, Jin-Xuan Fan, Si-Xue Cheng, Xian-Zheng Zhang. 2019. “Phage-Guided Modulation of the Gut Microbiota of Mouse Models of Colorectal Cancer Augments Their Responses to Chemotherapy.” Nature Biomedical Engineering 3: 717-728. https://doi.org/10.1038/s41551-019-0423-2

[662] Lindel, Katja, Karl T. Beer, Jean Laissue, Richard H. Greiner, Daniel M. Aebersold. 2001. “Human Papillomavirus Positive Squamous Cell Carcinoma of the Oropharynx: A Radiosensitive Subgroup of Head and Neck Carcinoma.” Cancer 92: 805-813. https://doi.org/10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9

[663] Chen, Allen M., Carol Felix, Pin-Chieh Wang, Sophia Hsu, Vincent Basehart, Jordan Garst, Phillip Beron, et al. 2017. “Reduced-Dose Radiotherapy for Human Papillomavirus-Associated Squamous-Cell Carcinoma of the Oropharynx: A Single-Arm, Phase 2 Study.” The Lancet. Oncology 18: 803-811. https://doi.org/10.1016/S1470-2045(17)30246-2

[664] Qu, Junxing, Zhiheng Sun, Chen Peng, Daoqian Li, Wenyue Yan, Zhen Xu, Yayi Hou, et al. 2021. “C. tropicalis Promotes Chemotherapy Resistance in Colon Cancer Through Increasing Lactate Production to Regulate the Mismatch Repair System.” International Journal of Biological Sciences 17: 2756-2769. https://doi.org/10.7150/ijbs.59262

[665] Kumpitsch, Christina, Christine Moissl-Eichinger, Jakob Pock, Dietmar Thurnher, Axel Wolf. 2020. “Preliminary Insights Into the Impact of Primary Radiochemotherapy on the Salivary Microbiome in Head and Neck Squamous Cell Carcinoma.” Scientific Reports 10: 16582. https://doi.org/10.1038/s41598-020-73515-0

[666] Shuwen, Han, Yang Xi, Pan Yuefen, Xu Jiamin, Qi Quan, Liao Haihong, Jiang Yizhen, Wu Wei. 2020. “Effects of Postoperative Adjuvant Chemotherapy and Palliative Chemotherapy on the Gut Microbiome in Colorectal Cancer.” Microbial Pathogenesis 149: 104343. https://doi.org/10.1016/j.micpath.2020.104343

[667] Panebianco, Concetta, Kaarel Adamberg, Madis Jaagura, Massimiliano Copetti, Andrea Fontana, Signe Adamberg, Kaia Kolk, et al. 2018. “Influence of Gemcitabine Chemotherapy on the Microbiota of Pancreatic Cancer Xenografted Mice.” Cancer Chemotherapy and Pharmacology 81: 773-782. https://doi.org/10.1007/s00280-018-3549-0

[668] Loman, B. R., K. R. Jordan, B. Haynes, M. T. Bailey, L. M. Pyter. 2019. “Chemotherapy-Induced Neuroinflammation Is Associated With Disrupted Colonic and Bacterial Homeostasis in Female Mice.” Scientific Reports 9: 16490. https://doi.org/10.1038/s41598-019-52893-0

[669] Stringer, Andrea M., Rachel J. Gibson, Richard M. Logan, Joanne M. Bowen, Ann S. J. Yeoh, Juliette Hamilton, Dorothy M. K. Keefe. 2009. “Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis.” Exp Biol Med (Maywood) 234: 430-441. https://doi.org/10.3181/0810-RM-301

[670] Stojanovska, Vanesa, Rachel M. McQuade, Sarah Fraser, Monica Prakash, Shakuntla Gondalia, Rhian Stavely, Enzo Palombo, et al. 2018. “Oxaliplatin-Induced Changes in Microbiota, TLR4+ Cells and Enhanced HMGB1 Expression in the Murine Colon.” PloS One 13: e0198359. https://doi.org/10.1371/journal.pone.0198359

[671] Kaźmierczak-Siedlecka, Karolina, Nikola Bulman, Paweł Ulasiński, Bartosz Kamil Sobocki, Karol Połom, Luigi Marano, Leszek Kalinowski, Karolina Skonieczna-Żydecka. 2023. “Pharmacomicrobiomics of Cell-Cycle Specific Anti-Cancer Drugs—Is it a New Perspective for Personalized Treatment of Cancer Patients?” Gut Microbes 15: 2281017. https://doi.org/10.1080/19490976.2023.2281017

[672] Chiba, Akiko, Alaa Bawaneh, Christine Velazquez, Kenysha Y. J. Clear, Adam S. Wilson, Marissa Howard-McNatt, Edward A. Levine, et al. 2020. “Neoadjuvant Chemotherapy Shifts Breast Tumor Microbiota Populations to Regulate Drug Responsiveness and the Development of Metastasis.” Molecular Cancer Research: MCR 18: 130-139. https://doi.org/10.1158/1541-7786.MCR-19-0451

[673] Forsgård, Richard A., Vannina G. Marrachelli, Katri Korpela, Rafael Frias, Maria Carmen Collado, Riitta Korpela, Daniel Monleon, Thomas Spillmann, Pia Österlund. 2017. “Chemotherapy-Induced Gastrointestinal Toxicity Is Associated With Changes in Serum and Urine Metabolome and Fecal Microbiota in Male Sprague-Dawley Rats.” Cancer Chemotherapy and Pharmacology 80: 317-332. https://doi.org/10.1007/s00280-017-3364-z

[674] Bowen, Joanne M., Andrea M. Stringer, Rachel J. Gibson, Ann S. J. Yeoh, Sarah Hannam, Dorothy M. K. Keefe. 2007. “VSL#3 Probiotic Treatment Reduces Chemotherapy-Induced Diarrhea and Weight Loss.” Cancer Biology & Therapy 6: 1449-1454. https://doi.org/10.4161/cbt.6.9.4622

[675] Shen, Shiqian, Grewo Lim, Zerong You, Weihua Ding, Peigen Huang, Chongzhao Ran, Jason Doheny, et al. 2017. “Gut Microbiota Is Critical for the Induction of Chemotherapy-Induced Pain.” Nature Neuroscience 20: 1213-1216. https://doi.org/10.1038/nn.4606

[676] Ramakrishna, Chandran, Jose Corleto, Paul M. Ruegger, Geoffrey D. Logan, Beth B. Peacock, Stacee Mendonca, Shanni Yamaki, et al. 2019. “Dominant Role of the Gut Microbiota in Chemotherapy Induced Neuropathic Pain.” Scientific Reports 9: 20324. https://doi.org/10.1038/s41598-019-56832-x

[677] Li, Shiyu, Shuangli Zhu, Jun Yu. 2024. “The Role of Gut Microbiota and Metabolites in Cancer Chemotherapy.” Journal of Advanced Research 64: 223-235. https://doi.org/10.1016/j.jare.2023.11.027

[678] Mirzaei, Sara, Milad Iranshahy, Hamid Gholamhosseinian, Maryam M. Matin, Fatemeh B. Rassouli. 2022. “Urolithins Increased Anticancer Effects of Chemical Drugs, Ionizing Radiation and Hyperthermia on Human Esophageal Carcinoma Cells In Vitro.” Tissue & Cell 77: 101846. https://doi.org/10.1016/j.tice.2022.101846

[679] Teng, Huajing, Yan Wang, Xin Sui, Jiawen Fan, Shuai Li, Xiao Lei, Chen Shi, et al. 2023. “Gut Microbiota-Mediated Nucleotide Synthesis Attenuates the Response to Neoadjuvant Chemoradiotherapy in Rectal Cancer.” Cancer Cell 41: 124-38.e6. https://doi.org/10.1016/j.ccell.2022.11.013

[680] Linn, Ye Htut, K. Khine Thu, Nang Hla Hla Win. 2019. “Effect of Probiotics for the Prevention of Acute Radiation-Induced Diarrhoea Among Cervical Cancer Patients: A Randomized Double-Blind Placebo-Controlled Study.” Probiotics and Antimicrobial Proteins 11: 638-647. https://doi.org/10.1007/s12602-018-9408-9

[681] Blake, Stephen J., Yochai Wolf, Ben Boursi, Lynn, David J. 2024. “Role of the Microbiota in Response to and Recovery From Cancer Therapy.” Nature Reviews Immunology 24: 308-325. https://doi.org/10.1038/s41577-023-00951-0

[682] Li, Zongjuan, Yang Zhang, Weifeng Hong, Biao Wang, Yixing Chen, Ping Yang, Jian Zhou, et al. 2022. “Gut Microbiota Modulate Radiotherapy-Associated Antitumor Immune Responses Against Hepatocellular Carcinoma via STING Signaling.” Gut Microbes 14: 2119055. https://doi.org/10.1080/19490976.2022.2119055

[683] Shi, Wei, Lijun Shen, Wei Zou, Jingwen Wang, Jianing Yang, Yuezhu Wang, Bingdong Liu, et al. 2020. “The Gut Microbiome Is Associated With Therapeutic Responses and Toxicities of Neoadjuvant Chemoradiotherapy in Rectal Cancer Patients—A Pilot Study.” Frontiers in Cellular and Infection Microbiology 10: 562463. https://doi.org/10.3389/fcimb.2020.562463

[684] Yi, Yuxi, Lijun Shen, Wei Shi, Fan Xia, Hui Zhang, Yan Wang, Jing Zhang, et al. 2021. “Gut Microbiome Components Predict Response to Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: A Prospective, Longitudinal Study.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 27: 1329-1340. https://doi.org/10.1158/1078-0432.CCR-20-3445

[685] Chen, Linda, Nadeem Riaz, Nancy Lee, Sean McBride. 2021. “Current Considerations for Radiotherapy in HPV-Associated Head and Neck Cancer.” Journal of Surgical Oncology 124: 945-951. https://doi.org/10.1002/jso.26689

[686] Shiao, Stephen L., Kathleen M. Kershaw, Jose J. Limon, Sungyong You, Junhee Yoon, Emily Y. Ko, Jlenia Guarnerio, et al. 2021. “Commensal Bacteria and Fungi Differentially Regulate Tumor Responses to Radiation Therapy.” Cancer Cell 39: 1202-13.e6. https://doi.org/10.1016/j.ccell.2021.07.002

[687] Mougeot, Jean-Luc C., Craig B. Stevens, Kathryn G. Almon, Bruce J. Paster, Rajesh V. Lalla, Michael T. Brennan, Farah Bahrani Mougeot. 2019. “Caries-Associated Oral Microbiome in Head and Neck Cancer Radiation Patients: A Longitudinal Study.” Journal of Oral Microbiology 11: 1586421. https://doi.org/10.1080/20002297.2019.1586421

[688] Arrifin, Azirrawani, Ellie Heidari, Mary Burke, Michael R. Fenlon, Avijit Banerjee. 2018. “The Effect of Radiotherapy for Treatment of Head and Neck Cancer on Oral Flora and Saliva.” Oral Health & Preventive Dentistry 16: 425-429. https://doi.org/10.3290/j.ohpd.a41364

[689] Danckaert, Willeke, Mathieu Spaas, Nora Sundahl, Aurélie De Bruycker, Valérie Fonteyne, Ellen De Paepe, Carlos De Wagter, Lynn Vanhaecke, Piet Ost. 2023. “Microbiome and Metabolome Dynamics During Radiotherapy for Prostate Cancer.” Radiotherapy and Oncology 189: 109950. https://doi.org/10.1016/j.radonc.2023.109950

[690] Reis Ferreira, Miguel, H. Jervoise N. Andreyev, Kabir Mohammed, Lesley Truelove, Sharon M. Gowan, Jia Li, Sarah L. Gulliford, Julian R. Marchesi, David P. Dearnaley. 2019. “Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 25: 6487-6500. https://doi.org/10.1158/1078-0432.CCR-19-0960

[691] Olivas, Andrea D., Benjamin D. Shogan, Vesta Valuckaite, Alexander Zaborin, Natalya Belogortseva, Mark Musch, Folker Meyer, et al. 2012. “Intestinal Tissues Induce an SNP Mutation in Pseudomonas aeruginosa That Enhances Its Virulence: Possible Role in Anastomotic Leak.” PloS One 7: e44326. https://doi.org/10.1371/journal.pone.0044326

[692] Bahig, Houda, Clifton D. Fuller, Aparna Mitra, Kyoko Yoshida-Court, Travis Solley, Sweet Ping Ng, Ibrahim Abu-Gheida, et al. 2021. “Longitudinal Characterization of the Tumoral Microbiome During Radiotherapy in HPV-Associated Oropharynx Cancer.” Clinical and Translational Radiation Oncology 26: 98-103. https://doi.org/10.1016/j.ctro.2020.11.007

[693] Reis Ferreira, Miguel, H. Jervoise N. Andreyev, Kabir Mohammed, Lesley Truelove, Sharon M. Gowan, Jia Li, Sarah L. Gulliford, Julian R. Marchesi, David P. Dearnaley. 2019. “Microbiota- and Radiotherapy-Induced Gastrointestinal Side-Effects (MARS) Study: A Large Pilot Study of the Microbiome in Acute and Late-Radiation Enteropathy.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 25: 6487-6500. https://doi.org/10.1158/1078-0432.CCR-19-0960

[694] Ciorba, Matthew A., Terrence E. Riehl, M. Suprada Rao, Clara Moon, Xueping Ee, Gerardo M. Nava, Monica R. Walker, et al. 2012. “Lactobacillus Probiotic Protects Intestinal Epithelium From Radiation Injury in a TLR-2/Cyclo-Oxygenase-2-Dependent Manner.” Gut 61: 829-838. https://doi.org/10.1136/gutjnl-2011-300367

[695] Zhao, Zhenguo, Wei Cheng, Wei Qu, Guoyi Shao, Shuanghai Liu. 2020. “Antibiotic Alleviates Radiation-Induced Intestinal Injury by Remodeling Microbiota, Reducing Inflammation, and Inhibiting Fibrosis.” ACS Omega 5: 2967-2977. https://doi.org/10.1021/acsomega.9b03906

[696] Abdollahi, Elham, Thomas P. Johnston, Zahra Ghaneifar, Parviz Vahedi, Pouya Goleij, Sara Azhdari, Abbas Shapouri Moghaddam. 2023. “Immunomodulatory Therapeutic Effects of Curcumin on M1/M2 Macrophage Polarization in Inflammatory Diseases.” Current Molecular Pharmacology 16: 2-14. https://doi.org/10.2174/1874467215666220324114624

[697] Jia, Dingjiacheng, Qiwen Wang, Yadong Qi, Yao Jiang, Jiamin He, YIFENG Lin, Yong Sun, et al. 2024. “Microbial Metabolite Enhances Immunotherapy Efficacy by Modulating T Cell Stemness in Pan-Cancer.” Cell 187: 1651-65.e21. https://doi.org/10.1016/j.cell.2024.02.022

[698] McCulloch, John A., Diwakar Davar, Richard R. Rodrigues, Jonathan H. Badger, Jennifer R. Fang, Alicia M. Cole, Ascharya K. Balaji, et al. 2022. “Intestinal Microbiota Signatures of Clinical Response and Immune-Related Adverse Events in Melanoma Patients Treated With Anti-PD-1.” Nature Medicine 28: 545-556. https://doi.org/10.1038/s41591-022-01698-2

[699] Gunjur, Ashray, Yan Shao, Timothy Rozday, Oliver Klein, Andre Mu, Bastiaan W. Haak, Ben Markman, et al. 2024. “A Gut Microbial Signature For Combination Immune Checkpoint Blockade Across Cancer Types.” Nature Medicine 30: 797-809. https://doi.org/10.1038/s41591-024-02823-z

[700] Björk, Johannes R., Laura A. Bolte, Andrew Maltez Thomas, Karla A. Lee, Niccolo Rossi, Thijs T. Wind, Lotte M. Smit, et al. 2024. “Longitudinal Gut Microbiome Changes in Immune Checkpoint Blockade-Treated Advanced Melanoma.” Nature Medicine 30: 785-796. https://doi.org/10.1038/s41591-024-02803-3

[701] Lee, Karla A., Andrew Maltez Thomas, Laura A. Bolte, Johannes R. Björk, Laura Kist De Ruijter, Federica Armanini, Francesco Asnicar, et al. 2022. “Cross-Cohort Gut Microbiome Associations With immune Checkpoint Inhibitor Response in Advanced Melanoma.” Nature Medicine 28: 535-544. https://doi.org/10.1038/s41591-022-01695-5

[702] Chaput, N., P. Lepage, C. Coutzac, E. Soularue, K. Le Roux, C. Monot, L. Boselli, et al. 2017. “Baseline Gut Microbiota Predicts Clinical Response and Colitis in Metastatic Melanoma Patients Treated With Ipilimumab.” Annals of Oncology 28: 1368-1379. https://doi.org/10.1093/annonc/mdx108

[703] Dubin, Krista, Margaret K. Callahan, Boyu Ren, Raya Khanin, Agnes Viale, Lilan Ling, Daniel No, et al. 2016. “Intestinal Microbiome Analyses Identify Melanoma patients at Risk for Checkpoint-Blockade-Induced Colitis.” Nature Communications 7: 10391. https://doi.org/10.1038/ncomms10391

[704] Frankel, Arthur E., Laura A. Coughlin, Jiwoong Kim, Thomas W. Froehlich, Yang Xie, Eugene P. Frenkel, Andrew Y. Koh. 2017. “Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated With Immune Checkpoint Therapy Efficacy in Melanoma Patients.” Neoplasia 19: 848-855. https://doi.org/10.1016/j.neo.2017.08.004

[705] Huang, Xiaowen, Muni Hu, Tiantian Sun, Jiantao Li, Yilu Zhou, Yuqing Yan, Baoqin Xuan, et al. 2023. “Multi-Kingdom Gut Microbiota Analyses Define Bacterial-Fungal Interplay and Microbial Markers of Pan-Cancer Immunotherapy Across Cohorts.” Cell host & microbe 31: 1930-43.e4. https://doi.org/10.1016/j.chom.2023.10.005

[706] Deng, Weiwei, Zhen Su, Panpan Liang, Yubo Ma, Yufang Liu, Kai Zhang, Yi Zhang, et al. 2021. “Single-Cell Immune Checkpoint Landscape of PBMCs Stimulated With Candida albicans.” Emerging Microbes & Infections 10: 1272-1283. https://doi.org/10.1080/22221751.2021.1942228

[707] Prasad, Rishika, Abdur Rehman, Lubna Rehman, Faezeh Darbaniyan, Viktoria Blumenberg, Maria-Luisa Schubert, Uria Mor, et al. 2025. “Antibiotic-Induced Loss of Gut Microbiome Metabolic Output Correlates With Clinical Responses to CAR T-Cell Therapy.” Blood 145: 823-839. https://doi.org/10.1182/blood.2024025366

[708] DeFilipp, Zachariah, Marcela V. Maus. 2023. “Linking the Microbiome to CAR-T Cell Responses.” Nature Medicine 29: 785-786. https://doi.org/10.1038/s41591-023-02272-0

[709] CD19 CAR T-Cell Clinical Outcome Is Associated With the Gut Microbiome. 2022. Cancer Discovery 12: 1182. https://doi.org/10.1158/2159-8290.CD-RW2022-052

[710] Smith, Melody, Anqi Dai, Guido Ghilardi, Kimberly V. Amelsberg, Sean M. Devlin, Raymone Pajarillo, John B. Slingerland, et al. 2022. “Gut Microbiome Correlates of Response and Toxicity Following Anti-CD19 CAR T Cell Therapy.” Nature Medicine 28: 713-723. https://doi.org/10.1038/s41591-022-01702-9

[711] Abid, Muhammad Bilal, Nirav N. Shah, Theresa C. Maatman, Parameswaran N. Hari. 2019. “Gut Microbiome and CAR-T Therapy.” Experimental Hematology & Oncology 8: 31. https://doi.org/10.1186/s40164-019-0155-8

[712] Shen, Junyi, Rong Hu, Anqi Lin, Aimin Jiang, Bufu Tang, Zaoqu Liu, Quan Cheng, et al. 2024. “Characterization of?Second Primary Malignancies Post CAR T-Cell Therapy: Real-World Insights From the Two Global Pharmacovigilance Databases of FAERS and VigiBase.” EClinicalMedicine 73: 102684. https://doi.org/10.1016/j.eclinm.2024.102684

[713] Hu, Yongxian, Jingjing Li, Fang Ni, Zhongli Yang, Xiaohua Gui, Zhiwei Bao, Houli Zhao, et al. 2022. “CAR-T Cell Therapy-Related Cytokine Release Syndrome and Therapeutic Response Is Modulated by the Gut Microbiome in Hematologic Malignancies.” Nature Communications 13: 5313. https://doi.org/10.1038/s41467-022-32960-3

[714] Stergiopoulos, Georgios M., Ianko Iankov, Evanthia Galanis. 2024. “Personalizing Oncolytic Immunovirotherapy Approaches.” Molecular Diagnosis & Therapy 28: 153-168. https://doi.org/10.1007/s40291-023-00689-4

[715] Sivan, Ayelet, Leticia Corrales, Nathaniel Hubert, Jason B. Williams, Keston Aquino-Michaels, Zachary M. Earley, Franco W. Benyamin, et al. 2015. “Commensal Bifidobacterium Promotes Antitumor Immunity and Facilitates Anti-PD-L1 Efficacy.” Science 350: 1084-1089. https://doi.org/10.1126/science.aac4255

[716] Vétizou, Marie, Jonathan M. Pitt, Romain Daillère, Patricia Lepage, Nadine Waldschmitt, Caroline Flament, Sylvie Rusakiewicz, et al. 2015. “Anticancer Immunotherapy by CTLA-4 Blockade Relies on the Gut Microbiota.” Science 350: 1079-1084. https://doi.org/10.1126/science.aad1329

[717] Mager, Lukas F., Regula Burkhard, Nicola Pett, Noah C. A. Cooke, Kirsty Brown, Hena Ramay, Seungil Paik, et al. 2020. “Microbiome-Derived Inosine Modulates Response to Checkpoint Inhibitor Immunotherapy.” Science 369: 1481-1489. https://doi.org/10.1126/science.abc3421

[718] Ravilla, Rahul, Hannah N. Coleman, Cheryl-Emiliane Chow, Luisa Chan, Barbara J. Fuhrman, William W. Greenfield, Michael Scott Robeson, et al. 2019. “Cervical Microbiome and Response to a Human Papillomavirus Therapeutic Vaccine for Treating High-Grade Cervical Squamous Intraepithelial Lesion.” Integrative Cancer Therapies 18: 1534735419893063. https://doi.org/10.1177/1534735419893063

[719] Guardamagna, Mora, Miguel-Angel Berciano-Guerrero, Beatriz Villaescusa-González, Elisabeth Perez-Ruiz, Javier Oliver, Rocío Lavado-Valenzuela, Antonio Rueda-Dominguez, Isabel Barragán, María Isabel Queipo-Ortuño. 2022. “Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition.” International Journal of Molecular Sciences 23: 11990. https://doi.org/10.3390/ijms231911990

[720] Mu, Wenxin, Yiqun Jia, Xiaobing Chen, Haoyu Li, Zhi Wang, Bin Cheng 2020. “Intracellular Porphyromonas gingivalis Promotes the Proliferation of Colorectal Cancer Cells via the MAPK/ERK Signaling Pathway.” Frontiers in Cellular and Infection Microbiology 10: 584798. https://doi.org/10.3389/fcimb.2020.584798

[721] Shan, Khine S., Tauseef U. Rehman, Stan Ivanov, Gelenis Domingo, Luis E. Raez. 2024. “Molecular Targeting of the BRAF Proto-Oncogene/Mitogen-Activated Protein Kinase (MAPK) Pathway Across Cancers.” International Journal of Molecular Sciences 25: 624. https://doi.org/10.3390/ijms25010624

[722] Kumar, Mukesh, Ramanpreet Kaur, Shruthi Kanthaje, Radha K. Dhiman, Anuradha Chakraborti. 2023. “Bacterial Metabolite Butyrate in Modulating Sorafenib-Targeted MicroRNAs to Curtail Its Resistance in Hepatocellular Carcinoma.” Journal of Cancer Research and Clinical Oncology 149: 5823-5839. https://doi.org/10.1007/s00432-022-04544-7

[723] Yu, Jingjing, Xiaoping Chen, Xiangliang Yang, Bixiang Zhang. 2024. “Understanding Gut Dysbiosis for Hepatocellular Carcinoma Diagnosis and Treatment.” Trends in Endocrinology & Metabolism 35: 1006-1020. https://doi.org/10.1016/j.tem.2024.06.003

[724] Ahmed, Lamiaa A., Khaled F. Al-Massri. 2023. “Gut Microbiota Modulation for Therapeutic Management of Various Diseases: A New Perspective Using Stem Cell Therapy.” Current Molecular Pharmacology 16: 43-59. https://doi.org/10.2174/1874467215666220222105004

[725] Hahn, Andrew W., Camryn Froerer, Sidney VanAlstine, Nityam Rathi, Erin B. Bailey, David D. Stenehjem, Neeraj Agarwal. 2018. “Targeting Bacteroides in Stool Microbiome and Response to Treatment With First-Line VEGF Tyrosine Kinase Inhibitors in Metastatic Renal-Cell Carcinoma.” Clinical Genitourinary Cancer 16: 365-368. https://doi.org/10.1016/j.clgc.2018.05.001

[726] Ianiro, Gianluca, Ernesto Rossi, Andrew M. Thomas, Giovanni Schinzari, Luca Masucci, Gianluca Quaranta, Carlo Romano Settanni, et al. 2020. “Faecal Microbiota Transplantation for the Treatment of Diarrhoea Induced by Tyrosine-Kinase Inhibitors in Patients With Metastatic Renal Cell Carcinoma.” Nature Communications 11: 4333. https://doi.org/10.1038/s41467-020-18127-y

[727] Van Praagh, Jasper B., Marcus C. De Goffau, Ilsalien S. Bakker, Harry Van Goor, Hermie J. M. Harmsen, Peter Olinga, Klaas Havenga. 2019. “Mucus Microbiome of Anastomotic Tissue During Surgery Has Predictive Value for Colorectal Anastomotic Leakage.” Annals of Surgery 269: 911-916. https://doi.org/10.1097/SLA.0000000000002651

[728] Rollins, Katie E., Hannah Javanmard-Emamghissi, Austin G. Acheson, Dileep N. Lobo. 2019. “The Role of Oral Antibiotic Preparation in Elective Colorectal Surgery: A Meta-analysis.” Annals of Surgery 270: 43-58. https://doi.org/10.1097/SLA.0000000000003145

[729] Darbandi, Atieh, Maryam Mirshekar, Aref Shariati, Majid Taati Moghadam, Vahid Lohrasbi, Parisa Asadolahi, Malihe Talebi. 2020. “The Effects of Probiotics on Reducing the Colorectal Cancer Surgery Complications: A Periodic Review During 2007-2017.” Clinical Nutrition 39: 2358-2367. https://doi.org/10.1016/j.clnu.2019.11.008

[730] Kiran, Ravi Pokala, Alice C. A. Murray, Cody Chiuzan, David Estrada, Kenneth Forde. 2015. “Combined Preoperative Mechanical Bowel Preparation With Oral Antibiotics Significantly Reduces Surgical Site Infection, Anastomotic Leak, and Ileus After Colorectal Surgery.” Annals of Surgery 262: 416-425; discussion 423-5. https://doi.org/10.1097/SLA.0000000000001416

[731] Cong, Jing, Hua Zhu, Dong Liu, Tianjun Li, Chuantao Zhang, Jingjuan Zhu, Hongying Lv, et al. 2018. “A Pilot Study: Changes of Gut Microbiota in Post-Surgery Colorectal Cancer Patients.” Frontiers in Microbiology 9: 2777. https://doi.org/10.3389/fmicb.2018.02777

[732] Lapthorne, Susan. 2015. “Changes in the Colon Microbiota and Intestinal Cytokine Gene Expression Following Minimal Intestinal Surgery.” World Journal of Gastroenterology 21: 4150-4158. https://doi.org/10.3748/wjg.v21.i14.4150

[733] Kong, Cheng, Renyuan Gao, Xuebing Yan, Linsheng Huang, Jide He, Hao Li, Jie You, Huanlong Qin. 2019. “Alterations in Intestinal Microbiota of Colorectal Cancer Patients Receiving Radical Surgery Combined With Adjuvant CapeOx Therapy.” Science China. Life Sciences 62: 1178-1193. https://doi.org/10.1007/s11427-018-9456-x

[734] Peng, Yu-Chong, Xin-Hua Zhao, Chuan-Fa Zeng, Jing-Xuan Xu, Lu-Nan Qi, Le-Qun Li. 2022. “Integrated Omics Analysis: The Relationship Between Significantly Increased Klebsiella Post-Hepatectomy and Decreased Hub-Metabolite 3-Methyl-2-Oxobutanoic Acid Is Associated With Induced Liver Failure.” Journal of Gastrointestinal Oncology 13: 326-343. https://doi.org/10.21037/jgo-21-906

[735] Yang, Jie, Yuhua He, Xi Liao, Jiankun Hu, Ka Li. 2023. “Does Postoperative Pulmonary Infection Correlate With Intestinal Flora Following Gastric Cancer Surgery?—A Nested Case-Control Study.” Frontiers in Microbiology 14: 1267750. https://doi.org/10.3389/fmicb.2023.1267750

[736] Xu, Fusheng, Zhiming Yu, Yaru Liu, Ting Du, Leilei Yu, Fengwei Tian, Wei Chen, Qixiao Zhai. 2023. “A High-Fat, High-Cholesterol Diet Promotes Intestinal Inflammation by Exacerbating Gut Microbiome Dysbiosis and Bile Acid Disorders in Cholecystectomy.” Nutrients 15: 3829. https://doi.org/10.3390/nu15173829

[737] Poutahidis, Theofilos, Sean M. Kearney, Tatiana Levkovich, Peimin Qi, Bernard J. Varian, Jessica R. Lakritz, Yassin M. Ibrahim, et al. 2013. “Microbial Symbionts Accelerate Wound Healing via the Neuropeptide Hormone Oxytocin.” PloS One 8: e78898. https://doi.org/10.1371/journal.pone.0078898

[738] Obermüller, Beate, Georg Singer, Bernhard Kienesberger, Barbara Mittl, Vanessa Stadlbauer, Angela Horvath, Wolfram Miekisch, et al. 2023. “Probiotic OMNi-BiOTiC® 10 AAD Reduces Cyclophosphamide-Induced Inflammation and Adipose Tissue Wasting in Mice.” Nutrients 15: 3655. https://doi.org/10.3390/nu15163655

[739] Yazdi, Mohammad Hossein, Mehdi Mahdavi, Neda Setayesh, Mohammad Esfandyar, Ahmad Reza Shahverdi. 2013. “Selenium Nanoparticle-Enriched Lactobacillus brevis Causes More Efficient Immune Responses In Vivo and Reduces the Liver Metastasis in Metastatic Form of Mouse Breast Cancer.” DARU Journal of Pharmaceutical Sciences 21: 33. https://doi.org/10.1186/2008-2231-21-33

[740] Xu, Fuqiang, Qiaoqiao Li, Shuyang Wang, Miaoyin Dong, Guoqing Xiao, Jin Bai, Junkai Wang, Xisi Sun. 2023. “The Efficacy of Prevention for Colon Cancer Based on the Microbiota Therapy and the Antitumor Mechanisms With Intervention of Dietary Lactobacillus.” Microbiology Spectrum 11: e0018923. https://doi.org/10.1128/spectrum.00189-23

[741] Zeighamy Alamdary, Shabnam, Shahnaz Halimi, Akram Rezaei, Roghayeh Afifirad. 2023. “Association Between Probiotics and Modulation of Gut Microbial Community Composition in Colorectal Cancer Animal Models: A Systematic Review (2010-2021).” The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale 2023: 3571184. https://doi.org/10.1155/2023/3571184

[742] Wei, Hao, Zhiying Yue, Jialong Han, Ping Chen, Ke Xie, Yu Sun, Jiang Zhu. 2024. “Oral Compound Probiotic Supplements Can Improve the Quality of Life for Patients With Lung Cancer During Chemotherapy: A Randomized Placebo-Controlled Study.” Thoracic Cancer 15: 182-191. https://doi.org/10.1111/1759-7714.15177

[743] Shi, Qi, Jia Wang, Mengnan Zhou, Rui Zheng, Xiaoli Zhang, Beixing Liu. 2023. “Gut Lactobacillus Contribute to the Progression of Breast Cancer by Affecting the Anti-Tumor Activities of Immune Cells in the TME of Tumor-Bearing Mice.” International Immunopharmacology 124: 111039. https://doi.org/10.1016/j.intimp.2023.111039

[744] Jang, Albert, Jake N. Lichterman, Jeffrey Y. Zhong, Jonathan E. Shoag, Jorge A. Garcia, Tian Zhang, Pedro C. Barata. 2023. “Immune Approaches Beyond Traditional Immune Checkpoint Inhibitors for Advanced Renal Cell Carcinoma.” Human Vaccines & Immunotherapeutics 19: 2276629. https://doi.org/10.1080/21645515.2023.2276629

[745] Lin, Anqi, Aimin Jiang, Lihaoyun Huang, Yu Li, Chunyanx Zhang, Lingxuan Zhu, Weiming Mou, et al. 2025. “From Chaos to Order: Optimizing Fecal Microbiota Transplantation for Enhanced Immune Checkpoint Inhibitors Efficacy.” Gut Microbes 17: 2452277. https://doi.org/10.1080/19490976.2025.2452277

[746] Wang, Xinjun, Di Zhao, Dexi Bi, Long Li, Hongliang Tian, Fang Yin, Tao Zuo, et al. 2025. “Fecal Microbiota Transplantation: Transitioning From Chaos and Controversial Realm to Scientific Precision Era.” Science Bulletin 70: 970-985. https://doi.org/10.1016/j.scib.2025.01.029

[747] Kim, Do-Yeon, So-Yeon Lee, Jae-Yun Lee, Tae Woong Whon, June-Young Lee, Che Ok Jeon, Jin-Woo Bae. 2024. “Gut Microbiome Therapy: Fecal Microbiota Transplantation vs Live Biotherapeutic Products.” Gut Microbes 16: 2412376. https://doi.org/10.1080/19490976.2024.2412376

[748] Yang, Yunwei, Yaping An, Yue Dong, Qiao Chu, Jingge Wei, Bangmao Wang, Hailong Cao. 2024. “Fecal Microbiota Transplantation: No Longer Cinderella in Tumour Immunotherapy.” EBioMedicine 100: 104967. https://doi.org/10.1016/j.ebiom.2024.104967

[749] Yadegar, Abbas, Haggai Bar-Yoseph, Tanya Marie Monaghan, Sepideh Pakpour, Andrea Severino, Ed J. Kuijper, Wiep Klaas Smits, et al. 2024. “Fecal Microbiota Transplantation: Current Challenges and Future Landscapes.” Clinical Microbiology Reviews 37: e0006022. https://doi.org/10.1128/cmr.00060-22

[750] Cao, Yanyan, Lijie Zhang, Fu Xiong, Xiaopeng Guo, Xuefeng Kan, Songlin Song, Bo Liang, et al. 2024. “Effect of Probiotics and Fecal Microbiota Transplantation in Dirty Rats With Established Primary Liver Cancer.” Future Microbiology 19: 117-129. https://doi.org/10.2217/fmb-2022-0234

[751] Cheng, Xiaoshuo, Xiaozheng Li, Xudong Yang, Shaojun Fang, Zhenyu Wang, Tingting Liu, Mengyao Zheng, et al. 2023. “Successful Treatment of pMMR MSS IVB Colorectal Cancer Using Anti-VEGF and Anti-PD-1 Therapy in Combination of Gut Microbiota Transplantation: A Case Report.” Cureus 15: e42347. https://doi.org/10.7759/cureus.42347

[752] Cui, Ming, Huiwen Xiao, Yuan Li, Lixin Zhou, Shuyi Zhao, Dan Luo, Qisheng Zheng, et al. 2017. “Faecal Microbiota Transplantation Protects Against Radiation-Induced Toxicity.” EMBO Molecular Medicine 9: 448-461. https://doi.org/10.15252/emmm.201606932

[753] Lythgoe, Mark P., Rohma Ghani, Benjamin H. Mullish, Julian R. Marchesi, Jonathan Krell. 2022. “The Potential of Fecal Microbiota Transplantation in Oncology.” Trends in Microbiology 30: 10-12. https://doi.org/10.1016/j.tim.2021.10.003

[754] Ninkov, Marina, Crystal L. Schmerk, Manoosh Moradizadeh, Seema N. Parvathy, Rene Figueredo, Jeremy P. Burton, Michael S. Silverman, et al. 2023. “Improved MAIT Cell Functions Following Fecal Microbiota Transplantation for Metastatic Renal Cell Carcinoma.” Cancer Immunology, Immunotherapy 72: 1247-1260. https://doi.org/10.1007/s00262-022-03329-8

[755] Hefazi, Mehrdad, Mrinal M. Patnaik, William J. Hogan, Mark R. Litzow, Darrell S. Pardi, Sahil Khanna. 2017. “Safety and Efficacy of Fecal Microbiota Transplant for Recurrent Clostridium Difficile Infection in Patients With Cancer Treated With Cytotoxic Chemotherapy: A Single-Institution Retrospective Case Series.” Mayo Clinic Proceedings 92: 1617-1624. https://doi.org/10.1016/j.mayocp.2017.08.016

[756] Halsey, Taylor M., Anusha S. Thomas, Tomo Hayase, Weijie Ma, Hamzah Abu-Sbeih, Baohua Sun, Edwin Roger Parra, et al. 2023. “Microbiome Alteration via Fecal Microbiota Transplantation Is Effective for Refractory Immune Checkpoint Inhibitor-Induced Colitis.” Science Translational Medicine 15: eabq4006. https://doi.org/10.1126/scitranslmed.abq4006

[757] Baruch, Erez N., Ilan Youngster, Guy Ben-Betzalel, Rona Ortenberg, Adi Lahat, Lior Katz, Katerina Adler, et al. 2021. “Fecal Microbiota Transplant Promotes Response in Immunotherapy-Refractory Melanoma Patients.” Science 371: 602-609. https://doi.org/10.1126/science.abb5920

[758] Davar, Diwakar, Amiran K. Dzutsev, John A. McCulloch, Richard R. Rodrigues, Joe-Marc Chauvin, Robert M. Morrison, Richelle N. Deblasio, et al. 2021. “Fecal Microbiota Transplant Overcomes Resistance to Anti-PD-1 Therapy in Melanoma Patients.” Science 371: 595-602. https://doi.org/10.1126/science.abf3363

[759] Routy, Bertrand, John G. Lenehan, Wilson H. Miller, Rahima Jamal, Meriem Messaoudene, Brendan A. Daisley, Cecilia Hes, et al. 2023. “Fecal Microbiota Transplantation Plus Anti-PD-1 Immunotherapy in Advanced Melanoma: A phase I Trial.” Nature Medicine 29: 2121-2132. https://doi.org/10.1038/s41591-023-02453-x

[760] Wang, Yinghong, Diana H. Wiesnoski, Beth A. Helmink, Vancheswaran Gopalakrishnan, Kati Choi, Hebert L. DuPont, Zhi-Dong Jiang, et al. 2018. “Fecal Microbiota Transplantation for Refractory Immune Checkpoint Inhibitor-Associated Colitis.” Nature Medicine 24: 1804-1808. https://doi.org/10.1038/s41591-018-0238-9

[761] Simin, Johanna, Rulla M. Tamimi, Lars Engstrand, Steven Callens, Nele Brusselaers. 2020. “Antibiotic Use and the Risk of Breast Cancer: A Systematic Review and Dose-Response Meta-Analysis.” Pharmacological Research 160: 105072. https://doi.org/10.1016/j.phrs.2020.105072

[762] Lurienne, Lise, Julie Cervesi, Lola Duhalde, Jean De Gunzburg, Antoine Andremont, Gérard Zalcman, Renaud Buffet, Pierre-Alain Bandinelli. 2020. “NSCLC Immunotherapy Efficacy and Antibiotic Use: A Systematic Review and Meta-Analysis.” Journal of Thoracic Oncology 15: 1147-1159. https://doi.org/10.1016/j.jtho.2020.03.002

[763] Imlay, Hannah, Nicholas C. Laundy, Graeme N. Forrest, Monica A. Slavin. 2023. “Shorter Antibiotic Courses in the Immunocompromised: The Impossible Dream?” Clinical Microbiology and Infection 29: 143-149. https://doi.org/10.1016/j.cmi.2022.08.007

[764] Singh, Vishal, Beng San Yeoh, Ahmed A. Abokor, Rachel M. Golonka, Yuan Tian, Andrew D. Patterson, Bina Joe, Mathias Heikenwalder, Matam Vijay-Kumar. 2020. “Vancomycin Prevents Fermentable Fiber-Induced Liver Cancer in Mice With Dysbiotic Gut Microbiota.” Gut Microbes 11: 1077-1091. https://doi.org/10.1080/19490976.2020.1743492

[765] Pinato, David J., Xiaoxue Li, Pallavi Mishra-Kalyani, Antonio D'Alessio, Claudia A. M. Fulgenzi, Bernhard Scheiner, Matthias Pinter, et al. 2023. “Association Between Antibiotics and Adverse Oncological Outcomes in Patients Receiving Targeted or Immune-Based Therapy for Hepatocellular Carcinoma.” JHEP Reports 5: 100747. https://doi.org/10.1016/j.jhepr.2023.100747

[766] Iida, Noriho, Eishiro Mizukoshi, Tatsuya Yamashita, Takeshi Terashima, Kuniaki Arai, Jun Seishima, Shuichi Kaneko. 2019. “Overuse of Antianaerobic Drug Is Associated With Poor Postchemotherapy Prognosis of Patients With Hepatocellular Carcinoma.” International Journal of Cancer 145: 2701-2711. https://doi.org/10.1002/ijc.32339

[767] López-Bucio, José. 2025. “Dietary Auxin May Help Patients to Fight Cancer.” Trends in Plant Science 30: 134-136. https://doi.org/10.1016/j.tplants.2024.10.016

[768] Arifuzzaman, Mohammad, Nicholas Collins, Chun-Jun Guo, David Artis. 2024. “Nutritional Regulation of Microbiota-Derived Metabolites: Implications for Immunity and Inflammation.” Immunity 57: 14-27. https://doi.org/10.1016/j.immuni.2023.12.009

[769] Ilerhunmwuwa, Nosakhare Paul, Abul Hasan Shadali Abdul Khader, Calvin Smith, Edward R Scheffer Cliff, Christopher M. Booth, Evevanne Hottel, Muhammad Aziz, et al. 2024. “Dietary Interventions in Cancer: A Systematic Review of All Randomized Controlled Trials.” Journal of the National Cancer Institute 116: 1026-1034. https://doi.org/10.1093/jnci/djae051

[770] Xiao, Yu-Ling, Yue Gong, Ying-Jia Qi, Zhi-Ming Shao, Yi-Zhou Jiang. 2024. “Effects of Dietary Intervention on Human Diseases: Molecular Mechanisms and Therapeutic Potential.” Signal Transduction and Targeted Therapy 9: 59. https://doi.org/10.1038/s41392-024-01771-x

[771] Bolte, Laura A., Karla A. Lee, Johannes R. Björk, Emily R. Leeming, Marjo J. E. Campmans-Kuijpers, Jacco J. De Haan, Arnau Vich Vila, et al. 2023. “Association of a Mediterranean Diet With Outcomes for Patients Treated With Immune Checkpoint Blockade for Advanced Melanoma.” JAMA Oncology 9: 705-709. https://doi.org/10.1001/jamaoncol.2022.7753

[772] Li, Ziyuan, Lei Qian, Jianghui Chu, Yuan Liu, Gusonghan Maitiniyazi, Yue Chen, Xinxin Cheng, et al. 2023. “Diet Is Associated With Frailty in Lung Cancer: A Possible Role of Gut Microbiota.” Nutrients 15: 4298. https://doi.org/10.3390/nu15194298

[773] Li, Lili, Shuling Yan, Shuangjiang Liu, Ping Wang, Wenjun Li, Yuetao Yi, Song Qin. 2023. “In-Depth Insight Into Correlations Between Gut Microbiota and Dietary Fiber Elucidates a Dietary Causal Relationship With Host Health.” Food Research International (Ottawa, Ont.) 172: 113133. https://doi.org/10.1016/j.foodres.2023.113133

[774] Wang, Chuhui, Tongtong Lan, Zhao Chen, Xiaowen Wang, Yisa Han, Ning Yang, Zhen Xu, et al. 2023. “The Preventive Effects of Inulin, Cellulose, and Their Mixture on Colorectal Cancer Liver Metastasis in Mice by Regulating Gut Microbiota.” Journal of Food Science 88: 4705-4717. https://doi.org/10.1111/1750-3841.16772

[775] Fang, Gaofeng, Shengquan Wang, Qianyao Chen, Han Luo, Xuemei Lian, Dan Shi. 2023. “Time-Restricted Feeding Affects the Fecal Microbiome Metabolome and Its Diurnal Oscillations in Lung Cancer Mice.” Neoplasia 45: 100943. https://doi.org/10.1016/j.neo.2023.100943

[776] Ronis, Martin J., Kelly E. Mercer, Kartik Shankar, Casey Pulliam, Kim Pedersen, Magnus Ingelman-Sundberg, Simonetta Friso, et al. 2020. “Potential Role of Gut Microbiota, the Proto-Oncogene PIKE (Agap2) and Cytochrome P450 CYP2W1 in Promotion of Liver Cancer by Alcoholic and Nonalcoholic Fatty Liver Disease and Protection by Dietary Soy Protein.” Chemico-Biological Interactions 325: 109131. https://doi.org/10.1016/j.cbi.2020.109131

[777] Yu, Yinglan, Xinran Shen, Xin Xiao, Lian Li, Yuan Huang. 2023. “Butyrate Modification Promotes Intestinal Absorption and Hepatic Cancer Cells Targeting of Ferroptosis Inducer Loaded Nanoparticle for Enhanced Hepatocellular Carcinoma Therapy.” Small (Weinheim an Der Bergstrasse, Germany) 19: e2301149. https://doi.org/10.1002/smll.202301149

[778] Wang, Hongbin, Mia Borlongan, Howard L. Kaufman, Uyen Le, Hans J. Nauwynck, Samuel D. Rabkin, Dipongkor Saha. 2024. “Cytokine-Armed Oncolytic Herpes Simplex Viruses: A Game-Changer in Cancer Immunotherapy?” Journal for Immunotherapy of Cancer 12: e008025. https://doi.org/10.1136/jitc-2023-008025

[779] Duan, Shijie, Shuhang Wang, Lei Qiao, Xinbo Yu, Nan Wang, Liting Chen, Xinyuan Zhang, et al. 2023. “Oncolytic Virus-Driven Biotherapies From Bench to Bedside.” Small (Weinheim an Der Bergstrasse, Germany) 19: e2206948. https://doi.org/10.1002/smll.202206948

[780] Burchett, Rebecca, Scott Walsh, Yonghong Wan, Jonathan L. Bramson. 2020. “A Rational Relationship: Oncolytic Virus Vaccines as Functional Partners for Adoptive T Cell Therapy.” Cytokine & Growth Factor Reviews 56: 149-159. https://doi.org/10.1016/j.cytogfr.2020.07.003

[781] Nguyen, Hong-My, Praveen K. Bommareddy, Ann W. Silk, Dipongkor Saha. 2022. “Optimal Timing of PD-1 Blockade in Combination With Oncolytic Virus Therapy.” Seminars in Cancer Biology 86: 971-980. https://doi.org/10.1016/j.semcancer.2021.05.019

[782] DePeaux, Kristin, Greg M. Delgoffe. 2024. “Integrating Innate and Adaptive Immunity in Oncolytic Virus Therapy.” Trends in Cancer 10: 135-146. https://doi.org/10.1016/j.trecan.2023.09.012

[783] Bahreyni, Amirhossein, Yasir Mohamud, Honglin Luo. 2024. “Oncolytic Virus-Based Combination Therapy in Breast Cancer.” Cancer Letters 585: 216634. https://doi.org/10.1016/j.canlet.2024.216634

[784] Kaufman, Howard L., Frederick J. Kohlhapp, Andrew Zloza. 2015. “Oncolytic Viruses: A New Class of Immunotherapy Drugs.” Nature Reviews Drug Discovery 14: 642-662. https://doi.org/10.1038/nrd4663

[785] Shalhout, Sophia Z., David M. Miller, Kevin S. Emerick, Howard L. Kaufman. 2023. “Therapy With Oncolytic Viruses: Progress and Challenges.” Nature Reviews Clinical Oncology 20: 160-177. https://doi.org/10.1038/s41571-022-00719-w

[786] Hennessy, Morgan L., Praveen K. Bommareddy, Genevieve Boland, Howard L. Kaufman. 2019. “Oncolytic Immunotherapy.” Surgical Oncology Clinics of North America 28: 419-430. https://doi.org/10.1016/j.soc.2019.02.007

[787] Ma, Rui, Zhenlong Li, E. Antonio Chiocca, Michael A. Caligiuri, Jianhua Yu. 2023. “The Emerging Field of Oncolytic Virus-Based Cancer Immunotherapy.” Trends in Cancer 9: 122-139. https://doi.org/10.1016/j.trecan.2022.10.003

[788] Han, Zi-Yi, Qi-Wen Chen, Zhuang-Jiong Fu, Si-Xue Cheng, Xian-Zheng Zhang. 2022. “Probiotic Spore-Based Oral Drug Delivery System for Enhancing Pancreatic Cancer Chemotherapy by Gut-Pancreas-Axis-Guided Delivery.” Nano Letters 22: 8608-8617. https://doi.org/10.1021/acs.nanolett.2c03131

[789] Nguyen, Vu H., Hyung-Seok Kim, Jung-Min Ha, Yeongjin Hong, Hyon E. Choy, Jung-Joon Min. 2010. “Genetically Engineered Salmonella typhimurium as an Imageable Therapeutic Probe for Cancer.” Cancer Research 70: 18-23. https://doi.org/10.1158/0008-5472.CAN-09-3453

[790] Ballister, Edward R., Alexander Michels, Rosa L. Vincent, Lior Kreindler, Sreyan Chowdhury, Samik Upadhaya, Ana Rosa Saez-Ibañez, et al. 2025. “The Emerging Landscape of Engineered Bacteria Cancer Therapies.” Nature Biotechnology 43: 672-676. https://doi.org/10.1038/s41587-025-02623-x

[791] Schmitz-Winnenthal, Friedrich H., Hohmann Nicolas, Andreas G. Niethammer, Tobias Friedrich, Heinz Lubenau, Marco Springer, Klaus M. Breiner, et al. 2015. “Anti-Angiogenic Activity of VXM01, an Oral T-Cell Vaccine Against VEGF Receptor 2, in Patients With Advanced Pancreatic Cancer: A Randomized, Placebo-Controlled, Phase 1 Trial.” Oncoimmunology 4: e1001217. https://doi.org/10.1080/2162402X.2014.1001217

[792] Le, Dung T., Dirk G. Brockstedt, Ran Nir-Paz, Johannes Hampl, Shruti Mathur, John Nemunaitis, Daniel H. Sterman, et al. 2012. “A Live-Attenuated Listeria Vaccine (ANZ-100) and a Live-Attenuated Listeria Vaccine Expressing Mesothelin (CRS-207) for Advanced Cancers: Phase I Studies of Safety and Immune Induction.” Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 18: 858-868. https://doi.org/10.1158/1078-0432.CCR-11-2121

[793] Wang, Heng, Fang Xu, Chao Wang. 2025. “Metabolic Reprogramming of Tumor Microenviroment by Engineered Bacteria.” Seminars in Cancer Biology 112: 58-70. https://doi.org/10.1016/j.semcancer.2025.03.003

[794] Zhang, Hao, Li Fu, Xinwen Leiliang, Chunrun Qu, Wantao Wu, Rong Wen, Ning Huang, et al. 2024. “Beyond the Gut: The Intratumoral Microbiome's Influence on Tumorigenesis and Treatment Response.” Cancer Communications 44: 1130-1167. https://doi.org/10.1002/cac2.12597

[795] Sieow, Brendan Fu-Long, Kwok Soon Wun, Wei Peng Yong, In Young Hwang, Matthew Wook Chang. 2021. “Tweak to Treat: Reprograming Bacteria for Cancer Treatment.” Trends in Cancer 7: 447-464. https://doi.org/10.1016/j.trecan.2020.11.004

[796] Li, Tong, Wenjing Wang. 2021. “New Strategy for Cancer Immunotherapy: Using Live Engineered Bacteria for Metabolic Modulation.” Signal Transduction and Targeted Therapy 6: 415. https://doi.org/10.1038/s41392-021-00829-4

[797] Cubillos-Ruiz, Juan R., Andres Cubillos-Ruiz. 2021. “Engineered Bacteria Recycle Tumor Metabolic Waste to Boost Immunotherapy.” Cell Host & Microbe 29: 1725-1727. https://doi.org/10.1016/j.chom.2021.11.008

[798] Wang, Yifan, Anqi Dong, Jianping Man, Hua Chen, Wenhao Shen, Lei Wang, Hongli Yang, Lin Hu, Kai Yang. 2025. “TREM2 scFv-Engineering Escherichia coli Displaying Modulation of Macrophages to Boost Cancer Radio-Immunotherapy.” Advanced Materials (Deerfield Beach, Fla.) 37: e2417920. https://doi.org/10.1002/adma.202417920

[799] Xie, Beibei, Linmiao Dong, Leo Wang, Ruibing Wang, Chunlai Li. 2024. “Supramolecularly Engineered Bacteria Mediated Calcium Overload and Immunotherapy of Tumors.” Theranostics 14: 6560-6570. https://doi.org/10.7150/thno.99931

[800] Liu, Xuemeng, Mengyu Sun, Fang Pu, Jinsong Ren, Xiaogang Qu. 2023. “Transforming Intratumor Bacteria Into Immunopotentiators to Reverse Cold Tumors for Enhanced Immuno-chemodynamic Therapy of Triple-Negative Breast Cancer.” Journal of the American Chemical Society 145: 26296-26307. https://doi.org/10.1021/jacs.3c09472

[801] Zhang, Lilong, Dongqi Chai, Chen Chen, Chunlei Li, Zhendong Qiu, Tianrui Kuang, Mungur Parveena, et al. 2022. “Mycobiota and C-Type Lectin Receptors in Cancers: Know Thy Neighbors.” Frontiers in Microbiology 13: 946995. https://doi.org/10.3389/fmicb.2022.946995

[802] De Menezes, Ag-Anne P. M., Raí P. S. Aguiar, José V. O. Santos, Chandan Sarkar, Muhammad T. Islam, Antonio L. Braga, Mohammad M. Hasan, et al. 2023. “Citrinin as a Potential Anti-Cancer Therapy: A Comprehensive Review.” Chemico-Biological Interactions 381: 110561. https://doi.org/10.1016/j.cbi.2023.110561

[803] Jin, Jianshi, Reiko Yamamoto, Katsuyuki Shiroguchi. 2024. “High-Throughput Identification and Quantification of Bacterial Cells in the Microbiota Based on 16S rRNA Sequencing With Single-Base Accuracy Using BarBIQ.” Nature Protocols 19: 207-239. https://doi.org/10.1038/s41596-023-00906-8

[804] Galeano Niño, Jorge Luis, Hanrui Wu, Kaitlyn D. LaCourse, Andrew G. Kempchinsky, Alexander Baryiames, Brittany Barber, Neal Futran, et al. 2022. “Effect of the Intratumoral Microbiota on Spatial and Cellular Heterogeneity in Cancer.” Nature 611: 810-817. https://doi.org/10.1038/s41586-022-05435-0

[805] Gerber, Georg K. 2024. “AI in Microbiome Research: Where Have We Been, Where Are We Going?” Cell Host & Microbe 32: 1230-1234. https://doi.org/10.1016/j.chom.2024.07.021

[806] Ghannam, Ryan B., Stephen M. Techtmann. 2021. “Machine Learning Applications in Microbial Ecology, Human Microbiome Studies, and Environmental Monitoring.” Computational and Structural Biotechnology Journal 19: 1092-1107. https://doi.org/10.1016/j.csbj.2021.01.028

[807] Pepke, Michael L., Søren B. Hansen, Morten T. Limborg. 2024. “Unraveling Host Regulation of Gut Microbiota Through the Epigenome-Microbiome Axis.” Trends in Microbiology 32: 1229-1240. https://doi.org/10.1016/j.tim.2024.05.006

[808] Ma, Yong-Jing, Yuan-Chen Sun, Lu Wang, Wan-Xing Xu, Xiao-Dan Fan, Jun Ding, Christopher Heeschen, Wen-Juan Wu, Xiao-Qi Zheng, Ning-Ning Liu. 2024. Dissection of Intratumor Microbiome-Host Interactions at Single-Cell Level in Lung Cancer.” hLife: in press. https://doi.org/10.1016/j.hlife.2024.09.001

[809] Ratiner, Karina, Dragos Ciocan, Suhaib K. Abdeen, Eran Elinav. 2024. “Utilization of the Microbiome in Personalized Medicine.” Nature Reviews Microbiology 22: 291-308. https://doi.org/10.1038/s41579-023-00998-9

[810] Redenti, Andrew, Jongwon Im, Benjamin Redenti, Fangda Li, Mathieu Rouanne, Zeren Sheng, William Sun, et al. 2024. “Probiotic Neoantigen Delivery Vectors for Precision Cancer Immunotherapy.” Nature 635: 453-461. https://doi.org/10.1038/s41586-024-08033-4

[811] Li, Zhaoting, Yixin Wang, Jun Liu, Piper Rawding, Jiyoon Bu, Seungpyo Hong, Quanyin Hu. 2021. “Chemically and Biologically Engineered Bacteria-Based Delivery Systems for Emerging Diagnosis and Advanced Therapy.” Advanced Materials (Deerfield Beach, Fla.) 33: e2102580. https://doi.org/10.1002/adma.202102580

[812] Shen, Haosheng, Nikhil Aggarwal, Kwok Soon Wun, Yung Seng Lee, In Young Hwang, Matthew Wook Chang. 2022. “Engineered Microbial Systems for Advanced Drug Delivery.” Advanced Drug Delivery Reviews 187: 114364. https://doi.org/10.1016/j.addr.2022.114364

[813] Krishnamurthy, Malathy, Richard T. Moore, Sathish Rajamani, Rekha G. Panchal. 2016. “Bacterial Genome Engineering and Synthetic Biology: Combating Pathogens.” BMC Microbiology 16: 258. https://doi.org/10.1186/s12866-016-0876-3

[814] Cianci, Rossella, Mario Caldarelli, Paola Brani, Annalisa Bosi, Alessandra Ponti, Cristina Giaroni, Andreina Baj. 2025. “Cytokines Meet Phages: A Revolutionary Pathway to Modulating Immunity and Microbial Balance.” Biomedicines 13: 1202. https://doi.org/10.3390/biomedicines13051202

[815] Lei, Lei, Yan, Jiayao, Kai Xin, Lin Li, Qi Sun, Ying Wang, Tianran Chen, et al. 2024. “Engineered Bacteriophage-Based In?Situ Vaccine Remodels a Tumor Microenvironment and Elicits Potent Antitumor Immunity.” ACS Nano 18: 12194-12209. https://doi.org/10.1021/acsnano.4c00413

[816] Hou, Xiao-Lin, Bin Zhang, Kai Cheng, Fang Zhang, Xiao-Ting Xie, Wei Chen, Lin-Fang Tan, et al. 2024. “Engineering Phage Nanocarriers Integrated With Bio-Intelligent Plasmids for Personalized and Tunable Enzyme Delivery to Enhance Chemodynamic Therapy.” Advanced Science (Weinheim, Baden-Wurttemberg, Germany) 11: e2308349. https://doi.org/10.1002/advs.202308349

[817] Al-Bahrani, Mariam, Paladd Asavarut, Sajee Waramit, Keittisak Suwan, Amin Hajitou. 2023. “Transmorphic Phage-Guided Systemic Delivery of TNFα Gene for the Treatment of Human Pediatric Medulloblastoma.” The FASEB Journal 37: e23038. https://doi.org/10.1096/fj.202300045R

[818] Li, Dengxiong, Ruicheng Wu, Qingxin Yu, Zhouting Tuo, Jie Wang, Koo Han Yoo, Wuran Wei, et al. 2024. “Microbiota and Urinary Tumor Immunity: Mechanisms, Therapeutic Implications, and Future Perspectives.” Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu 36: 596-615. https://doi.org/10.21147/j.issn.1000-9604.2024.06.03

[819] Zhao, Lihong, Mei Li, Chen Shen, Yurui Luo, Xiaoming Hou, Yu Qi, Ziwei Huang, et al. 2024. “Nano-Assisted Radiotherapy Strategies: New Opportunities for Treatment of Non-Small Cell Lung Cancer.” Research (Washington, D.C.) 7: 0429. https://doi.org/10.34133/research.0429

[820] Fang, Yiran, Yuyun Kong, Guangda Rong, Qingcong Luo, Wangjun Liao, Dongqiang Zeng. “Systematic Investigation of Tumor Microenvironment and Antitumor Immunity With IOBR.” Med Research 1: 136-140. https://doi.org/10.1002/mdr2.70001

[821] Yu, Li, Ke Huang, Yixiang Liao, Lingzhi Wang, Gautam Sethi, Zhaowu Ma. 2024. “Targeting Novel Regulated Cell Death: Ferroptosis, Pyroptosis and Necroptosis in Anti-PD-1/PD-L1 Cancer Immunotherapy.” Cell Proliferation 57: e13644. https://doi.org/10.1111/cpr.13644

[822] Jiang, Aimin, Jinxin Li, Ziwei He, Ying Liu, Kun Qiao, Yu Fang, Le Qu et al. 2024. “Renal Cancer: Signaling Pathways and Advances in Targeted Therapies.” MedComm 5: e676. https://doi.org/10.1002/mco2.676

[823] Zetrini, Abdulmottaleb E., HoYin Lip, Azhar Z. Abbasi, Ibrahim Alradwan, Taksim Ahmed, Chunsheng He, Jeffrey T. Henderson, Andrew M. Rauth, Xiao Yu Wu. 2023. “Remodeling Tumor Immune Microenvironment by Using Polymer-Lipid-Manganese Dioxide Nanoparticles With Radiation Therapy to Boost Immune Response of Castration-Resistant Prostate Cancer.” Research (Washington, D.C.) 6: 0247. https://doi.org/10.34133/research.0247

[824] Li, Zizhuo, Anqi Lin, Zhifei Gao, Aimin Jiang, Minying Xiong, Jiapeng Song, Zaoqu Liu, et al. 2024. “B-Cell Performance in Chemotherapy: Unravelling the Mystery of B-Cell Therapeutic Potential.” Clinical and Translational Medicine 14: e1761. https://doi.org/10.1002/ctm2.1761

[825] Lin, Anqi, Chang Qi, Ting Wei, Mengyao Li, Quan Cheng, Zaoqu Liu, Peng Luo, Jian Zhang. 2022. “CAMOIP: A Web Server for Comprehensive Analysis on Multi-Omics of Immunotherapy in Pan-Cancer.” Briefings in Bioinformatics 23: bbac129. https://doi.org/10.1093/bib/bbac129

[826] Zhang, Haonan, Ge Zhang, Pengyuan Xu, Fengyi Yu, Liwen Li, Runzhi Huang, Pengpeng Zhang, et al. “Optimized Dynamic Network Biomarker Deciphers a High-Resolution Heterogeneity Within Thyroid Cancer Molecular Subtypes.” Med Research 1: 10-31. https://doi.org/10.1002/mdr2.70004

[827] Zhu, Xiaoqiang, Muni Hu, Xiaowen Huang, Lingxi Li, Xiaolin Lin, Xiaoyan Shao, Jiantao Li, et al. 2025, 37, 806-823.e6. “Interplay Between Gut Microbial Communities and Metabolites Modulates Pan-Cancer Immunotherapy Responses.” Cell Metabolism. https://doi.org/10.1016/j.cmet.2024.12.013

[828] Battaglia, Thomas W., Iris L. Mimpen, Joleen J. H. Traets, Arne Van Hoeck, Laurien J. Zeverijn, Birgit S. Geurts, Gijs F. De Wit, et al. 2024. “A Pan-Cancer Analysis of the Microbiome in Metastatic Cancer.” Cell 187: 2324-35.e19. https://doi.org/10.1016/j.cell.2024.03.021

[829] Liu, Yali, Chi Chun Wong, Yanqiang Ding, Mengxue Gao, Jun Wen, Harry Cheuk-Hay Lau, Alvin Ho-Kwan Cheung, Dan Huang, He Huang et al. 2024. “Peptostreptococcus anaerobius Mediates Anti-PD1 Therapy Resistance and Exacerbates Colorectal Cancer via Myeloid-Derived Suppressor Cells in Mice.” Nature Microbiology 9: 1467-1482. https://doi.org/10.1038/s41564-024-01695-w

[830] Tian, Jinzhong, Chong Li, Zhixiang Dong, Yunpeng Yang, Jing Xing, Peijun Yu, Ying Xin, et al. 2023. “Inactivation of the Antidiabetic Drug Acarbose by Human Intestinal Microbial-Mediated Degradation.” Nature Metabolism 5: 896-909. https://doi.org/10.1038/s42255-023-00796-w

[831] Schupack, Daniel A., Ruben A. T. Mars, Dayne H. Voelker, Jithma P. Abeykoon, Purna C. Kashyap. 2022. “The Promise of the Gut Microbiome as Part of Individualized Treatment Strategies.” Nature Reviews Gastroenterology & Hepatology 19: 7-25. https://doi.org/10.1038/s41575-021-00499-1

[832] Liu, Yafeng, Shujun Zhang, Kaijie Liu, Xinjun Hu, Xinyu Gu. 2024. “Advances in Drug Discovery Based on Network Pharmacology and Omics Technology.“ Current Pharmaceutical Analysis 21: 33-43. https://doi.org/10.1016/j.cpan.2024.12.002

[833] Chen, Jinghong, Anqi Lin, Peng Luo. 2024. “Advancing Pharmaceutical Research.” Current Pharmaceutical Analysis 21: 1-19. https://doi.org/10.1016/j.cpan.2024.11.001

[834] Wang, Ziheng, Yang Zhao, Lin Zhang. 2024. “Emerging Trends and Hot Topics in the Application of Multi-Omics in Drug Discovery.” Current Pharmaceutical Analysis 21: 20-32. https://doi.org/10.1016/j.cpan.2024.12.001

RIGHTS & PERMISSIONS

2025 The Author(s). iMeta published by John Wiley & Sons Australia, Ltd on behalf of iMeta Science.